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Abstract 
Crystal Engineering is the design of crystalline material using non-covalent synthesis.  Co-
crystals are multi-component crystals which are constructed from complementary 
intermolecular interactions, they are also known as supramolecular complexes.   Design of 
such materials utilises the synthon approach, this involves the understanding of common 
intermolecular interactions which occur in the crystal packing and is used to design new 
solids with desired physical properties and chemical properties.  Primary amides form 
supramolecular heterosynthons, these synthons represent an opportunity for a design of multi-
component crystals in which one molecule contains a primary amide and a second molecule 
which is complimentary to the primary amide, usually carboxylic acids. The progress with 
regards to the screening process for the determination of co-crystals is evident in the 
literature, In particular, high throughput solution growth methods and solvent drop grinding.   
The comparison of Isonicotinamide and Benzamide as a co-crystal component has been 
presented.  This study was motivated by the observation that the CSD contains 24 
Isonicotinamide and 1 Benzamide co-crystal.  The interaction with carboxylic acids is the 
focus of the work, in particular those which form Isonicotinamide co-crystal are being 
screened with Benzamide. 
Our work utilises a ReactArray Microvate to carry out the low throughput solution growth on 
a matrix of carboxylic acid with Benzamide, this study has been coupled with the Kofler hot 
stage microscope method which visually aids to screen and view co-crystal phase formation.  
Crystallisation screens have resulted in the identification of known co-crystal phases of 
Isonicotinamide and Benzamide, additionally new co-crystal phases have also been identified 
with Fumaric, 3-hydroxybenzoic acid, Mandelic Acid, 4-Nitrobenzoic Acid and Tartaric 
Acid.  Single crystal structures of the Fumaric and 4-Nitrobenzoic acid have been obtained.   
 
In order to develop an understanding of co-crystal formation in Isonicotinamide and 
Benzamide with our supramolecular library, packing landscape analysis is being undertaken 
using both the CSD and crystal structures we have obtained.   This is undertaken as 
collaboration with Dr Andy Parkin and Professor Gilmore (University of Glasgow), we have 
identified that the dSNAP analysis is a way forward for the analysis of how co-crystals 
pack.  The analysis highlighted the subtleties that were present in the packing motifs of the 
Isonicotinamide co-crystals.  In particular the cis and trans orientation of the amide and acid 
carbonyl to each other and the planar and off planar layer assemblies.   All of which are 
required to maximise the hydrogen bond usage of the components comprising the co-crystals. 
 
Further investigations have led to the collaborative project with Syngenta Ltd in the design of 
a co-crystal screen using a high through-put robot, Crissy® -Automation Platform by Zinsser 
Analytical, using an extended screen of 16 acid coformers with Isonicotinamide, Benzamide 
and Nicotinamide the sample have been characterised using a reflectance diffraction method, 
GADDS.  Further analysis of this data involves the use of polySNAP, which has led to 
further collaboration with Professor Gilmore’s group.   
Another method of screening includes thermal microscopy, which involves the Kofler contact 
method.  This procedure is simple and quick to identify new phases, and can be verified with 
DSC thermal analysis ensuring correlation of new phase melting points. 
 
This work also presents an attempt in mapping ternary phase diagrams to understand phase 
behaviour of the three model AI’s with Succinic Acid.    The choice of approach through the 
construction of a phase diagram of a two-component system was undertaken as these phase 
diagrams can give a practical insight for preparing co-crystals.  Previously it has been 
discussed how similar solubility determines the straight forward phase diagram of a 1:1 
mixture where all the regions are well defined, however, components with a less comparable 
solubility tend to map a phase diagram skewed like the one shown in the study by Chiarella et 
al, 2007, thus narrowing the region where co-crystal growth is possible. 
 
Structure determination is the most desirable confirmation method of co-crystal formation, 
although other methods are superior in identifying a new phase, but to grow a crystal requires 
a skill in fine tuning solvent evaporation techniques.  This study has revealed the limitations 
of these simple techniques and attempted to apply low through-put and high through-put 
methods to maximise co-crystal output.  Thermal techniques, Kofler contact and DSC have 
also been studied as screening methods which show positive results as compared to solution 
growth.  It has also been shown that identifying solubility of components is important as the 
differences alter the location and size of the phase regions of where the co-crystal is 
thermodynamically stable.  
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Chapter One: Introduction 
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1.1General Introduction 
Crystal engineering is the design and targeted synthesis of a crystal with specified 
desirable physicochemical properties (these may include electrical, magnetic, optical, 
etc).  The basis of crystal engineering is to employ an understanding of intermolecular 
interactions present in the crystal packing (Desiraju, 2003), to target specific assemblies 
which optimise the desired physicochemical properties.  This is achieved by employing 
molecular building blocks which generate specific assemblies via targeted 
intermolecular interactions to generate the desired functionality within the solid.  The 
selectivity inherent to the building blocks or synthons are molecules or ions which 
interact with one another by exploiting non-covalent interactions.  (Desiraju, 2003)  
Crystal engineering stems from a branch of chemistry known as supramolecular 
chemistry, this is chemistry beyond the molecule.   
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1.2 Crystal Engineering 
Crystal engineering requires a link to be made between molecular structures and the 
occurrence of classes of intermolecular interactions which consistently lead to specific 
crystal packing features.  To highlight this ethos the following definition from the 
literature and work of Gautum Desiraju has led to a clear definition and recognition of 
Crystal Engineering: 
‗...defined as the understanding of intermolecular interaction in the context of crystal 
packing and in the utilisation of such an understanding in the design of new solids with 
desired physical and chemical properties.‘ (Desiraju, 1989) 
Crystal engineering is a branch of supramolecular chemistry (Steed & Atwood, 2006) 
where the ambition is to generate crystal structures from first principals using 
intermolecular non-covalent interactions (Steed & Atwood, 2006, Aakeröy & Beatty, 
2001), and as such is chemistry beyond the molecule.  It is an approach, which employs 
molecular building blocks, which are assembled via intermolecular forces to produce 
functional solid materials.  The building blocks/synthons are molecules or ions which 
interact with one another exploiting non-covalent interactions.  (Desiraju, 1989, Steed & 
Atwood, 2006)  These non-covalent interactions define the self assembly process in 
crystallisation, the behaviour of the molecular components involved, and their tendency 
to associate or isolate themselves, i.e. the chemical selectivity in solution.  (Lehn, 1994) 
The fundamentals of crystal engineering were described in 1962 by Von Hippel as 
‗molecular engineering‘.  Modern crystal engineering can be traced to studies by 
Schmidt, where his studies on light-induced or photochemical reactions of molecules 
complexes in the solid state pioneered this branch of supramolecular chemistry.  
Schmidt for instance reports the targeted photodimerization through specific packing 
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arrangements of Cinnamic acids, the reversible photochromy of the anils of 
salicylaldehyde, fulgides, and tetrachloronaphthoquinone, and all were well established 
by the early 20th century (Corey, 1967).  However, the relationship between the 
photochemistry of organic compounds and the resulting molecular stereochemistry was 
poorly understood.  This problem prompted the use of the term ―crystal engineering‖, 
which was first introduced by Schmidt and co-workers at the Weizmann Institute in 
1964 (Desiraju, 1989, Corey, 1967).   
 
Since Schmidt, modern crystal engineering has developed quickly with the arrival of 
modern crystallographic techniques such as the use of four-circle diffractometers and 
charged-coupled device (CCD) instruments.  As a result, modern crystal engineering 
has expanded to study intermolecular forces in the solid state, as well as structure 
prediction, control and rationalisation.  In addition, it incorporates the synthesis of 
crystalline materials and novel molecular building blocks for applications in the 
pharmaceutical and petrochemical industries.  Crystal engineering as it is practised now 
can be broken down in the components of analysis and synthesis (Steed & Atwood, 
2006). 
 
This concept of analysis and synthesis has been ascribed by Dario Braga as a ‗bottom-
up‘ approach involving supramolecular entity from the convolution of physical and 
chemical properties of the individual building blocks with the periodicity of symmetry 
operators of the crystals (Braga, 2002, Braga, et al 2002, Vishweshwar, 2006). 
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1.3 Intermolecular Interactions 
Intermolecular bonding describes the intermolecular forces between stable molecules or 
between functional groups.  Most intermolecular interactions are electrostatic in nature, 
and can be classified according to their distance dependency and directionality for 
crystal engineering purposes (Desiraju, 1995, 2003).  These intermolecular forces 
comprise hydrogen bonds and van der Waals forces (dipole-dipole, dipole-induced 
dipole, induced dipole-induced dipole, and π···π interactions). 
 
Van der Waals interactions are medium range forces, these are isotropic in character and 
define molecular shape, size, and they contribute to the overall crystal stability, 
providing a driving force for close packing of the molecules.  Longer range forces such 
as hydrogen bonds are much more highly directional than van der Waals forces and also 
exhibit some covalent character.  Very long range ionic forces exert very specific 
controls and constraints on crystal structure (Desiraju, 1995, 2003). 
1.3.1 Hydrogen Bonding 
Hydrogen bonding is an important concept in supramolecular chemistry and molecular 
biology (Jeffery, 1997).   
The concept has stemmed from the hydrogen bond chapter in Pauling‘s (1940 2nd edt) 
Nature of the Chemical Bond. 
‗...Under certain conditions an atom of hydrogen is attracted by rather strong forces to 
two atoms, instead of only one, so that it may be considered to be acting as a bond 
between them.  This is called the hydrogen bond.‘   
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He also has stated ‗...the hydrogen atom with one stable orbital (1s orbital) can only 
form one covalent bond, and that the hydrogen bond is largely ionic in character and is 
formed only between the most electronegative atoms..‘ (Pauling, 1940)   
Research shows that hydrogen bonding is frequently encountered and the most 
important interaction in crystals.  The frequency with which the elements nitrogen and 
oxygen occur in organic compounds, coupled with the strength and directionality of the 
hydrogen bond as compared to other forces account for its significance (Desiraju, 1989).  
Hence, the hydrogen bond possesses the most reliable directional dependence, and can 
be considered as the ―master key‘‘ for molecular recognition (Desiraju, 1995, Steed & 
Atwood, 2005).  
 
Hydrogen bonding has been defined as a donor acceptor interaction specifically 
involving hydrogen atoms.  Hydrogen bonds may be simple, with one donor and one 
acceptor, bifurcated (three-centre), or trifurcated (four centred) (Aakeröy, 1993).   
 
 
The simplest and most common arrangement shows a donor and acceptor interaction 
can be defined as D−H···A where D and A are atoms that have electro negativities 
higher than hydrogen, these are presented in the table 1.1 below. 
Table 1.1: Typical hydrogen bond donors and acceptors commonly seen in the literature in 
multicomponent systems such as co-crystals.   
Donors Acceptors 
C      H C      C, C      C, arenes 
N      H N, O 
P      H P 
O      H O, N 
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S      H S 
F      H F 
Cl      H Cl 
Br      H Br 
I      H I 
 
The hydrogen bond is mainly electrostatic in nature, where the hydrogen atom has a 
partial positive charge, δ+, while the more electronegative atoms each have a partial 
negative charge, δ-, Figure 1.1   
Figure 1.1:  Partial positive and negative charges associated with the hydrogen atom (H), the donor 
atom (D), and the acceptor atom (A) in a hydrogen bond. 
 
D    H          A 
The bond is formed when the electronegativity of the donor atom, D, relative to the 
hydrogen in the covalent D      H is such that the effect is the removal of electrons from 
the hydrogen atom leaving it with a partial positive charge (partially unshielded).  The 
hydrogen bond acceptor, A, must have a lone pair electrons or polarisable π electrons to 
interact with the D    H bond, typically H (*) to A(n) orbital interactions are involved.  
The strength of hydrogen bonds lie between covalent bonds (200 - 400 kJ mol
-1 
) and 
weak Van der Waals interactions (≤ 5 kJ mol-1), depending on the electro negativity of 
the donor and acceptor atoms participating in the interaction.  Hydrogen bonds can be 
classified as strong, moderate or weak hydrogen bond interactions (Aakeröy, 1993, 
Jeffery, 1997) discussed further in section 1.3.1.1. 
In order for an interaction to be considered a hydrogen bond, certain geometric criteria 
need to be met.  The characteristic hydrogen bond geometry D      H     A     X, is given 
δ-          δ+        δ- 
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by the covalent bond length D     H, the H     A hydrogen bond length, and the D  to  A 
separation distance.  These three quantities define the hydrogen bond angle θ, this angle 
is useful in determining whether or not a certain interaction is a hydrogen bond as is the 
H    A    X angle and the planarity of the DHAX system are valuable indicators, 
particularly for strong hydrogen bonds (Desiraju, 1995).   
 
Figure 1.2: Hydrogen bonds have an angular dependence, θ and φ. 
 
 
The net effect in the system D      H     A is to weaken the D      H bond compared to the 
same bond being in an isolated system.  Therefore, hydrogen bonding can be observed 
by a wide range of spectroscopic analysis, i.e. vibrational shift of the bonds in IR and 
Raman spectroscopy, NMR observes the chemical shift caused by the change in the 
electronic environment around the proton, and characteristic bond lengths and angles 
associated with the hydrogen bonding by X-ray diffraction (Jeffery, 1997). 
1.3.1.1 Strong, Medium and Weak Hydrogen Bonding 
As mentioned earlier, hydrogen bonding can be classified as (i) strong, (ii) medium and 
(iii) weak hydrogen bonds.  The classification of hydrogen bonds varies according to 
authors, Jeffery (1997) describes as:     
 
(i) Strong hydrogen bonds are formed by groups in which there is a deficiency of 
electron density in the donor group, i.e.,     O    H,    N     H, or an excess of electron 
density in the acceptor group, i.e., F   , O    H, O     C, O     P, N   or involve D-A pairs 
as ionic bonds.  This is typically expected as a deficiency of electron of the donors 
+ + 
_ _ 
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group further de-shields the proton and increases the positive charge, while an electron 
excess on the acceptor group increases its negative charge and the interaction with the 
de-shielded proton, these are sometimes referred to as ionic hydrogen bonds.  Hydrogen 
bond can also be forced; this is when configuration and conformation of the molecule 
forces the neutral donor and acceptor groups into a closer hydrogen bond contact than 
normal hydrogen bonding contact.   
 
 (ii) Moderate hydrogen bonds are generally formed by neutral donor and acceptor 
groups, i.e.,   O   H,   N  H,    N(H)     H, and O     , O   C, N    , whereby the donor 
atoms are electronegative relative to hydrogen and the acceptor atoms have lone pair 
unshared electrons.  This type of bonding is regarded as normal hydrogen bonds with 
the other two categories being the minority exceptions.  Moderate bonds are the most 
common hydrogen bonds in chemistry and nature, they are important and essential 
components of the structure and function of biological molecules.   
 
(iii) Weak hydrogen bonds are formed when the hydrogen atom is covalently bonded to 
a slightly more elector-neutral atom relative to hydrogen, for example, C    H or Si    H, 
or when the acceptor group has no lone pairs but has π electrons, as in C   C or an 
aromatic ring.  Table 1.2 describes the properties of these three categories. 
Table 1.2: Properties of strong, moderate and weak hydrogen bonds (Jeffery, 1997 where A-H···B 
is replaced by D-H···A) 
 Strong Moderate Weak 
D-H···A interaction Mainly covalent Mainly electrostatic Electrostatic 
Bond energy 
(kjmol
-1
) 
60-120 16-60 12 
Bond lengths (Å) 
H···D 
A···D 
 
~1.2-1.5 
2.2-2.5 
 
~1.5-2.2 
2.5-3.2 
 
~2.2-3.2 
3.2-4.0 
Bond angles (°) 175-180 130-180 90-150 
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Relative IR 
vibration shift 
(symmetrical 
stretching mode, 
cm
-1
) 
25% 10-25% <10% 
1
H NMR chemical 
shift downfield 
(ppm) 
14-22 <14 ----- 
Examples Gas phase dimers 
with strong 
acids/bases 
Proton sponges 
HF complexes 
Acids 
Alcohols 
Phenols 
Hydrates 
Biological 
molecules 
Gas phase dimers 
with weak 
acids/bases 
Minor components 
of 3- centre bonds 
C-H hydrogen 
bonds 
O-H π hydrogen 
bonds 
 
The strength of hydrogen bonds is governed by the electronegativities of both the donor 
and acceptor atoms participating in the interaction.  For example, the energies for 
O−H···O and N−H···O hydrogen bonds, range from 20 to 40 kJ mol-1 (Desiraju 1995).  
Generally, when the donor and acceptor atoms are neutral, hydrogen-bond strength 
corresponds to energies between 20 - 65 kJ mol
-1 
(Steiner, 2002).  This range is typical 
of medium strength hydrogen bonds, while for weaker hydrogen bonds such as 
C−H···O interactions the energies are between 2 - 20 kJ mol-1(Desiraju, 1995).  When 
the donor and acceptor atoms in a hydrogen bond are ionic (i.e. as a result of proton 
transfer), hydrogen-bond strength can increase to 40 - 190 kJ mol
-1
, and is thus defined 
as a strong hydrogen bond.  Covalent bonds are usually stronger than hydrogen bonds, 
with energies between 100 - 400 kJ mol
-1
, although the strongest of hydrogen bonds can 
be greater than the weakest of covalent bonds (Steiner, 2002).  
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1.4 Introduction to Co-crystals 
The broad scope of crystal engineering and design ethos will now be outlined.  In order 
to understand the activity of crystal engineering as applied to co-crystallisation, the 
fundamentals of the crystalline state need to be summarised.  In particular, this section 
reviews the definition of a crystal in the solid state and what constitutes as a co-crystal.   
 
1.4.1 What is a Crystal? 
The key concept of crystal engineering is the deliberate construction of crystalline 
materials from molecules or ions using selected non-covalent interactions.  As 
mentioned in previous sections, the goal in this area is to synthesize functional 
materials, which have specific tuneable properties (Aakeröy, 2001).   
There are two classes of solid, (i) crystalline and (ii) amorphous, both of which differ 
from one another in how the constituent molecules are arranged.  Mullin, defines 
(Mullin, 2004) crystals in his book as „…a regular arrangement of constituent 
molecules, atoms or ions, into a fixed and regular repeating pattern known as a 
lattice..‟ 
Hence, crystals are solids that have a regular arrangement, leading to a fixed geometry 
or lattice, e.g.  diamonds, whereas amorphous solids have a more random arrangement 
e.g.  glass (Mullin, 2004) with local but no long range order.   
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1.4.2 What is a Co-crystal? 
The term ‗Co-crystal‘ was thought to have been introduced by Etter and Panunto in 
1988 (Etter & Panunto, 1988), however, a definition of the term is again of debate and 
is discussed by Desiraju in his 2003 paper (Desiraju, 2003) and Dunitz answer to 
Desiraju‘s paper (Duntz, 2003).  Aakeröy, in his 2005 paper „…building co-crystals 
with molecular sense and supramolecular sensibility…‟ (Aakeröy, 2005), suggests that 
co-crystals are „…made from reactants that are solids at ambient temperature and that 
a co-crystal is structurally homogeneous crystalline material that contains two or more 
neutral building blocks…‟ (Aakeröy, 2005).  The definition which clarifies the basis of 
what a co-crystal is that „…A co-crystal is multi-component crystal in which two or 
more molecules that are solid at ambient conditions and are constructed from 
complementary intermolecular interactions (hydrogen bond)…‟ (Almarsson & 
Zaworotko, 2004, (Aakeröy, 2005).  In the broadest sense Co-crystals may also include 
molecular complexes, solvates, inclusion compounds and many other multi-component 
crystal systems (Almarsson & Zaworotko, 2004).  More recently co-crystals may be 
referred to as supramolecular complexes (Almarsson & Zaworotko, 2004).   
There is still considerable debate on whether to include solvates in the set of co-crystals.  
Morrisette et al.  (2004) claim that co-crystals (of drugs and drug candidates) are part of 
the broader family of multi-component crystal systems that includes salts, solvates, 
clatherates, inclusion crystals and hydrates, and that the primary difference between 
solvates and co-crystals is the physical state of the single components.  If at room 
temperature one component is liquid, then the crystals are designated solvates, however 
if both components are solids at room temp then the crystals are designated co-crystals.  
Solvate are commonplace as they often occur as a serendipitous result of crystallisation 
from solution (Almarsson & Zaworotko, 2004), these may be unstable as dehydration / 
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desolvation may be observed; depending on storage conditions.  Solvent loss may lead 
to an amorphous phase which are usually less chemically stable and can crystallise into 
less soluble forms.  Co-crystals can be rationally designed to achieve the stable phase 
because they are unlikely to separate from solid dosage forms, especially when the co-
crystallising agents are solid at room temperature (Almarsson & Zaworotko, 2004).   
 
1.4.2.1 Co-crystals: Commercial value and beneficial use in industry in the context 
of active pharmaceutical ingredient, (API). 
We have discussed that crystal engineering is the design of crystalline materials, and 
that these materials can be fine tuned to produce desirable physical properties e.g. 
solubility, crystal morphology, mechanical stability etc whilst retaining its biophysical 
or molecular activity is of great interest to industry.  The classical method used in 
industry to improve the solubility and the bioavailability involves the pharmacologically 
active molecule to be processed as solvates (hydrates) or to convert an API into one of 
its salts; typically either chloride or nitrate salt (Aakeröy, 2003).  Although these routes 
can lead to materials that eventually become commercially viable, there is a potential 
chance of potentially useful drugs that may never reach this point due to stringent 
requirements of processing, storage or bioavailability.   
 
Co-crystallisation is becoming a steadfast approach to modifying an API‘s properties, 
and the increased interest in this subset of solid state crystal engineering has arisen, as 
the approach is able to simultaneously address a mode of crystal form which is able to 
utilise multiple functional groups present in a single active pharmaceutical ingredient.  
Consequently, pharmaceutical co-crystals are an attractive alternative to polymorphs, 
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salts and solvates a route to the modification of an active pharmaceutical ingredient 
(API) during dosage form.  If a crystalline material contains both a pharmaceutically 
relevant molecule and a structure-directing (but biologically/environmentally passive) 
component which can be rationally assembled through intermolecular synthesis, then 
the inherent activity of the drug molecule remains intact while the physical properties of 
the bulk material are modified (Aakeröy, 2003).   
 
Co-crystal formers which are suitable for pharmaceutical applications remain to be 
enumerated fully, however, there are over a hundred solid materials which have 
―Generally Regarded As Safe‖ (―GRAS‖) status, this includes food additives and other 
accepted substances.  It may also be considered to make use of sub therapeutic amounts 
of eminently safe drug substances. 
Carbamazepine (CBZ) is well studied API for co-crystallisation.  Oral administration of 
CBZ holds challenges such as low water solubility with high dosage requirement for 
therapeutic effect, dissolution limited bioavailability and auto induction for metabolism.  
It has complex crystal forms which have been identified as four anhydrous polymorphs, 
a dehydrate, an acetone solvate, and two ammonium salts.  These are all self-
complementary.  Carbamazepine is therefore, ideal to demonstrate how APIs can be 
converted to pharmaceutical co-crystals and how they optimise physicochemical 
properties over existing forms.  A study of CBZ : Saccharin co-crystal appears to be 
superior to the existing crystal forms of CBZ in terms of stability relative to the 
anhydrous polymorph of CBZ, it posses more favourable dissolution and suspension 
stability and favourable oral absorption profile in dogs (Hickey, 2007, Shan
 
& 
Zaworotko, 2007). 
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The dissolution study of Itraconazole-dicarboxylic acid co-crystals compared the pure 
crystalline and amorphous drug.  The co-crystals were found to have better solubility 
and bioavailability as compared to the pure crystalline drug (Remenar et, al, 2003).  
Thus, the space of pharmaceutical co-crystals would therefore be on a much larger scale 
with thousands of possibilities for any given drug when at least two synthons are 
present in the API.  A combinatorial approach such as high-throughput crystallisation is 
the most probable way to screen such volumes, however, this could be time consuming 
and expensive in industry and therefore the challenge for researches in both industry 
and academia lies with identifying those combinations without carrying out endless 
crystallisation experiments.   
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1.5 Design Strategies of Co-crystallisation 
Crystal engineering has matured into a paradigm for the preparation of new crystalline 
materials.  The initial approach prior to experimental work involves systematic searches 
using the Cambridge structural database (CSD) to gain a detailed understanding of the 
supramolecular chemistry of the functional groups present in a given molecule.  This is 
a precondition for designing co-crystals, and this process aids the selection of 
appropriate co-crystal formers (Desiraju, 1995).  Many authors (Aakeröy, 2005, Braga 
2005, Fleishman 2003), have highlighted the hierarchical approach using 
supramolecular synthons that are present for a range of functional groups in order to 
design and build new co-crystals.   
1.5.1 Hydrogen bond rules 
It is useful to have a set of guidelines when predicting hydrogen bond patterns in the 
solid state.  Systematic searching of the CSD to identify preferential hydrogen-bond 
patterns in organic crystals and co-crystals was initiated by Etter, (Etter, 1991), and has 
led to the formulation of three rules for hydrogen bond utilisation.  (Etter, 1991, 
Aakeroy, 2001, Donohue, 1952)  The first rule was developed by work done by 
Donohue in 1952: „…all acidic hydrogen available in a molecule will be used in 
hydrogen bonding in the crystal structure of that compound…‟ (Donohue, 1952).  The 
second and third rules were formulated by Etter‘s studies on organic co-crystals: ‗…all 
good acceptors will be used in hydrogen bonding when there are available hydrogen-
bond donors, and the best hydrogen-bond donor and the best hydrogen-bond acceptor 
will preferentially form hydrogen bonds to one another…‘ (Etter, 1990,1991).   
In short : 
1) All good proton donors and acceptors are used in hydrogen bonding 
17 
 
2) Six-membered ring intramolecular hydrogen bonds form in preference to 
intermolecular hydrogen bonds 
3) The best proton donor and acceptor remaining after intramolecular hydrogen 
bond formation will form intermolecular hydrogen bonds to one another (but all 
acceptors may not necessarily interact with donors). 
 
These rules are based upon energetically favourable types of hydrogen-bond patterns, 
geometries and functional groups.  With the knowledge of known hydrogen bond 
lengths crystal engineers are able to apply these rules and predict hydrogen bond motifs. 
 
1.5.2 Synthon approach 
Design of such materials utilises the synthon approach that involves the understanding 
of common intermolecular interactions, which occur in the crystal packing and using 
this to design new solids with desired physical properties and chemical properties.  The 
term ―synthon‖ was first introduced by Corey in 1967 (Corey, 1967) in his article 
‗General Methods for the Construction of Complex Molecules‘.  The molecular 
synthons possess complementary functional groups of a molecule, which can engage in 
molecular association (Desiraju, 1995, 2003, Vishweshwar, 2006).  Desiraju in 1995 
(Desiraju, 1995) defined these supramolecular synthons as „…structural units within 
supermolecules which can be formed and/or assembled by known or conceivable 
synthetic operations involving intermolecular interactions…‟.  The synthons are spatial 
arrangements of intermolecular interaction, a desirable attribute of a supramolecular 
synthon is the property of robustness.  Identification of robust synthons greatly 
facilitates the synthetic aspects of crystal engineering (Desiraju, 2003).   
The relationship between functional groups in molecules and derived supramolecular 
synthon is illustrated in Scheme 1.1 (Desiraju, 2003).   
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1         2           3           4 
Scheme 1.1: Common motifs observed in Crystal Engineering, Type 1 & 3 show a dimer, Type 2 & 
4 show a catemer.  Adapted from Supramolecular Synthons in Crystal Engineering-A New Organic 
Synthesis (Desiraju, 1995)   
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Generally, carboxylic acids and amides contain functional groups are self-
complementary and thus are capable of forming supramolecular homosynthons.   
Scheme 1.1 presents the most common hydrogen bonding of the conventional OH···N 
and NH···O variety (Desiraju, 1995), the hydrogen bonds have identical 
centrosymmetrically related hydrogen bonds.  Clearly two different types of synthons 
are being formed, type 1 carboxylic acid dimer and 3 shows carboxamide dimer, 
whereas type 2 and 4 show catemer.   
 
Scheme 1.1 and 1.2 show how the carboxylic acid and amide groups are self-
complementary and capable in forming homo synthons (type 1, 3 from scheme 1.1 and 
Scheme 1.2a).  It is observed that acid and amide homodimers can be formed a two-
point donor-acceptor molecular recognition path, this is shows in Scheme 1.2a.  There is 
also possible interaction with functional groups that are different but complementary, 
Scheme 1.2b shows that carboxylic acids and amides are complementary to each other 
and can interact to form a supramolecular heterosynthon (Etter, 1991, Almarsson, 
2004).   
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Scheme 1.2: The formation of supramolecular synthons between acids and amides: a) 
Supramolecular homosynthons exhibited by acid-acid and amide-amide dimers; b) Supramolecular 
heterosynthon exhibited by acid-amide dimers (Almarsson & Zaworotko, 2004).   
 
 
Figure 1.3 presents benzoic acid, a classic example to illustrate hierarchical self 
organisation of the carboxylic dimer (Desiraju, 2003). 
Figure 1.3:  Self assembly of a crystal structure, showing the functional group involved in the 
synthon.,(Adapted from Desiraju, 2003) 
 
 
 
 
 
 
 
 
These highlighted synthons are typical examples of a library of synthons that can be 
employed in crystal engineering to construct / predict zero, one-, two- and three-
dimensional supramolecular networks.   
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1.5.2.1 Zero-dimensional structures 
The benzoic acid dimer is zero dimensional structure, the simplest level of 
supramolecular architecture.  Figure 1.4 (a) (Desiraju, 1995).   
Figure 1.4:  Zero-dimensional structures in the (a) benzoic acid dimer and (b) benzoic 
acid···pyridine hetero system. 
 
 
Hetero synthons such as carboxylic acid···pyridine are also involved in zero 
dimensional structures, this is shown in the benzoic acid···pyridine hetero system, 
Figure 1.4 (b). 
 
1.5.2.2 One-dimensional architectures 
Extending from zero-dimensional structures into infinite one-dimensional chains, 
ribbons, and ladders requires at least two recognition sites are required by the molecule 
for the extension to increased dimensionality to be accomplished.  Critical is the angle 
between the recognition sites decides the shape of the one-dimensional chains.  This can 
be seen in the example of terephathalic acid, where there are two carboxylic acid 
moieties separated by 180° with respect to each other, and a linear chain is formed of 
these molecules, Figure 1.5.( Desiraju 1995). 
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Figure 1.5: An infinite, linear chain formed upon the assembly of terephthalic acid molecules via a 
homomeric acid synthon. 
 
An infinite one-dimensional chain is also formed by isophthalic acid; though the angle 
between the two carboxylic acid groups is 120°, the consequential chain adopts a zigzag 
pattern or a crinkled ribbon Figure 1.6.(Desiraju 1995) 
Figure 1.6: An infinite zigzag chain formed by the assembly of isophthalic acid molecules via a 
homomeric acid synthon.. 
 
 
1.5.2.3 Two-dimensional sheets 
When molecules possess at least one more recognition site, a two-dimensional 
architecture develops, hence a one-dimensional system interlinks and expands into a 
two-dimensional entity (Desiraju 1995).  For example, trimesic acid contains one more 
carboxylic acid moiety than isophthalic acid, upon extension the cross-linking of chains 
formed by isophthalic acid fragments yields an infinite two-dimensional honeycomb 
sheet, Figure 1.7. 
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Figure 1.7: An infinite two-dimensional honeycomb sheet formed from the assembly of trimesic 
acid molecules. 
 
1.5.2.4 Three-dimensional architectures 
The most primitive of supramolecular systems are the three-dimensional architectures 
when it comes to crystal engineering since they require extensions of building blocks in 
all three spatial coordinates and create open ended architectures, with void or channel 
features   
Infinite three-dimensional architectures can also be composed from organic building 
blocks via hydrogen bonding (Desiraju 1995, Aakeröy, 1994).  A three-dimensional 
diamondoid structure is formed in the crystal structure of adamantane-1, 3, 5, 7-
tetracarboxylic acid, where carboxylic acid moieties are arranged tetrahedrally about the 
adamantyl center, Figure 1.8 (Desiraju, 1995). 
Figure 1.8: Three-dimensional diamondoid framework 
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1.5.3 Graph set notation: Hydrogen bonding networks 
Etter reports that graph set were first employed by Kuleshova and Zorkii (Etter, 1990-
1991) on organic crystal structures.  Etter presents a description of how hydrogen bond 
motifs can be described by assigning a graph set notation to the motif.  Figure 8 
highlights the basic motifs observed in a range of molecular solids.  Motifs are 
described by the nature of the hydrogen bond, i.e.  hydrogen donor or acceptor, in the 
hydrogen-bonded molecules of interest.  These hydrogen bonds configure to form 
dimers and chains.  The molecules that are hydrogen bonded together by repetition are 
then designated by descriptors, which describe whether the motif is infinite or finite and 
whether it is cyclic or not.  The designators are C (chain), D (dimer or other finite set) R 
(rings) and S (intramolecular hydrogen bond).  The numbers of donors (d) in each motif 
are assigned subscript whereas acceptors (a) are assigned superscripts.  The size of the 
motif corresponds to the number of atoms in the repeat unit (n) (Etter, 1990).  
Figure 1.9: Graph set Notation showing the common examples where intermolecular interaction 
may occur in a multicomponent system; I: shows a head to tail chain formation via the  - - - H----N-
--C==O- - - where there is one donor atom and one acceptor atom and four atoms in the unit,   II: 
shows the common homo synthon exhibited by amide and carboxylic acids dimers, III: shows the 
typical discrete hydrogen bonding, IV: less commonly seen self intramolecular hydrogen bond 
between an C==O- - -H----O.      
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1.5.4 Phase Equilibria 
Phase equilibria is one of the foundations of crystal engineering, as it defines the 
thermodynamic picture of phase formation.  This section will discuss a few basic 
definitions and examine the phase rule and how understanding of the phase transitions 
and the nature of crystalline material under a given set of conditions is important with 
respect to solubility and phase diagrams. 
   
1.5.4.1 Phase Rule 
A phase is defined to be the homogeneous portion of a system (Mullin, 2004), which is 
physically distinct, and mechanically separable (Davey &Garside, 2000), these would 
be gases, pure liquids (melts), solids and solutions.  Therefore a heterogeneous system 
comprises of two or more phases, e.g. gases or vapours are one-phase systems as are 
mixtures of two or more completely miscible liquids or solids, but mixtures which 
consist of two partially miscible liquids or a heterogeneous mixture of two solids are 
two-phase systems. 
Equilibrium is a state of rest of a system, where at constant temperature T, pressure P, 
and composition x, the phases remain constant for infinite time.  A change in any of 
these will alter the equilibrium state.  It is important to understand that every system has 
a number of degrees of freedom, which is the number of variables that can be changed 
without altering the number of phases present (Mullin, 2004).  In 1876, J. Willard 
Gibbs, introduced the phase rule which explains this relationship of number of 
components, phases and degrees of freedom of a system by means of the equation  
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Equation 1.5 the phase rule 
P + F = C + 2      (Eq.1.5) 
Where:  
P is the number of phases in the system.  Phase is homogeneous, physically distinct and 
mechanically separable component of a mixture. 
C is the minimum number of chemical components required to compromise all the 
phases in the system 
F is the number of degrees of freedom in a system.  The number of variables (e.g. 
pressure composition and temperature) that are independently changed without affecting 
the number of phases 
Phase diagrams can be used map out the behaviour and relation between T, P and x, 
along with the crystal structure of solid phases.  The data generated, graphically map out 
the equilibria between phases of a system in two or three dimensions (Mullin, 2004, 
Davey & Garside, 2000). 
1.5.4.2 Phase diagrams 
Here we will focus on two types of phase diagrams, the binary phase diagram and 
ternary phase diagrams.   
1.5.4.2.1 Binary systems and Eutectics 
The three variables that affect the phase equilibria of a binary system are temperature, 
pressure and concentration.  The behaviour of this type of system can be represented by 
a space model of three mutually perpendicular axes of pressure, temperature and 
concentration or three diagrams with pressure-temperature, pressure-concentration and 
temperature-concentration axes.  However, in the case of crystallisation process the 
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focus is on the liquid and solid phases of a system.  Therefore,  phase diagrams are 
constructed using a temperature - concentration profile to map phase stability zones.  
Co-crystal phase formation and eutectic behaviour are identifiable from a two-
component mixture, A and B, by measuring either their melt temperatures or just the 
temperatures at which B just dissolves or at which A crystallises.  Diagram 1.1 depicts a 
typical single eutectic diagram for component A and B.   
Diagram 1.1:  Simple eutectic phase diagram for a two component system.  Highlighting the 
liquidus line and the point at which when a eutectic is reached upon temperature increase.  Also 
highlighting the melt zones, solid zones.   
                
                    
 
 
 
 
 
 
Lines ACB is referred to as the liquidus line, it gives the equilibrium composition of the 
liquid phase.  The point where the line intersects, point C, is the eutectic point.  Line BC 
correspond to the solution of B and AC corresponds to the solutions of A and B, along 
this line pure A is in equilibrium with A/B liquid, whilst at point C solid A, B and liquid 
composition C and vapour are at equilibrium.  Therefore, at point C there are no degrees 
of freedom and thus, the eutectic temperature and concentration are fixed.  In a three 
component system the eutectic temperature varies with composition.   
Liquid/ Melt 
A + Liquid/Melt 
B + Liquid/Melt 
Crystals A+B 
C 
D 
B 
A 
E 
100% A                            Composition                                100% B 
Temperature 
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1.5.4.2.2 Ternary systems 
For a co-crystal in equilibrium with solvent, the phase diagram required is that of a 
ternary system consists of three components and can be presented as an equilateral 
triangle.  Each apex represents the pure components A, B and C.  The points on the side 
of the triangle stand for the binary system, AB, BC or AC; points within a system 
represent a ternary system ABC.   
Figure 1.10: A schematic of a typical ternary phase diagram where each apex/axis highlights either 
solid phases or liquid phase.   
 
1.5.4.2.3 Phase diagrams in Co-crystal systems 
The route to co-crystal growth is solvent evaporation, phase diagrams can be used to 
locate the co-crystal zone in the phase diagram.  A typical phase diagram expected from 
a 1:1 mixture is shown in Figure 1.11a,  where components have similar solubility, the 
region are well defined and it is easy to locate the co-crystal region.  Figure 1.11 b 
shows a much different picture, components which have dissimilar solubility produce a 
more skewed phase diagram, and the region where a co-crystal maybe located is 
reduced to a much narrower region.   
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Figure 1.11: Typical Phase diagram where a) solubility of component 1 and 2 are similar, b) 
difference in solubility in system b causing a skew in the plot 
 
 
 
A worked example, (Chiarella, 2007), presents trans-Cinnamic and Nicotinamide 
system.  They employed a solubility test and found that trans-Cinnamic acid and 
Nicotinamide have similar solubility in Nicotinamide, however in water Nicotinamide is 
much more soluble.  The phase diagrams produced show that in a 1:1 mixture of the two 
components in methanol yield co-crystals Figure 1.12, and the water systems is much 
more skewed toward the Nicotinamide therefore a co-crystal may not be formed from 
the 1:1 mixture from water Figure 1.13.   
  
a b 
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Figure 1.12: Ternary phase diagram of methanol, Cinnamic acid and Nicotinamide (Chiarella, 
2007)   
 
Figure 1.13: Ternary phase diagram of water, Cinnamic acid and Nicotinamide (Chiarella, 2007) 
 
 
 
Phase diagrams highlight subtle difference in solubilities between target compounds and 
the co-crystallising agent, and the effect this has on the location of the co-crystal.   
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1.6 Crystal Growth and Nucleation 
Crystallisation is a supramolecular process which by definition is a self-assembly 
process where component molecules find and recognise one another in solution and 
form an ordered solid crystalline solid.  For crystallisation to occur, the solution must 
undergo three steps, supersaturation, nucleation and crystal growth (Mullin, 2004, 
Davey & Garside, 2000). 
 
1.6.1 Supersaturation 
Supersaturation refers to a solution which contains a higher concentration of the 
dissolved material (solute) than it would be expected in the same solution at equilibrium 
at a specific temperature.  The degree of supersaturation is the primary driving force for 
the crystallisation process (Davey & Garside, 2000). 
Figure 1.14 represents a hypothetical solubility curve, the blue curve is the solubility 
curve, the composition of a solution below this curve is undersaturated and existing 
crystals will be dissolved.  The region above this solubility curve is supersaturated.  The 
red line illustrates the composition of a solution above which spontaneous 
crystallisation occurs.  The space between the two curves is the metastable zone; here 
crystallisation is not probable, but maybe induced by seeding (Mullin, 2004). 
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Concentration 
Figure 1.14: Diagram showing the solubility-supersolubiltiy diagram, the favourable metastable 
zone where crystallisation is prominent is highlighted to be between the red and blue lines.   
 
 
 
1.6.2 Nucleation 
Creating new crystalline solid phases from a supersaturated solution is central to all 
types of crystallisation; however, supersaturation alone is not sufficient to initialise 
crystal growth.  Before crystals can develop the solution must have building blocks, 
nuclei or seeds that act as central crystallisation sites.  Nucleation may occur 
spontaneously or it may be induced artificially by a variety of methods such as 
mechanical shock, ultrasound, UV light and magnetic fields.  Nucleation has been 
subdivided into primary and secondary nucleation.  Primary is when a nucleus 
spontaneously forms, and secondary when a solution is seeded, these can either occur as 
heterogeneous or homogeneous processes (Figure 1.15)   
labile 
metastable 
undersaturated 
Temperature 
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Figure 1.15: Subdivisions of nucleation routes primary and secondary (Mullin, 2004) 
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1.7 Co-crystal preparation methods 
There are a number of procedures which can be used for co-crystal synthesis.  Co-
crystals are usually prepared by slow evaporation or solutions containing stoichiometric 
mole ratios of two or more components.  They can also be prepared using the grinding 
method where two components are ground together, a co-crystal phase is formed from 
the ground mixture (Etter, 1991).  Examples of acid-amide co-crystals i) Hex-2-enoic 
Acid: Isonicotinamide.  (Aakeroy, 2003), ii) Piracetam and Gentistic acid 
(Vishweshwar, 2005). 
Figure 1.16: Packing arrangements of i) Hex-2-enoic Acid: Isonicotinamide ii) Piracetam and 
Gentistic acid 
 
 
 
Figures 16(i) and 16(ii) show co-crystals with the anticipated hydrogen bond patterns of 
the acid to amide dimer, Figure 1.16(ii) and amide-to-amide dimer Figure 1.16(i).  The 
hex-2-enoic acid: Isonicotinamide co-crystal also exhibits a pyridine and carboxylic 
acid moiety.   
i) 
ii) 
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Solvent drop grinding has led to increased interest of solid-state grinding as a method 
which may help to control (Shan et al, 2002, Trask, 2004 a, b, c, d) polymorphs and also 
enhance kinetics and co-crystal formation.  Additionally to this, sublimation and growth 
from the melt are also suitable methodologies for co-crystal growth.   
 
1.8 Polymorphism and Polymorphism in Co-crystals 
McCrone defined polymorphism as ―…a solid crystalline phase of a given compound 
resulting from the possibility of at least two different arrangements of the molecules of 
that compound in the solid state…‖ (McCrone, 1965).  In the 1999 Joel Bernstein and 
Roger Davey paper, (Bernstein & Davey, 1999) the authors comment on how different 
polymorphs have different structures and therefore each molecule has its own chemical 
and physical properties.  The definition above is appropriate when speaking in the 
context of active pharmaceutical drugs (API‘s).  These are highly functional and 
conformationally flexible molecules,  this situation manifests itself when API‘s 
associate in the form of diverse set of multiple modes of self-organisation or self-
assembly with other molecules.  Hence crystal nucleation and growth is governed by a 
combination of thermodynamic and kinetic factors.  Attaining a desired polymorph is of 
the utmost importance in drugs, agrochemicals, explosives, dyes, pigments flavours and 
confectionary products (Vishweshwar, 2006).  
Awareness of polymorphs has grown, there has been a huge increase in the effort by 
crystal engineers to understand the phenomenon and to gain control over crystallisation 
process in order to selectively obtain a desired polymorph or suppress the growth of an 
undesired one.  (Vishweshwar, 2006, Bernstein & Davey, 1999)  It is important for 
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pharmaceuticals in the context of intellectual property (IP) rights to make sure that that 
they have control over polymorphism in the development and marketing of drugs.   
The Cambridge Structural Database is helpful in the study of polymorphism, both in 
crystals and co-crystals.  An analysis on polymorphism using the CSD is presented in 
„Pharmaceutical Co-crystals- Review‟ by Vishwesherwar et, al 2005 (Vishweshwar, 
2005).  The results are presented in Table 1.3.   
Table 1.3:  CSD search statistics shown (Aug’05 update) for all polymorphic systems.  
(Vishweshwar, 2006) 
 No.  Of entries in 
CSD 
% Of organic 
structures 
Organic crystal structures 130448 100
c
 
Single component molecular organic 
structures 
9621 7.3
c
 
Single component polymorphic 
structures 
94900 72.7
c
 
Hydrates 1600
a
 1.7
d
 
Co-crystals 1487
b
 1.1
e
 
Polymorphic co-crystals 21
a
 1.5
d
 
The CSD searches were conducted with only organic crystal structures.  A CSD with ‗only organics‘ as a parameter also retrieves 
structures containing metals like Na, K, Ca etc.  Such entries were excluded from the statistics shown in the table above.   
a 
Only one ref code was counted for each polymorphic compound. 
b
 Co-crystals sustained by strong hydrogen bonds. 
c
 Percentage with respect to organic systems only. 
d
 Percentages with respect to 94, 900 and 1, 487 sub-totals respectively. 
 
From Table 1.3 it is evident that 21 hydrogen-bonded co-crystals were identified in the 
CSD that exhibit polymorphism.  As time progresses and research in this field continues 
we are likely to see an increase in the number of co-crystal reported in the CSD.  The 
CSD supports both the archiving of crystal structures and software to search these 
archives.  The specific features in the CSD relevant to the research in this project are as 
follows.   
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1.9 The Cambridge Structural Database (CSD) 
The Cambridge Crystallographic Data Centre (CCDC) is the centre of the Cambridge 
Structural Database (CSD).  The CCDC manages and maintains the CSD and all other 
components available for structural analysis.  The CSD is an invaluable tool for the 
organisation and statistical analysis of experimental structure data for crystal engineers.  
It was initiated in 1965 by Dame Cathy Lonsdale, with almost 2000 entries initially, 
however today it carries accurate X-ray crystal structures of over a quarter of a million 
compounds (Nangia, 2002).  The article by McMahon, Vishweshwar et al (McMahon, 
2005), illustrates the apparent simplicity in data mining and structural analysis for 
today‘s crystal engineer.  McMahon and colleagues carried out a CSD analysis of 
primary amides.  The results show that Primary amides are very diverse in their ability 
to form hydrogen bonds with the two hydrogen bond donors (NH2) and an acceptor 
(CO).   
Figure 1.17: Extracted from (McMahon et al., 2005) A Histogram of N-H···O hydrogen bond 
lengths in primary amide dimers retrieved from the CSD 
 
 
The histogram above has been extracted from McMahon, it illustrates the N-H···O 
hydrogen bond formation in Primary amide dimers.  The CSD survey carried out also 
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took the formation of heterosynthons into consideration.  Table 1.4 lists key contact data 
for amides, and has been extracted from the paper presented by McMahon, 2005.   
Table 1.4:  Primary amide general acceptor-donor table 
 
The trends in the analysis indicate that there are 80 primary amide structures in which 
competing hydrogen bond donor and/or acceptor groups are absent.  The percentage or 
occurrence for the dimer is seen to be 84% with 14% for catemer.  Focussing on Acid-
Amide interactions, McMahon et al‘s results show that there are 148 crystal structures 
where both the acid and amide moiety is present, 69 of these structures hold the acid-
amide heterosynthon, whereas only 9 hold the acid-amide homosynthon and 65 exhibit 
the amide homosynthon (McMahon, 2005).   
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1.10 Characterisation techniques 
1.10.1 Thermal analysis 
Thermal analysis is the ideal tool to examine the variation of one or more properties of a 
sample with increase of temperature.  It is a powerful tool which provides valuable 
information for chemists on a multitude of thermodynamic events such as melting 
points and crystal phase transitions.   
1.10.1.1 Differential Scanning Calorimetry (DSC) 
The International Confederation for Thermal Analysis (ICTA) nomenclature committee 
has defined DSC to be ―a technique for recording the energy necessary to establish a 
zero temperature difference between a substance and a reference material against either 
time or temperature, as the two specimens are subjected to identical temperature 
regimes in an environment heated or cooled at a controlled rate‘ (Pope & Judd, 1977). 
In some differential scanning calorimeters, separate heat source and temperature 
detecting devices are applied to the sample and reference materials.  Most differential 
scanning calorimeters fall into two categories:  
1. Power compensation: The DSC cell is designed to have the provision of separate 
temperature sensors and heaters for the sample and the reference.  During a 
thermal process, any temperature difference between the sample and reference 
materials will be resigned by differential thermal power supplied to the heaters 
to eliminate the difference.  The differential thermal power is recorded as 
instrument signal, and therefore, this type of calorimeters belongs to ―power-
compensation‖ calorimeter (Wilson & Haines, 2002). 
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2. Heat-flux: Another type of calorimeter is ―heat-flux‖ type where the sample and 
reference materials share the same furnace.  The instrumental signal is derived 
from the temperature difference between the sample and reference whilst 
heating.  Additional software is incorporated in the instrument to convert the 
temperature difference into differential thermal power (Wilson & Haines, 2002). 
DSC is a universal and versatile technique for the characterisation of pharmaceutical 
solids because it gives useful insights on thermal reaction of the sample.  The technique 
can be used to measure the glass transitions, ‗cold‘ crystallisation, phase changes, 
melting points, crystallisation, product stability and the decomposition of the material.  
In addition to this mixture analysis of polymorphs can also be performed as well as 
establishing a relationship between DSC profile and two-component phase diagram, so 
that it may provide some clues of the formation of co-crystal (Pope & Judd, 1977). 
 
1.10.1.2 Thermogravimetric Analysis (TGA) 
TGA is the evaluation and the interpretation of the results from an experimental 
technique called thermogravimetry (TG).  This technique has been defined by the 
International Confederation for Thermal Analysis and Calorimetry (ICTAC), as “a 
technique in which the mass change of a substance is measured as a function of 
temperature whilst the substance is subjected to a controlled temperature programme” 
(Wilson & Haines, 2002). 
 
The instrument consists of several essential components, such as the microbalance, 
furnace, and thermocouples.  Modern microbalance design incorporates an electronic 
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zero detection device, with an electromagnetic system to restore the balance.  This new 
design allows users to reduce the amount of sample loaded from one gram or more to 
10-100 mg, so that a more uniform temperature can be accomplished throughout the 
sample.  The temperatures generated by the furnace are dependent on the type of alloy 
wire or ribbon wound on the ceramic or silica tube in the furnace.  More commercial 
systems can cool samples using liquid nitrogen, they can be programmed to control 
sample temperature from -160°c to 1600°c.  During heating, an inert purge gas such as 
nitrogen or argon is used to prevent air-mediated oxidation or combustion.  To measure 
the temperature of the sample and to maintain a linear heating rate of the furnace, the 
TGA houses two separate sets of thermocouples.  One is used for the measurement of 
sample temperature; this has to be located very close to the sample, usually underneath 
the sample but not quite touching.  The other couple is to measure the furnace 
temperature in order to obtain a steady and linear heating rate (Wilson & Haines, 2002). 
TGA is an ideal technique to determine thermal properties of pharmaceutical solids.  It 
is highly sensitive as it can detect many thermal events such as decomposition, 
sublimation, reduction, desorption, absorption and vaporization, based by weight 
changes in a material as a function of temperature under controlled atmosphere 
(Hatakeyama & Zhenhai, 1998).  In case a solvate crystal is obtained from solvent co-
crystallization.  TG can be used to detect any lose of a volatile component from the 
sample.  Such a reaction can be picked by an allied technique like Differential Scanning 
Calorimetry (DSC). 
 
41 
 
1.10.1.3 Hotstage microscopy, the Kofler approach 
Thermomicroscopy provides a simple and quick screening method which helps 
determine chemical and physical properties of compounds.  The hot stage contact 
method is based on the work carried out by Lehmann, where he developed hot stages to 
elucidate co-crystal formation in 1877 (Davis, 2004).  These mixed fusion methods 
have been further refined by Kofler and Kofler (Davis, 2004).  Kofler and Kofler 
developed the Kofler Hot Stage which allows controlled heating under the microscope.  
A mixed fusion sample is prepared by melting the component with the highest melting 
point (A) first on one edge of a cover slip on a microscope slide, once cooled then the 
other component (B) is melted on another edge of the coverslip.  (Figure 1.18).  The two 
components will meet as component B melt is drawn under the coverslip and mixes 
with the solid of the component A.  The point at which the two components meet is the 
mixing zone.  Both ends of the slide contain 100% of either component where the area 
between forms a concentration gradient.  When the slide is reheated and observed under 
the microscope, any new phase formed can be observed. 
This region is then placed under a microscope and heated on a hot stage, Observations 
of this region are done using cross polarised filters, anisotropic crystals possess certain 
optical properties such as interference or polarisation (McCrone, 1957). 
Figure 1.18: A schematic representation of the regions when preparing a Kofler slide: region A 
represents the highest melting component, region B represents the lowest melting zone and the 
region in-between is the mixing zone where any potential new phases may appear upon heating 
under polarised light.   
 
 
Mixing Zone 
Lowest melting point 
component 
Highest melting 
point component 
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1.10.2 X-ray Powder Diffraction 
In X-ray diffraction the data collected from the scattering of the radiation beam provides 
necessary information on the atomic arrangements and structure of crystalline materials.  
A pattern is produced from which the positions of the atoms and the structure can be 
determined.  The pattern is produced by the scattering of the waves spread out 
spherically from all the atoms in the sample.  There is some interference caused in the 
radiation beam by the atoms, this affects the intensity of the scattered radiation, which 
can be positive or negative.  Negative interference reduces the strength of the signal, 
therefore only the positive interference is recorded, thus giving a pattern full of peaks.  
The peaks in an X-ray diffraction pattern are directly related to the atomic spacing of 
the material that is being irradiated.  X-ray diffraction is one of the most important tools 
of solid-state chemistry.  It is key to the determination of atomic arrangements, 
geometry and crystal structures.   
W.  L.  Bragg showed that every beam that is diffracted from a crystal can be regarded 
geometrically as if it were a reflection from sets of parallel planes passing through 
lattice points.   
 This is very similar to light being reflected on a mirror, where the angle of incidence 
and reflection are equal.  Thus suggesting the incoming and outgoing beams lie on one 
plane as do the normal and reflecting planes, Figure 1.19.   
In order to define a plane three integers are necessary.  These correspond to the three 
unit-cell edges, hkl.  The spacing between successive planes is determined by lattice 
geometry, which is a function of the unit cell parameters.  Thus allowing each observed 
diffracted beam/reflection to be labelled with its three indices and the net scattering 
angle, (2from the direct beam direction) to be calculated from the unit cell geometry.  
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This is well described by the Bragg equation (equation 1.10), this equation has become 
universally used as the basis for X-ray diffraction geometry (Clegg, 1998). 
Figure 1.19: The Bragg’s law, for diffraction by a 3D crystal structure; one set of parallel lines is 
seen edge-on.  Adapted from (Clegg, 1998) 
 
 
 
 
 
 
Equation 1.10 Braggs Law 
n =2dhkl sinθ     (1.10) 
 
Where: 
dhkl = inter-planar cross sectional 
space
Wavelength of X-ray 
Scattering angle 
n = integer of the diffraction 
order 
 
Incoming 
incidence beams 
2 x dhkl sin
  
dhkl 

  

  
Lattice planes 
hkl 
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1.10.2.1 X-ray diffraction methodology 
X-ray powder diffraction was the principal technique used in determining co-crystal 
formation.  A Bruker AXS D8 Advance powder X-ray diffractometer was used, it has a 
copper Kα radiation source and scintillation counter detector.  The software used to 
collect the data is the DIFFRAC
plus
, files were converted and read into EVA, which is a 
qualitative and Semi-quantitative phase analysis package.  Samples are in the form of a 
microcrystalline powder, this should present all possible crystal faces.  Once irradiated, 
each of them gives its own diffraction pattern.   
Samples are prepared by grinding larger crystals into a crystalline powder.  This was 
then presented on a Perspex disc and placed perpendicular to the incident beam in the 
Bruker D8 machine.  The powder patterns collected where then compared against the 
patterns of the starting materials to determine whether co-crystal is present.  These 
powder patterns were taken from published structures in the CSD using the Mercury 
program.   
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1.10.2.2 Single crystal X-ray diffraction 
Single-crystal X-ray diffraction is a non-destructive analytical technique which provides 
detailed information of the three-dimensional arrangement of atoms in a crystal by 
examining the diffraction of X-rays from an ordered array of many molecules 
(Bernstein, 2002).  The fundamental principles of single crystal X-ray diffraction is the 
same as PXRD, however the analysis is much more challenging.   
This technique is mostly used for precise determination of a unit cell, including cell 
dimensions and positions of atoms within a lattice.  Bond lengths and angles are directly 
related to the atomic positions in the crystal lattice.  Applications of single-crystal 
diffraction include:  
 New mineral identification, crystal solution and refinement 
 Determination of unit cell, bond-lengths, bond-angles and site-ordering 
 Characterization of cation-anion coordination 
 Variations in crystal lattice with chemistry 
 With specialized chambers, structures of high pressure and/or temperature 
phases can be determined 
 Determination of crystal-chemical vs.  environmental control on mineral 
chemistry 
 Powder patterns can also be derived from single-crystals 
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Chapter Two: Design Strategy for co-
crystallisation 
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2.1 Introduction 
The previous chapter introduced the concepts of crystal engineering and co-
crystallisation.  This chapter explains the rationale behind the strategy that has been 
employed to initiate co-crystal growth.  The techniques used to screen, the primary 
amides and co-crystallising agents and the thesis aims and objectives. 
2.2 Thesis aims and objectives 
2.2.1 Project Aims 
The project aims to understand contrast the formation of carboxylic acid co-crystal with 
two amides by probing the packing arrangement similarities and subtleties in structural 
conformation in order to design co-crystals by use of structural features which are 
desirable to the pharmaceutical, fine chemicals and agrochemical industry.  
Isonicotinamide and Benzamide were selected for this work, as the former is a well 
documented and used co-crystal former whilst the latter has only two reported 
compounds.  The approach adopted was to examine the crystal growth of these systems 
in a limited screen, along with concurrent work on developing a database search of co-
crystal packing.  To this end collaboration with the developer of dSNAP, Dr Gordon 
Barr of The University of Glasgow, was undertaken.  This code integrates the output 
from the Cambridge Structural Database for key molecular packing features within a 
series of crystal structures.  The limited crystal screen protocols were developed and 
implemented on a series of target systems.  The focus was to setup a generic route to 
molecular solid formation which could be assessed for robustness.  This screen was then 
extended to a low through-put device and then further extended to the high through-put 
with the addition of a structurally similar active ingredient Nicotinamide, the screen for 
which was designed and developed on site at Syngenta, the data from this screen will be 
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analysed by the use of polySNAP, further extending collaborative work with Professor 
Gilmores group at The University of Glasgow.  Simultaneous work also involves the 
Kofler contact method which allows visual inspection of potential co-crystal phases, 
this work will be validated with extended thermal experiments using DSC.   
To further understand phase behaviour during co-crystallisation, phase diagrams have 
been investigated with co-crystals formed with the three active ingredients and Succinic 
Acid.     
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2.2.2 Objectives 
The objectives of the work is outlined by four key issues which will be addressed 
1. Synthon and Motif strategies within the literature, by identification of known co-
crystals of the target formers.  Solution screen development using basic slow 
evaporation methods, low through put and high through put.  (chapters 3, &5) 
2. Understanding of the packing arrangements of the comparison model by 
implementation of dSNAP for co-crystal systems (chapter 4) 
3. How does the analysis of PXRD patterns from a High through-put screen 
compare to results from thermal techniques of the binary systems.  (chapter 5 & 
6) 
4. Understanding phase behaviour by plotting Phase diagrams of three models in 
methanol system and a water system (chapter 7) 
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2.3 Compound Selection   
The main concept to consider when selecting compounds for co-crystallisation is 
whether they hold functional characteristics to act as hydrogen bond donors and 
acceptors as well as the general rules for hydrogen bonding in the design of hydrogen 
bonded solids as outlined in section 1.3.1.  Also, compounds that are polymorphic 
display structural flexibility, which can therefore increase the chances of co-
crystallisation as mentioned in section 1.8.  For the initial work the co-crystal examples 
given below will be the basis of the work presented in later chapters, with the 
introduction of programs such as dSNAP and polySNAP, screening methods using 
Hotstage microscopy and a High through-put robot.  
 
2.3.1 Isonicotinamide 
Extensive research carried out by Christer Aakeröy and his group (Aakeröy et, al, 2002-
2006) include the co-crystallisation of Isonicotinamide (INA) and shows that this amide 
has demonstrated to be a reliable supramolecular reagent (SR) when combined with 
carboxylic acids.  Additionally a review of the Cambridge Structural database (CSD) 
revealed that INA co-crystallises with a series of carboxylic acid.  The search shows 
that there are over 25 co-crystal structures reported in the CSD, 20% of which exhibit 
the acid-pyridine hydrogen bond motif.  As discussed in the previous chapter pyridines 
and primary amides can hydrogen bond to carboxylic acids forming robust synthons.  
The co-crystals from this review are presented in Table 2.1, consist of the following co-
formers.  
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Table 2.1: Co-crystal structures viewed in the literature and corresponding Reference codes from 
CSD deposits.  All structures have been labelled 1-13 and have been referred to accordingly 
through this chapter.   
 Acids Isonicotinamide Benzamide 
1 Acetic Acid JAWWAG N/A 
2 Tartaric Acid Private communication N/A 
3 Succinic Acid LUNNUD 
LUNNUD01 
BZASUC 
4 Fumaric Acid LUNNOX N/A 
5 Glutaric Acid ULAWOT 
ULAXAG 
N/A 
6 Adipic Acid ULAWUZ 
ULAXAG 
N/A 
7 Benzoic Acid BUDWEC N/A 
8 2-Hydroxybenzoic Acid XAQQEM N/A 
9 3-Hydroxybenzoic Acid LUNMEM N/A 
10 4-Hydroxybenzoic Acid VAKTOR N/A 
11 Cinnamic Acid LUNMAI N/A 
12 d, l-Mandelic Acid LUNPAL N/A 
13 4-Nitrobenzoic Acid AJAKEB N/A 
 
A description of the crystal packing seen in the amide co-crystals present in the CSD 
will be covered, the aim is to present a view of the types of motifs present.   
2.3.1.1 Acid - Amide packing of Isonicotinamide co-crystal review: 
In this section the packing arrangements of Isonicotinamide – Carboxylic Acid co-
crystal is discussed and examples using Mercury outputs are provided, the numbers 
correspond to the numbers associated to the co-crystal phase listed in Table 2.1.  
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Mono Carboxylic Acids/Benzoic Acid Derivatives: 1:1 ratio.   
Isonicotinamide with carboxylic acid 1, 7-13, supramolecules are formed with 4 
components (2 INA, 2 Acid), these are assembled via acid-pyridine and exhibit 
complementary amide-amide Hydrogen interactions. 
 
Co-crystal 1 is extended into a 2-D sheet, formed via N-H---O and C-H---O H-Bonds 
between supermolecules, whereas for 7, 9, 12, 13, components are assembled via acid-
pyridine H-bond interactions and self complementary amide-amide interactions, which 
when extended gives a 2-D cross linked laddered network.  8, 11 form an infinite tape, 
while 10 forms an infinite zig zag chain.   
Figure 2.1: a) showing packing for co-crystal 8 and b) co-crystal system 10  
a) b) 
  
Di-Carboxylic Acids: 1:1 ratio.  Co-crystals 5, 6. Hydrogen bonded tapes assembled via 
acid-pyridine and acid-amide hydrogen interactions.  The N-H---O and C-H---O 
interactions between the tapes extend to form an extended tape/ribbon. 
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Figure 2.2: showing packing for co-crystal system 5 
 
 
Di-Carboxylic Acids: 2:1 ratio.  Co-crystals 3, 4. 4 component supermolecule via 
acid-pyridine H-bond interactions and self complementary amide-amide interactions 
forms 1-D chain when extended, between the chain interaction between N-H---O gives 
a 2-D sheet. 
5, 6. Tapes assembled via acid-pyridine H-bond interactions.  A sheet is formed via N-
H---O and C-H----O interactions between the tapes.   
 
The packing reveals that the primary intermolecular interaction is the O-H---N 
hydrogen bond between the acid and the N-heterocyclic nitrogen atom as well as the 
amide-amide dimer.   
For this project we have selected Isonicotinamide as a model active ingredient (AI) 
because it has robust acceptor and donor sites allowing co-crystallisation with small 
simple carboxylic acids, which range as mono-carboxylic acids, di-carboxylic acids and 
benzoic acid derivatives.  These are to be compared with another 1° amide, Benzamide.  
The rationale behind this was to switch off/ neutralise one end of the ditopic 
Isonicotinamide.  Since the pyridine is the best hydrogen bond acceptor and donor, 
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taking away this site will leave a monotopic structure.  A CSD search was once again 
established and only one co-crystal with the selected carboxylic acid has been reported, 
Table 2.1 also displays the results from this search.    
 
2.3.2 Benzamide 
A literature review and structure search of the database has revealed that this primary 
amide has a low success rate in the formation of co-crystals with small carboxylic acids.  
The CSD search showed 7 structures which contain Benzamide, only one of which has 
the  acid-amide hydrogen bond motif.   Because of this low rate of co-crystals present in 
the CSD for Benzamide, and the literature indicating a number of carboxylic acids 
which co-crystallise with Isonicotinamide; also highlighted in Table 2.1, these acids 
shall be investigated as co-crystallisers with Benzamide.  Consequently, any successful 
single crystals would be analysed and the structures obtained with Benzamide and the 
respective Isonicotinamide co-crystals shall be reviewed for structural similarities.   
2.3.2.1 Acid - Amide packing of Benzamide co-crystal review:1:1 ratio 
Co-crystal 3. Components are assembled via acid-amide interactions, which when 
extended gives a tape formed via C-H---O interactions. 
Figure 2.3: showing packing for co-crystal system 3 
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On the basis of the success rate and the compatibility of Isonicotinamide and the 
carboxylic acids presented here it would be interesting to compare the success of co-
crystal formation with Benzamide.   
2.3.3 Nicotinamide 
For the studies presented later, Nicotinamide has been employed in the high through-put 
screen and phase diagram determination.   
Nicotinamide, also known as niacinamide and nicotinic acid amide, is a water-soluble 
vitamin and is part of the vitamin B group (B3).  It has been reported that Nicotinamide 
possesses six polymorphs (Kofler & Kofler, 1943), however only form I of the 
polymorphs can be obtained from solution, the others being meta-stable (Hino et al, 
2001, Berry et al, 2008).  Nicotinamide structurally possess potential synthons which 
are compatible for intermolecular interaction with carboxylic acids.  Searches of the 
literature and the CSD identified that there are 23 structures which contain 
Nicotinamide, only 8 of these structures were molecular adducts whilst the remaining 
were redeterminations of Nicotinamide form I, salts and have no coordinates.  This 
search shows that this AI is a promising contender for co-crystal formation with the 
carboxylic acids selected for the high through-put screen.   
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2.4 Experimental Design  
Co-crystals have been prepared from solution and by solid-state/solvent mediated 
grinding as discussed in section 1.7.  The examples of the Isonicotinamide carboxylic 
acids discussed in section 2.3.1 and have been prepared with following stoichiometric 
amounts. With one Isonicotinamide per mono-carboxylic acids, with two 
Isonicotinamide per di-carboxylic acid, and all of these were dissolved in warm ethanol 
and then cooled to room temperature, crystals were formed upon slow evaporation of 
the solvents, and this could take from hours to days for any crystals to nucleate 
(Aakeröy et al., 2002).   
2.4.1 Slow Evaporation 
The work undertaken for this study includes crystallisation using the slow evaporation 
method, as this is the simplest way to grow crystals.  Solutions must be prepared in a 
suitable solvent and it must be saturated or nearly saturated.  For this the solubility of 
the two must have similar solubility in the solvent otherwise the least soluble 
component will crystallise out exclusively.   
 
This evaporation method has been established in this work as a preliminary technique to 
reiterate the Isonicotinamide work established by Aakeröy et al., 2002, and additionally 
to form a comparison with a structurally similar amide, Benzamide.  This bench method 
will then be modified to be implemented on a low through-put device, ReactARRAY 
(chapter 3).  This will allow slow-evaporation in a temperature controlled environment.  
The results from these screens will be further analysed to identify the structural 
similarities and behaviour of successful co-crystals from the least competitive amide 
using dSNAP. 
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2.5 dSNAP 
The Cambridge Structural Database (CSD) is forever growing, with this and the large 
number of datasets retrieved whilst searching, it can be sometimes difficult to classify 
chemical information.  However, although there are various algorithms and data mining 
strategies in the literature, (Orpen 2002, Allen & Motherwell 2002), there is however a 
niche for a freely available program which classifies results from database searches 
(Aakeröy & Beatty, 2001).  In 2005 Barr et al indicated detail in flexibility and 
presented a new approach encoded in the dSNAP program which is designed to assist 
structural chemist in classifying information extracted from CSD searches.   
 
dSNAP is a computer program which classifies and clusters structural fragments 
extracted from the Cambridge Structural Database.  The methodology is based on 
cluster analysis and multivariate data processing of distance matrix information 
describing the extracted fragments. 
 
For this program, it is essential to have single crystal data from the CSD or 
experimental single crystals from the screens carried out in this work.   
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2.6 High through-put 
The concepts of high through-put (HTP) screening have been well established and 
applied across the entire pharmaceutical value chain, including the screening of active 
molecules in discovery, form selection for preclinical candidates, final form 
optimisation, and process chemistry development of crystallisation processes for bulk 
drug and intermediates as well as identification of new solid forms for product life cycle 
management.  High through-put form screening is available and has been described in 
the literature, indicating that this new methodology is just at beginning to make a 
platform for itself (Morissette el al., 2004).   
 
A contribution to this work involves the use of a high through-put robot as a method to 
screen for co-crystals with the above mentioned active ingredients, Isonicotinamide, 
Benzamide and Nicotinamide, along with the following coformers and solvents.   
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Figure 2.4: Benzoic acid derivatives used for the High through-put screen and Hotstage microscopy. 
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Figure 2.5: di-carboxylic acids used for High through-put screen and Hotstage microscopy. 
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Table 2.2: Active ingredients and coformers used in High through-put screen with corresponding 
solubilites and respective solvents.  Solubility measure are according to 0.1g/ ml 
Active Ingredient 
RMM 
(g) 
Solubility 
(%) 
Solvent 
Benzamide 121.14 10 Methanol 
Isonicotinamide 122.12 10 Methanol 
Nicotinamide 122.12 10 Methanol 
Coformer 
RMM 
(g) 
Solubility 
(%) 
Solvent 
1, 4 Benzene 
dimethanol 
138.16 5 Propanol 
2 Nitrobenzoic acid 167.12 10 Methanol 
3 Aminobenzoic acid 137.14 3 Methanol 
3 Nitrobenzoic acid 167.12 10 Acetone 
4 Aminobenzoic acid 137.14 10 Methanol 
4 Nitrobenzoic acid 167.12 3 Acetone 
Adipic acid 146.14 10 Methanol 
Butanoic acid 88.1 10 Methanol 
Fumaric acid 116.07 5 Methanol 
Maleic acid 116.1 10 Methanol 
Malic acid 134.09 10 Methanol 
Phthalic acid 166.14 5 Ethanol 
Pimelic acid 160.17 10 Methanol 
Succinic acid 118.09 10 Methanol 
Tartaric acid 150.09 10 Methanol 
Trans  hydromuconic 
acid 
144.13 3 Methanol 
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The preparation of co-crystals from solution requires the two components to have 
similar solubility in the solvent used otherwise the least soluble component will tend to 
crystallise out.  One of the key points in co-crystallisation of an AI is to modify its 
physicochemical properties such as poor solubility.  It is therefore a necessary condition 
for successful co-crystallisation to occur that the coformer is mutually soluble.  All 
solvents selected have been approved by the FDA guidelines and Syngenta health and 
safety policy.   
 
2.7 Kofler Hotstage 
Another method used to screen and identify co-crystal phases is the Kofler contact 
method (Kofler, 1941).  This method is a quick and simple way, it involves the melting 
of the component with the highest melting point between a microscope slide and a cover 
slip, and allowing cooling and re-crystallising.  The second component should have a 
lower melting point, this is added to a free edge of the cover slip and heated so that the 
melt seeps under the cover slip and makes contact with the higher melting component.  
Where these two phases meet is the mixing zone, here the determination of a eutectic, 
mixed phase, or molecular compound of the liquid phases can be observed when placed 
on a temperature controlled hot stage and microscope using polarised light.  For this 
work many new phases have been observed, with only a small number of failed 
attempts due to decomposition of coformers/carboxylic acids upon heating.   
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2.8 Future Thought of Work 
Further investigation and rationalisation of co-crystal formation have been attempted 
using dSNAP and working with the a limited dataset has certainly highlighted subtleties 
in the crystal packing, however, to develop a protocol/method to understand these 
subtleties, further understanding is required of the entities by which co-crystals form. In 
particular the link between the pair wise design strategies and the impact on overall 
success with minor structural modification.  For this project was contrasting the co-
crystal behaviour of Benzamide, Isonicotinamide and Nicotinamide with a series of 
carboxylic acid co-formers.   
With this in mind, a preliminary study was undertaken and is presented here as an 
indication to highlight a possible way forward using a computational led approach.  
Historically the interaction between a solute and solvent and the co operative impact of 
the electronic densities was profiled using the induced dipole moment.  Work by Le 
Fèvre (1948), discusses the induced moment in a solvent molecule collinear with the 
chief moment of the solute as shown in equation 2.8 
Equation 2.8 Fèvre Induced Dipole:         
                        
               (2.8) 
Where α is the polarizability of a solvent molecule and µ is the dipole moment, we have 
attempted to adopt this equation to accommodate pair-wise association of solutes 
undergoing molecular complex formation. The success for specific combination is 
experimentally verified by the outcome conditions of the Hotstage screen.  For our 
purposes and to simplify the initial feasibility of this approach, the focus was upon 
calculating the product of dipole moment and polarizability of interacting pairs as being 
proportional to the overall induced moment.   
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Equation 2.8.1 Modified dipole equation: 
                 (2.8.1) 
 
Using equation  2.8.1, we have attempted to calculate the group contribution to a 
specific mode of association,  where the difference in the dipole (µ) define the dipole of 
the hydrogen bond donor or acceptor site, and polarizability (α) which defines the 
polarisability of the hydrogen bond donor or acceptor site, of the coformers used in the 
study.  This requires computation of the co-former and their parent molecules (the co-
former with the hydrogen bond moiety replaced by hydrogen) and then computing the 
differences in dipole and polarisability of the coformers from that of the parent.  This 
generates an approximation of the group contribution these quantities.  The chemical 
entities used match the AI models used during Hotstage analysis.  The aim of this 
calculation is to evaluate an estimation of product bond differences calculated with 
parent molecule and compare with the AI models, this would highlight the extent of 
dipole moment and polarisability along the hydrogen bond fragment (amino, nitro, 
carbonyl acid).   
For this approach the following annotation was assigned to the amides and acid 
employed for the co-crystal systems presented in Chapter 5.  Three groupings are 
envisaged acid self association, amide self association and the association for the 
complex permutation of these quantities.  For the complex an average was taken to 
reach the average figure of the induced dipole moment.   
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Where            and 
α1 µ1 is for acid coformer 
α2 µ2 is for acid parent 
α3 µ3 is for amide (AI) 
α4 µ4 is for amide parent 
 
 
 
For the initial step in this study MOPAC within Mercury has been used with 
Hamiltonian method, PM3, to calculate the dipole and polarizability, details of which 
are widely reported in the literature (Le Fèvre, 1948). We have only used the 
conformations as is from the crystal structures a full future study would have to 
examine conformation and minimisation.   
Below in table 2.3- 2.4the total sum of the dipole (μ) and the polarisability (α) average 
in Å
3 
for the acids are given, along with the appropriate parent compound. (i.e. 
removing acid group from aminbenzoic acid and replacing with hydrogen leads to 
aniline).  Those values for the amides are given for comparison.   
Table 2.3: Sum of calculated dipole and polarisation of coformer and parent molecule of coformer.   
 
Coformers 
Isotropic 
Average (α) 
(Å
3
) 
Dipole 
Total 
Sum (μ) 
Parent 
Isotropic 
Average (α) 
(Å
3
) 
Dipole 
Total 
Sum 
(μ) 
2 Aminobenzoic 
Acid 
14.26067 1.16 Analine 23.12611 2.806 
                                      
                                      
                               
 
 
                       =  
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3 Aminobenzoic 
acid 
28.8063 0.603 Analine 23.12611 2.806 
4 Aminobenzoic 
Acid 
28.83104 0.553 Analine 23.12611 2.806 
Benzoic Acid 12.74775 2.396 Benzene 10.18784 0 
Phthalic Acid 15.41667 3.102 Benzene 10.18784 0 
Malic Acid 9.02892 5.636 
Butanoic 
Acid 
8.85973 6.661 
Succinic Acid 9.25186 0 
Butanoic 
Acid 
8.85973 6.661 
Tartaric Acid 10.23043 3.834 
Butanoic 
Acid 
8.85973 6.661 
Fumaric Acid 18.33078 0.127 
Crotonic 
Acid 
8.15323 2.151 
Maleic Acid 9.7636 2.393 
Crotonic 
Acid 
8.15323 2.151 
Pimelic Acid 14.76023 3.273 
Heptanoic 
Acid 
13.79883 1.955 
Adipic Acid 25.66317 0.134 
Hexanoic 
Acid 
11.98047 2.006 
Trans B 
Hydromuconic 
Acid 
20.07063 0 
Hexanoic 
Acid 
11.98047 2.006 
2 Nitrobenzoic 
Acid 
14.82729 6.496 Nitrobenzene 12.17161 5.162 
3 Nitrobenzoic 
Acid 
29.85699 1.642 Nitrobenzene 12.17161 5.162 
4 Nitrobenzoic 
Acid 
14.90951 4.083 Nitrobenzene 12.17161 5.162 
2 
Hydroxybenzoic 
Acid 
13.42965 2.346 Phenol 32.14642 3.56 
3 
Hydroxybenzoic 
Acid 
13.43805 1.92 Phenol 32.14642 3.56 
4 
Hydroxybenzoic 
13.35981 3.483 Phenol 32.14642 3.56 
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Acid 
Malonic Acid 8.6809 3.581 
Propanoic 
Acid 
6.66292 1.831 
1, 4 Benzene 
dimethanol 
14.91808 0.054 p-xylene 13.82214 0 
Cinnamic Acid 16.60408 2.933 Styrene 13.63709 0.039 
Mandelic Acid 15.6876 3.885 Toluene 23.74607 0.128 
Glutaric Acid 11.01605 3.2 Valeric Acid 11.28113 9.999 
Active 
Ingredient (AI) 
Isotropic 
Average (α) 
(Å
3
) 
Dipole 
Total 
Sum (μ) 
   
Benzamide 13.54311 3.73    
Isonicotianmide 12.95283 3.67    
Nicotinamide 12.95221 3.857    
 
 
Table 2.4: The self association of the dipole and polarisability of the acid coformer and its parent 
molecule, amide and its parent molecule is also presented.   
Coformers 
α1 
(Å
3
) 
µ1 Parent 
α2 
(Å
3
) 
µ2 
Self association ( 
α1 - α2 )( µ1 - µ2 ) 
2 Aminobenzoic 
Acid 
14.2
6 
1.1
6 
Analine 
23.1
3 
2.81 14.59 
3 Aminobenzoic 
acid 
28.8
1 
0.6
0 
Analine 
23.1
3 
2.81 -12.51 
4 Aminobenzoic 
Acid 
28.8
3 
0.5
5 
Analine 
23.1
3 
2.81 -12.85 
Benzoic Acid 
12.7
5 
2.4
0 
Benzene 
10.1
9 
0.00 6.13 
Phthalic Acid 
15.4
2 
3.1
0 
Benzene 
10.1
9 
0.00 16.22 
Malic Acid 9.03 
5.6
4 
Butanoic 
Acid 
8.86 6.66 -0.17 
Succinic Acid 9.25 
0.0
0 
Butanoic 
Acid 
8.86 6.66 -2.61 
Tartaric Acid 
10.2
3 
3.8
3 
Butanoic 
Acid 
8.86 6.66 -3.87 
Fumaric Acid 
18.3
3 
0.1
3 
Crotonic 
Acid 
8.15 2.15 -20.60 
Maleic Acid 9.76 
2.3
9 
Crotonic 
Acid 
8.15 2.15 0.39 
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Pimelic Acid 
14.7
6 
3.2
7 
Heptanoic 
Acid 
13.8
0 
1.96 1.27 
Adipic Acid 
25.6
6 
0.1
3 
Hexanoic 
Acid 
11.9
8 
2.01 -25.61 
Trans B 
Hydromuconic 
Acid 
20.0
7 
0.0
0 
Hexanoic 
Acid 
11.9
8 
2.01 -16.23 
2 Nitrobenzoic 
Acid 
14.8
3 
6.5
0 
Nitrobenzen
e 
12.1
7 
5.16 3.54 
3 Nitrobenzoic 
Acid 
29.8
6 
1.6
4 
Nitrobenzen
e 
12.1
7 
5.16 -62.25 
4 Nitrobenzoic 
Acid 
14.9
1 
4.0
8 
Nitrobenzen
e 
12.1
7 
5.16 -2.95 
2 Hydroxybenzoic 
Acid 
13.4
3 
2.3
5 
Phenol 
32.1
5 
3.56 22.72 
3 Hydroxybenzoic 
Acid 
13.4
4 
1.9
2 
Phenol 
32.1
5 
3.56 30.68 
4 Hydroxybenzoic 
Acid 
13.3
6 
3.4
8 
Phenol 
32.1
5 
3.56 1.45 
1, 4 Benzene 
dimethanol 
14.9
2 
0.0
5 
p-xylene 
13.8
2 
0.00 0.06 
Cinnamic Acid 
16.6
0 
2.9
3 
Styrene 
13.6
4 
0.04 8.59 
Mandelic Acid 
15.6
9 
3.8
9 
Toluene 
23.7
5 
0.13 -30.28 
Glutaric Acid 
11.0
2 
3.2
0 
Valeric Acid 
11.2
8 
10.0
0 
1.80 
       
Active ingredient 
Α3 
(Å
3
) 
µ3 
Parent 
molecule 
α4 
(Å
3
) 
µ4 
Self Association ( 
α3 - α4 )( µ3 - µ4 ) 
Benzamide 
13.5
4 
3.7
3 
Benzene 
10.1
9 
0.00 12.52 
Isonicotianmide 
13.5
4 
3.6
7 
Pyridine 0.31 
37.7
2 
-450.72 
Nicotinamide 
13.5
4 
3.8
6 
Pyridine 0.31 
37.7
2 
-448.24 
 
The data set were then used to construct Table 2.5, which includes the outcomes from 
the melt screens, and these experimental outcomes are described in fully in chapter six,. 
Table 2.5 contrasts the computed average of the component models used for the 
Hotstage microscopy work with the parent components using equation 2.8.1.   
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Table 2.5: Average induced dipole moments calculated for component molecules used during 
Hotstage microscopy.  Key below gives identification of results 
from Hotstage. 
 
 Benzamide Isonicotinamide Nicotinamide 
Coformers 
[( α1 – α2 )( µ3 - 
µ4 ) + ( α3 - α4 )( 
µ1 - µ2 )]/2 
[( α1 - α2 )( µ3 - µ4 ) 
+ ( α3 - α4 )( µ1 - µ2 
)]/2 
[( α1 - α2 )( µ3 - µ4 
) + ( α3 - α4 )( µ1 - 
µ2 )]/2 
2 Aminobenzoic 
Acid 
-19.30 140.05 139.22 
3 Aminobenzoic 
acid 
6.90 -111.29 -110.76 
4 Aminobenzoic 
Acid 
6.86 -112.04 -111.51 
Benzoic Acid 8.79 -27.73 -27.49 
Phthalic Acid 14.96 -68.50 -68.01 
Malic Acid -1.40 -9.66 -9.65 
Succinic Acid -10.44 -50.76 -50.72 
Tartaric Acid -2.19 -42.05 -41.92 
Fumaric Acid 15.59 -186.68 -185.73 
Maleic Acid 3.41 -25.82 -25.67 
Pimelic Acid 4.00 -7.65 -7.56 
Adipic Acid 22.38 -245.35 -244.07 
Trans B 
Hydromuconic 
Acid 
11.72 -151.02 -150.26 
2 Nitrobenzoic 
Acid 
7.19 -36.39 -36.14 
3 Nitrobenzoic 
Acid 
27.08 -324.41 -322.75 
4 Nitrobenzoic 
Acid 
3.30 -53.76 -53.50 
2 
Hydroxybenzoic 
Acid 
-36.94 310.64 308.89 
3 
Hydroxybenzoic 
Acid 
-37.64 307.68 305.93 
4 
Hydroxybenzoic 
Acid 
-35.17 319.35 317.60 
1, 4 Benzene 
dimethanol 
2.13 -18.30 -18.20 
Cinnamic Acid 10.39 -31.36 -31.09 
Mandelic Acid -8.73 162.07 161.31 
Glutaric Acid -11.90 -40.48 -40.51 
Key  
  Hotstage Hit 
 Hotstage Fail 
  
Thermal 
Decomposition  
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Visual inspection Table 2.5 highlighted certain trends as follows.  For the 
Isonicotinamide and Nicotinamide, where Hotstage showed a positive new phase, 
values calculated show a similarity in the computed dipole moment of the functional 
group taking part in the intermolecular interaction of a co-crystal.  If we take the 
Succinic acid example, we already know from the structure determination and packing 
discussed with this work that the carbonyl acid group forms an acid-pyridine interaction 
and a homo amide-amide dimer for the Isonicotinamide and Nicotinamide system.  
However, for the Benzamide with Succinic acid system, we have found that a hetero 
dimer of acid-amide is formed.  If we look at the values of these system from the table 
above (highlighted in red), we find that the Isonicotinamide and Nicotinamide have an 
average value of which are -50.76, -50.72 respectively, they are quite similar, but for 
Benzamide, a value of -10.44 is calculated, this suggest that in the absence of the 
pyridine ring the association of the dipole moment of the Benzamide Succinic acid 
system is much higher than its competitor amides, but lower than the self associated 
coformer and parent molecules, 12.52 (amide self association), -2.61 (coformer self 
association).   
If we consider the benzoic acid example, we can highlight that with benzoic has a 
higher dipole with Benzamide, whereas a much lower negative dipole with 
Isonicotinamide and Nicotinamide.  The Hotstage shows that benzoic acid shows a new 
phase with all three amides.  However, if we introduce nitro, amino and hydroxyl 
groups, the dipole moments decreases with Benzamide, but increases with the 
Isonicotinamide and Nicotinamide.  On addition of nitro and amino, the dipole 
decreases with Isonicotinamide and Nicotinamide, but increases with Benzamide.   
Since Benzamide has only one donor/acceptor site, we assume that it can only form a 
hetero dimer, as literature shows and the examples shown here.  However, to build a 
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hypothesis single crystal structures are required of the hits found during Hotstage.  
Similar trends are observed for the other systems suggesting this approach should be 
developed further.   
We have attempted, to display a quick investigation of the induced dipole moment as an 
indication of the level of initial association viability of our model AI and the acid-
coformers presented here. The data applied to the MOPAC software is from crystal 
structures that have been deposited into the CSD, the calculation involves a semi-
empirical method, PM3, and due to time constraints, structure geometry has not been 
established. 
To further investigate the effect of dipole moments using the PM3 method, each 
molecule taken from the CSD should be refined prior to running the semi-empirical 
formula to calculate the dipole and polarisability.  The inclusion of popular API 
components such as Carbamazepine can be studied to build further understanding of the 
behaviour of the functional groups as a first principal method.   
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Chapter Three: Investigating and comparing 
co-crystallisation of 1° amides with 
carboxylic acids 
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3.1 Introduction 
The literature revealed that Isonicotinamide (INA) successfully forms co-crystals with 
carboxylic acids whereas Benzamide has a lower success rate. An experimental matrix 
was set up using the reported Isonicotinamide-carboxylic acid co-crystals from the 
literature and compared with Benzamide using the same carboxylic acids.  Two 
methods have been exploited here: 
Slow evaporation: Quick and simple bench method of a super saturated solution where 
the samples are left to incubate at a set temperature of 20° C 
Low through-put method: A streamline device called ReactArray Microvate, allows 48 
samples to be simultaneously incubated at controlled temperatures.   
3.2 Experimental 
3.2.1 Bench slow evaporation  
Crystal growth was undertaken from supersaturated solutions, typical quantities are 
given in Table 3.1, using the slow evaporation method.  Crystallisation studies for each 
system were at 1:1 and 2:1 ratios for di-carboxylic acid to amide respectively.  The 
compositions employed are given in Table 3.1,  the ratio of acid: amides in grams is 
indicated, and for each sample, the specified mass components were dissolved in 50 ml 
of a series of selected solvents (Water, Methanol, Ethanol, and Tetrahydrofuran) and 
left in an incubator at 25° C.  All materials, solvents and compounds were bought from 
Sigma-Aldrich.   
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3.2.2 Low through-put method using a ReactArray Microvate 
The ReactArray device has 48 wells, set on a heating block which has 12 independent 
temperature zones.  Each well has a depth of 3 cm.  The sample vials used for this 
experiment were glass tubes, with a diameter of 1 cm and volume capacity of 5 ml if 
filled to the top.  Magnetic beans which were 1.5 x 5mm where used to equilibrate 
samples. This device has been used to grow single crystals of Benzamide and 4-
Nitrobenzoic Acid, Tartaric Acid and Fumaric Acid as discovered from the evaporation 
method above.  Additionally the above mentioned matrix has been used with this device 
to further screen for co-crystals which may not have been successful using the simple 
bench evaporation technique.  Experiments were set up using solvents; Hexane, 
Toluene, Ethyl Acetate, Tetrahydrofuran, Ethanol, Methanol and Water. Stoichiometric 
ratios of 1:1, 1:2 and 2:1 were used with 2 ml of solvent. The ReactArray was 
programmed to equilibrate sample at 25 °C for an hour, temperature was then ramped to 
60 °C and held for 8 hours and then cooled to 25° C at a rate of 5° C/min. The previous 
matrix which gave a success rate of 5 co-crystals out of 11 have been reproduced.  The 
weights are given in Table 3.2.   
Figure 3.1: ReactARRAY Microvate showing the 48 wells and the 12 independent heating regions  
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Table 3.1: Summary of the quantities of Acid: Amide in grams used in the bench solvent 
evaporation solution co-crystallisation.   
 Isonicotinamide  Benzamide 
 1:1 1g   1:1 1g 
 2:1 2g   2:1 2g 
Fumaric Acid 0.958g 0.950g 
Succinic Acid 0.975g 0.970g 
Tartaric acid 1.239g 1.230g 
Glutaric Acid 1.091g 1.081g 
Adipic Acid 1.206g 1.197g 
Benzoic Acid 1.008g 1.00g 
2-Hydroxybenzoic Acid 1.140g 1.131g 
3-Hydroxybenzoic Acid 1.140g 1.131g 
4-Hydroxybenzoic Acid 1.140g 1.131g 
Mandelic Acid 1.256g 1.249g 
Cinnamic Acid 1.223g 1.213g 
4-Nitrobenzoic Acid 1.380g 1.370g 
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Table 3.2: Summary of the quantities and solvents used in grams for the co-crystallisation of acid: Amide using the ReactARRAY Microvate as a Low 
through-put method 
 
    
Isonicotinamide 
(g) 
  
   Benzamide 
         (g) 
 1:1 1:2 2:1 1:1 1:2 2:1 
 0.025g 0.025g 0.050g 0.025g 0.025g 0.050g 
Fumaric Acid 0.024 0.048 0.024 0.024 0.048 0.024 
Succinic Acid 0.024 0.048 0.024 0.024 0.049 0.024 
Tartaric acid 0.03 0.061 0.03 0.031 0.062 0.031 
Glutaric Acid 0.027 0.054 0.027 0.027 0.055 0.027 
Adipic Acid 0.03 0.06 0.03 0.03 0.06 0.03 
Benzoic Acid 0.025 0.05 0.025 0.025 0.05 0.025 
2-Hydroxybenzoic Acid 0.028 0.057 0.028 0.029 .0.57 0.029 
3-Hydroxybenzoic Acid 0.028 0.057 0.028 0.029 .0.57 0.029 
4-Hydroxybenzoic Acid 0.028 0.057 0.028 0.029 .0.57 0.029 
Mandelic Acid 0.031 0.062 0.031 0.031 0.063 0.031 
Cinnamic Acid 0.03 0.06 0.03 0.031 0.061 0.031 
4-Nitrobenzoic Acid 0.034 0.068 0.034 0.034 0.069 0.034 
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3.3 Results and Discussion 
3.3.1 Bench method vs. Low through-put method 
The summative results from the screen using quantities in Tables 3.1 and 3.2 are 
presented in Table 3.3.  Table 3.3 is laid out to highlight the respective success and 
failures seen during the Co-crystallisation studies.  The outcome with regards success or 
failure was determined using a combination of PXRD and Hotstage microscopy.   
Table 3.3:  Positive or negative result of experimental screen, where in the case of Isonicotinamide 
successful growth is identified as being previously published.  A positive result is highlighted with a 
green box and a tick, a failure is highlighted with a cross in a red box 
  
Isonicotinamide 
 
Benzamide 
 Co-
crystallisati
on 
 Co-
crystallisati
on 
 
Adipic Acid  Published   
Glutaric Acid  Published   
Fumaric Acid  Published  
New 
Phase/Mixtu
re 
Succinic Acid  Published  Published 
Tartaric Acid  Published  
New 
Phase/Mixtu
re 
Benzoic Acid  Published   
2-Hydroxybenzoic 
Acid 
 Published   
3-Hydroxybenzoic 
Acid 
 Published  
New 
Phase/Mixtu
re 
4-Hydroxybenzoic 
Acid 
 Published   
Cinnamic Acid  Published   
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DL-Mandelic Acid  Published  
New 
Phase/Mixtu
re 
4-Nitrobenzoic Acid  Published  
New 
Phase/Mixtu
re 
 
Results from the slow evaporation have also been recreated using the low through-put 
screen, some single crystals have been grown which represent new co-crystal phases, 
and these will be discussed in the next section.  However, as mentioned earlier the vial 
size used for the ReactARRAY experimental procedure had a diameter 1cm and volume 
of 5ml, these were made of glass which caused difficulty when extracting crystal 
samples from the bottom of the vial.  In attempt to overcome this problem, experiments 
where repeated using polypropylene round bottomed centrifuge tube, however, these 
tubes also seemed to be difficult when extracting crystal sample. 
3.3.2 Discussion solution growth 
The experimental results obtained indicate that the examples of Isonicotinamide co-
crystals reported in the literature were all successfully re-created using the following 
solvents (water, methanol, ethanol and THF).  This highlights the robust nature of the 
associated synthons.  However, a number of potentially new Benzamide co-crystals 
were also identified from the screens.  Previously only the Benzamide: Succinic acid 
(Chiarella, Davey, & Peterson, 2007) system has been published.  Currently further 
analysis is being undertaken to fully identify the new co-crystals phases of Benzamide. 
Figures 3.2 - 3.6 presents a comparison of X-ray powder patterns where a new phase is 
indicated from mixture of Benzamide and Fumaric Acid, Tartaric Acid, 3-Hydroxy 
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benzoic Acid, DL-Mandelic Acid, 4-Nitrobenzoic Acid.  These new phases have been 
indicated by an arrow.  Details of the critical peaks are given in Appendix B. 
Figure 3.2: Powder diffraction comparison of potential Benzamide with Fumaric acid grown from 
low through-put method 
 
Figure 3.3: Powder diffraction comparison of potential Benzamide with Tartaric acid grown from 
low through-put method 
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2 Theta
Potential Benzamide with Tartaric acid co-crystal
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Benzamide
Tartaric Acid
New 
Phase 
New 
Phase 
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Figure 3.4: Powder diffraction comparison of potential Benzamide with 3-hydroxybenzoic acid 
grown from low through-put method 
 
Figure 3.5: Powder diffraction comparison of potential Benzamide with Mandelic acid grown from 
low through-put method 
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Figure 3.6: Powder diffraction comparison of potential Benzamide with Mandelic acid grown from 
low through-put method 
 
3.3.2.1 Discussion on X-ray results 
From Figures 3.2 - 3.6 the trend which emerges is that the evaporation method, gives 
five possible new phases with Benzamide.  The X-ray patterns show four new peaks 
with Fumaric Acid at 2θ angles (˚) (6.02, 10.052, 11.906 and 15.311), 2 new peaks with 
Tartaric Acid (5.424, 10.557), 2 new peaks 3-Hydroxybenzoic Acid (9.297, 14.015), 2 
new peaks with Mandelic Acid (7.284, 9.10), and 2 new peaks with 4-Nitrobenzoic 
Acid (5.799, 11.544) which are not present in the parent structures.  However, further 
determination and characterisation is required to fully justify a new phase being present.  
These methods will be Single crystal X-ray, hot stage microscopy and DSC.   
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 3.3.2.2 Single Crystal analysis 
From the X-ray powder diffraction new phases have been identified.  Suitable material 
for single crystal structure determination has been grown.  Single crystal determination 
was sent to University of Glasgow for Benzamide: Fumaric Acid sample, whilst the 
Benzamide: 4-Nitrobenzoic Acid was determined on the in-house system by Dr Ian 
Scowen.  Experimental details for both structures are given below in Table 3.4 
The literature review and CSD search shows there are far more co-crystal with 
Isonicotinamide than Benzamide, but here it has been observed that using the same 
carboxylic acids which successfully co-crystallise with Isonicotinamide, Benzamide co-
crystallises with 5 of the acids out of the 13 acids investigated.  (All the relevant CIF files 
are contained in a CD within Appendix H)   
Table 3.4: Crystallographic Data For Benzamide: Fumaric Acid and Benzamide : 4-Nitrobenzoic 
acid 
 
 
 
 
 
 
 
 
 
Compound Benzamide: Fumaric 
Acid 
Compound Benzamide:4-
Nitrobenzoic Acid 
Formula C9H9N1O3 Formula C14H12N2O4 
Mass, Mr 179.18 Mass, Mr 272.26 
Temp (K) 150 K Temp (K) 296 (2) K 
Cryst Syst Monoclinic Cryst Syst  
Space Group P21/n Space Group P-1 
Z 4 Z 2 
a (Å) 5.318 (6) Å a (Å) 6.3184 (4) Å 
b (Å) 5.351 (6) Å b (Å) 6.8802 (5) Å 
c (Å) 29.64 (4) Å c (Å) 15.6401 (11) Å 
α (deg) 90° α (deg) 95.749 (5)° 
β (deg) 96.03 (5)° β (deg) 98.806 (4)° 
γ (deg) 90° γ (deg) 106.239 (4)° 
V (Å) 838.8 (18) Å
3
 V (Å) 637.72 (8) Å
3
 
R-Factor % 5.69 R-Factor % 12.03 
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A full detail of refinement, atomic coordinates, isotropic displacement parameters (Å
2
), 
atomic displacement parameters (Å
2
), geometric parameters (Å), and hydrogen-bond 
geometry (Å) is given in Appendix D. 
3.3.2.2.1 Analysis of Benzamide: Fumaric Acid: 
This crystal is Monoclinic with a space group of P21/n.  It has the unit cell dimensions 
of 5.318 5.351 29.64 Å, and β = 96.03 ˚.  The crystal structure, forms dimerised 
hydrogen bonding, showing the common hetero-synthon (Figure 3.7). 
Figure 3.7:  Mercury analysis of Benzamide : Fumaric Acid crystal structure  
 
The bond types which are present are the N-H∙∙∙O Benzamide to Fumaric acid and O-
H∙∙∙O Fumaric Acid to Benzamide leading to a ring (R22(8)), i.e. hetero-dimer synthon.  
Closer inspection on the packing shows a herringbone ladder which is stacked, Figure 
3.8 i-iii. 
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Figure 3.8: Herringbone stacking Packing i) down the a axis we see a stacking in the zigzag stack, 
ii) packing in a single unit cell, iii) shows the packing down the b axis   
 
  
The Hydrogen bonding angles and distances for the dimer are shown in the Table 3.5 
below  
Table 3.5: Hydrogen-bond geometry lengths are give in  Angstrom(Å), and bond angles are given in 
degrees ( °) 
D—H···A D—H H···A D···A D—H···A 
N8—H81···O4 0.95 1.95 2.893 (2) 169 
O3—H31···O7 0.96 1.67 2.620 (2) 171 
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- 
3.3.2.2.2 Analysis of Benzamide: 4-NitrobenzoicAcid  
This structure has a Z value of 2 in space group P1 with angles 95.75, 98.81, 106.24˚ 
and unit cell dimensions of 6.318 6.88 15.64 Å.  The Figure below depicts the hydrogen 
bonding to be a hetero dimer synthon i), by expanding the contact we can see that the 
packing is stacked forming 2D layers.  We can see that the stacking is of π- π stacking, 
offset slightly over the nitro group of the acid Figure 3.9 iii). 
Figure 3.9: Packing analysis of Benzamide and 4-Nitrobenzoic Acid i) Dimer hydrogen bonding, ii) 
view of the packing down a axis, iii) packing down b axis, we can see the offset stacking over the 
nitro group 
 
 
However, the 12.03 R % factor from the structures analysis for this new phase is 
slightly high, suggesting poor quality crystals.  New crystals are in the process of being 
grown using different methods and solvents.   
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3.4 Thermal Analysis 
Methods of analysis of the solid-state have been carefully reviewed in the study of 
polymorphic behaviour of crystals (Bernstein, 2002) as well as the solid-state chemistry 
of drugs (Byrn et al, 1999).  For this study we have focussed on the thermal activity of 
the above mentioned screen using the Kofler contact method on a Hotstage microscope 
and Differential scanning calorimetry (DSC). 
 
3.4.1 Hotstage Microscopy 
In this study, the acid and amide was mixed using the Kofler contact method, where one 
end contains pure acid and the other pure amide.  The region in between the pure 
phases, also referred to as the mixing zone, holds the presence of a new phase upon 
heating, this can be observed under a polarised light microscope.  A detailed account of 
the preparation of the slides has been described in chapter 1 and 6.   
The heating stage (Hotstage) was purchased from Linkam, and a Zeiss microscope was 
used which has the axioplan imaging software.  A heating profile from room 
temperature to 260° C at a rate of 1° C per minute was employed.  Images were 
captured at 5x‘s magnification at 60 second intervals.   
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3.4.2 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) is one of the most widely used thermal analysis 
techniques for the characterization of pharmaceutical solids.  It measures the 
temperature and heat flow associated with thermal transition in a material.  Properties 
measured by DSC include glass transitions, ‗cold‘ crystallisation, phase changes, 
melting, crystallization, product stability, and decomposition.  For this study all 
experiments have been carried out for the successful Benzamide co-crystal phases for 
which powder X-ray diffraction has been discussed earlier.  The DSC machine used is a 
TA instruments Q2000.  The temperature axis and cell constant of the DSC cell were 
calibrated with indium (10 mg, 99.999% pure, melting point 156.60 ° C, the heat of 
fusion 28.40 J.g).  A small sample of each co-crystal phase identified from the solution 
screen was weighed to 0.001 mg of quantities of 2-5 mg into aluminium pans, crimped 
with aluminium lids.  All samples where heated from 25 ° C to the relevant temperature 
for each material (up to a maximum of 250 ° C) at 10° C min
-1
.   
 
3.4.3 Thermalgravimetric Analysis (TGA) 
Thermogravimetric Analysis (TGA) measures weight changes in a material as a 
function of temperature under a controlled atmosphere.  TGA is an ideal technique to 
determine the thermal properties of pharmaceutical material.  The same samples were 
analysed using TA instruments Q5000 TGA machine, where quantities of 2-5 mg of 
crystals from solvent co-crystallisation were heated from 25° C to 400° C at 10° C min
-
1
. 
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3.4.4 Thermal analysis Results and Discussion 
Thermal analysis has been used as a method to identify new phases in the solid state.  
The new co-crystal phases discovered by PXRD characterisation and single crystal 
where single crystals have grown from solution screen have been the subject of this 
analysis.  Table 3.6 represents the results of the samples which hold new phases and the 
respective temperatures at which starting material melts and at which the new phases 
emerge and melt away.  The same samples have been investigated using DSC and TGA 
to identify melting points and endothermic peaks which would highlight presence of 
crystallisation upon heating.     
Table 3.6: A summary of the Hotstage microscopy results and DSC endothermic peaks of 
Benzamide co-crystal phases as identified from the solution screen.  The results show the number of 
new phases and the respective temperatures and ratios 
Benzamide Co-crystal 
phases 
Hotstage °C 
DSC endothermic peaks 
°C 
 
Fumaric Acid n/a 139.62    
Tartaric Acid n/a 120.74 141.21   
3-Hydroxybenzoic Acid n/a 93    
Mandelic Acid 76 76.2    
4-Nitrobenzoic Acid 180-185.6 123.47 180.5 184.13 239.81 
Succinic Acid 117 117.07 128.48   
 
The Hotstage experiment has deemed to be very informative as a visual aid of the 
emergence of new phases for Mandelic, 4-nitrobenzoic acid and the already reported 
Succinic acid co-crystal with Benzamide.  However, it has not been possible to identify 
the co-crystal phases of the Benzamide with Fumaric and Tartaric acid, since both the 
pure acid components sublime during the preparation of the microscope slides, where as 
with Benzamide: 3-hydroxybenzoic acid, a microscope slide was prepared but upon 
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heating no new phases emerged.  Below are the images taken during Hotstage for 
Benzamide and Mandelic acid, it is clear to see the new phases for each sample with the 
temperature highlighted in the top left corner.   
Figure 3.10:  Images highlighting the emergence of new phases of the Benzamide Mandelic acid 
system, using Hotstage microscopy with Linkam controlled heating stage mounted on a Zeiss 
Microscope using cross polarised light and axiocam camera at times 5 magnification lens.   
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With the increase in the temperature, the remaining phases melt away at their respective 
melting points.  The images for the whole Mandelic acid experiment and the remaining 
Fumaric and 4-Nitrobenzoic acid can be viewed from the compact disc attached in 
Appendix I.   
DSC has been coupled with the Hotstage microscopy to view endothermic peaks at the 
temperatures as viewed from the Kofler contact method.  These are also displayed in 
Table 3.2.  The DSC traces are given below in Figure 3.11-16 for each sample taken 
from the solution screen.  Each Figure highlights the onset temperature and average 
peak temperature and enthalpy of fusion, ΔHf (J/g) of the samples.   
Figure 3.11: DSC results for Benzamide Fumaric acid co-crystal sample from solution  
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Figure 3.12: DSC results for Benzamide Tartaric acid co-crystal sample from solution  
 
Figure 3.13: DSC results for Benzamide 3-Hydroxybenzoic acid co-crystal sample from solution
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Figure 3.14: DSC results for Benzamide Mandelic acid co-crystal sample from solution  
 
 
Figure 3.15: DSC results for Benzamide 4-nitrobenzoic acid co-crystal sample from solution  
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Figure 3.16: DSC results for Benzamide Succinic acid co-crystal sample from solution  
 
For the samples which sublime during the preparation of the microscope slide for 
Hotstage analysis, it is not possible to make a comparison to validate the findings of the 
Hotstage work, however with Mandelic, 4-Nitrobenzoic acid and Succinic acid, it is 
possible.  The Hotstage for Mandelic shows the appearance of a new phase in the 
mixing zone which melts away at 76 ° C (Figure 3.10), the DSC data shown in Figure 
3.14 is in agreement to the Hotstage result hosting an endothermic peak at 76.2° C.  The 
same trend is displayed for each of the thermal experiments, giving a positive 
correlation of temperature.  As well as the characteristic endothermic peaks for the new 
phases at 180-185.6 ° C (Hotstage) for 4-Nitrobenzoic acid the DSC shows an early 
peak at 123.47 ° C which is not viewed in the Hotstage, and two peaks at 180.5 and 
184.13 ° C, this suggest that during Hotstage it could be possible that there is a 
conversion of the new phase we are seeing.  Also, the DSC pattern for Succinic acid 
sample gives two endothermic peaks, but the Hotstage, only shows one phase present as 
the temperature is increased.   
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The Hotstage microscopy technique seems to be a quick and simple way to screen and 
identify phase changes of binary components.  The DSC technique, also acts as a 
complementary method and can be useful in confirming transition changes which may 
be seen during Hotstage melting.  Although these techniques show some degree of 
agreement with the findings, they have their limitations with respect to these samples.  
To further investigate the work presented here later chapters discuss this initial co-
crystal screen and an expanded screen which utilises the Hotstage microscopy method 
as one route to identify co-crystal phases.   
3.5 Summary 
To summarise, this chapter discusses the techniques used to grow co-crystals and the 
atypical model compound Isonicotinamide was selected, which according to the 
literature tends to be a high yielding supramolecular building block (Aakeroy et, al. 
2002).  In contrast forming co-crystals with the less reported Benzamide as the active 
ingredient was undertaken; which to date has only one reported co-crystal, with the co-
formers which have formed co-crystals with Isonicotinamide .  The methods discussed 
here have been challenging in the approach of yielding nice crystalline material which 
can further be investigated by single crystal, however, we have present two cases where 
structure determination has confirmed two new co-crystals of Benzamide with Fumaric 
acid and Benzamide with 4-nitrobenzoic acid.  To further understand the behaviour and 
nature of why one compound is more robust than another all reported co-crystals 
mentioned from the CSD in this section have been the subject of a closer look at the 
crystal structure and the fragments present that build the crystal.  A collaborative project 
with the University of Glasgow using dSNAP software developed by them is the subject 
of the next chapter.   
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Chapter Four: Investigating and comparing 
structural difference using the structural 
comparison software dSNAP 
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4.1 Introduction  
4.1.1 dSNAP 
The Cambridge Structural Database (CSD) is forever growing, with this and the large 
number of datasets retrieved whilst searching, it can be sometimes difficult to classify 
chemical information.  However, although there are various algorithms and data mining 
strategies in the literature, (Orpen 2002, Allen & Motherwell 2002), there is however a 
niche for a freely available program which classifies results from database searches 
(Aakeroy, Beatty, 2001).  In 2005 Barr et al indicating detail in flexibility presented a 
new developed a new approach encoded in the dSNAP program which is designed to 
assist structural chemist in classifying information extracted from CSD searches.   
4.1.2 What is dSNAP? 
dSNAP is a computer program which classifies and clusters structural fragments 
extracted from the Cambridge Structural Database.  The methodology is based on 
cluster analysis and multivariate data processing of distance matrix information 
describing the extracted fragments. 
 
Previous papers by Barr et, al (Barr et al, 2004-2007) have shown how pattern matching 
coupled with cluster analysis and multivariate statistical methods can be used to classify 
large numbers of powder patterns (PolySNAP) (Krzanowski, 2000).   
 
In this section the term ‗structure‘ and ‗hit‘ refers to individual crystal structure 
determination mined from the CSD, these ‗structures‘ or ‗hits‘ contain the defined 
search query and are labelled by an individual CSD reference code, whilst the term 
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‗fragment‘ refers to the part of the structure matching the search query.  It is possible for 
a structure to contain one or more fragments, these fragments lie in chemically distinct 
environments and thus may exhibit significantly different geometries, these are 
therefore treated independently (Krzanowski, 2000).  In these circumstances, the 
software will suffix individual reference codes with a number consistent with the order 
in which the fragment is outputted, this then allows users to simply reference back to 
the fragments when studying structures within the ConQuest search program (Clegg, 
1998) 
 
4.1.2.1 Algorithms 
All the theory for dSNAP has been published by the authors of the programme.  For this 
work the approach will be briefly summarised to underline why the approach was 
adopted for studies in this thesis.  As mentioned above dSNAP uses Multivariate 
statistical analysis, this is described as a collection of procedures that involve 
observations and analysis of more than one statistical variable at a time.  dSNAP also 
uses clustering analysis which is a multivariate technique.  This section discusses 
Clustering analysis and the hierarchical approach used by dSNAP, and 
Multidimensional Scaling (MDS), (Barr, 2005, 2007, Krzanowski, 2000, Parkin, 2006). 
 
Clustering is the classification of objects into partitioning of a dataset into subsets 
(clusters), this is so that each subset shares some common trait, and this is often 
proximity according to some defined distance measure.  Clustering is a common 
technique for statistical data analysis.   
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Data clustering algorithms can be hierarchical or partitional.  Hierarchical algorithms 
locate successive clusters by using clusters which have previously established, where as 
a partitional algorithm will determine all the clusters at once.  Hierarchical algorithms 
can be agglomerative (‗bottom-up‘), which begin with each element as a separate 
cluster and then merges them into successively larger clusters, or divisive (‗top-down‘) 
algorithms, these begin with the whole set and proceed to divide into successively 
smaller clusters, (Barr, 2006, Parkin, 2006, Krzanowski, 2000).   
 
dSNAP uses agglomerative algorithms to build up a hierarchy of clusters.  This 
hierarchy is presented as a tree diagram (Dendrogram), where at one end of the tree are 
the individual fragments and the other end is a single cluster containing every fragment.   
 
The tree can be cut by a tie bar at different heights, this gives clustering at a selected 
precision of similarity.   
 
dSNAP uses 3D Metric Multidimensional scaling (MMDS) as a visualisation of 
similarities or dissimilarities in data.  Multidimensional scaling uses an algorithm that 
starts with a matrix of item-item similarities, a location is assigned to each item in low-
dimensional space, thus making this method suitable for 3D visualisation. 
 
Metric Multidimensional scaling is a superset of MDS, it generalises the optimisation 
procedure to a variety of loss functions and input matrices of known distances with 
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weights, (Barr, 2005, 2006).  For this reason, the co-crystal system packing subtleties 
would be with prudent use of the code be extracted and analysed.  The authors for 
dSNAP were keen for end users to test their scaling approach to this problem.  In order 
to undertake this analysis the user needs to aware of the variable and data space 
implementation.   
 
4.1.2.2 Variable space 
We have outlined how dSNAP investigates the data space using MMDS algorithms.  
dSNAP also allow users to explore variable space.  This section explains how variable 
space is used in dSNAP.   
 
Variable space is the underlying geometries that are stored in the data matrix x, this can 
be used to create a new distance matrix.  A single fragment will have many variables 
and the complete list of distances and angles completely defines a fragment (Barr, 2005, 
Krzanowski, 2000, Parkin, 2006). 
 
Each column of x contains a distance or an angle, there are m such columns, each of 
these are subjected to linear regression every other column in turn to generate an (m x 
m) symmetric correlation matrix ρv and the corresponding distance matrix dv using 
Equation 4.1, (Barr, 2005). 
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Equation 4.1 Distance correlation matrix 
              (4.1) 
Where  
I = identity matrix 
ρs = correlation matrix corresponding to ds 
 
The ρv and dv matrices can be used to generate a Dendrogram, an MMDS plot etc in the 
same way as d
s.  These can be viewed by accessing the ‗Variables‘ tab which is found 
on the left hand side of the main dSNAP window.  The results are interpreted 
differently, the spheres in the MMDS plot represent features such as a distance or angle, 
and variables that are-clustered tightly together have a high correlation.  This feature 
can also be shown in a Dendrogram (Barr, 2005, 2006).   
4.1.2.3 Data and Variable Space 
We have discussed how dSNAP allows separate analysis on the fragments and their 
underlying structural variables.  In dSNAP these are shown as data space and variables 
space.   
The calculations carried out in the Data Space section of dSNAP are concerned with the 
fragment structures.  This operates by collating all of the geometric data for a single 
fragment and treating it as a single entity to compare against the other fragments in the 
dataset.  This allows the program to calculate similarities between fragments.   
The calculations carried out in the Variables Space section are concerned with the 
geometric variables.  This groups every instance of each variable in all of the fragments 
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available and treating these as a single variables.  This allows trends and clustering of 
geometric variables to be established (Barr, 2005, 2006).   
4.2 Running dSNAP 
4.2.1 Limitations 
Currently dSNAP is limited to approximately 4000 fragments (n) and 4000 structural 
parameters (m) per fragment.  For each fragment only 3-10 atoms of any fragment can 
be used in the analysis. 
4.2.1.1 Program Requirements 
The software is a highly modified and extended version of the computer program 
PolySNAP (Barr, 2004).  The software requires a PC with windows 2000 or XP.  The 
program is written in a variety of languages: the user interface is written in Visual 
Basic, the underlying code is in C++, the graphics is also in C++ and OpenGL, whereas 
the cluster analysis code is written in FORTRAN 95, (Barr, 2006).  For this project, the 
authors of dSNAP; wanted to work in a collaborative contribution with an end user to 
gage the code operation in a new application area of co-crystals, and act on any critical 
issues that arise.   
4.2.1.2 Standard Run 
This section gives an outline of the main stages involved in a standard run and a 
diagram to show the process involved, Figure 4.1, (Barr, 2006).  All of which was 
modified to the needs of co-crystal systems which pertains to the work in this thesis.   
The main stages involved in a standard run are:  
1) In ConQuest, define search fragment of interest. 
2) In ConQuest, define a geometric variable in the fragment. 
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3) In Conquest, perform search. 
4) Export relevant files from ConQuest. 
5) Import and processing of data files into dSNAP. 
6) Perform cluster analysis. 
7) Output results to file and graphically to screen to allow interpretation 
8) Reclassification of results where necessary 
Figure 4.1: The process involved in a standard run of dSNAP (Barr, 2006)  
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4.2.2 dSNAP Features 
dSNAP presents results in Data space and Variables Space, this section discusses the 
key features of dSNAP.  The Cell Display, Dendrogram, 3D Metric Multidimensional 
Scaling, and Numerical Results are discussed when presented in the Data space, for the 
Variables space results, the Cell Display, Dendrogram, 3D Metric Multidimensional 
Scaling, and Numerical Results and Variable space plots will be discussed.  (This information 
has been taken from the online manual which can be accessed via the website, http://www.chem.gla.ac.uk/snap/dSNAP_beta.html)  
 
4.2.2.1 Data space results display 
Cell Display 
This screen is the default graphics pane, see Figure 4.2, all nodes are arranged as 
fragments alphabetically in Refcode order.  It displays the results by colour coding 
groups of fragments belonging to the same cluster group.  This colour labelling is 
derived from the Dendrogram.  The cell display is useful for easily identifying the 
number and variety of fragments in a single hit by displaying all the fragments in a hit 
as well as assigning them to the same or different clusters.  The display window also 
presents a key on the left-hand side with a legend to represent each cluster.  By clicking 
on one of the groups the user can highlight every cell in that cluster, this can be a useful 
feature when dealing with large data sets, (Barr, 2006).   
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Figure 4.2: A typical cell display from the dSNAP output.  The different colours represent the 
different groups that the data has been clustered into.  Each group has a specific feature.   
 
4.2.2.2 Dendrogram 
The Dendogram, see Figure 4.3, displays the results from the cluster analysis and is the 
most important display in dSNAP as it visually presents the results is a hierarchical 
method of classification.  As mention is previously, the Dendogram is like a tree 
diagram, each fragment is represented by one a box at the bottom of the screen.  Figure 
4.3  
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Figure 4.3: Dendrogram presented by dSNAP in the data space results.  This display is a much 
aesthetically pleasing way to view data as compared to the cell display.  Each sample is 
paired/grouped to a conformational/geometrically similar sample.   
 
 
Figure 4.3 shows a typical output, and we can see that the Dendogram shows a scale on 
the vertical axis which is an index of similarity.  The Dendrogram tree branches out 
according to the calculated similarity between the fragments that each branch connects 
to.  A horizontal bar (tie-bar) connects two branches according to the similarity, (Barr, 
2006).  For example the pale blue cluster from Figure 4.3 shows there are two groups 
labelled ULAWO, these are connected nearer the bottom of the Dendogram, this means 
that these two fragments are highly similar and can be justified in being grouped 
together.  On the other hand, two branches that do not meet until nearer the top of the 
Dendogram then the fragments associated are considered to be less similar and more 
loosely related to each other.  In Figure 4.3 this has been highlighted with rings, red for 
similar fragments, and green for less similar. 
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A manually adjustable yellow cut-level is also present on the Dendogram, this decides 
how the Dendogram is split into separate clusters, (Barr, 2006).   
4.2.2.3 3D MMDS Plot 
A multidimensional scaling upon the distance matrix is plotted and shown as a series of 
spheres arranged in 3D space.  Similarity is represented by the spatial distance between 
the spheres in the plot.  Hence, the closer the spheres are the more similar the fragments 
are.  Fragments that are strongly related will group together in the 3D plot and form a 
cluster, (Barr, 2006).   
This 3D screen is the second important visual feature of dSNAP, this allows users to 
interpret the level of similarity between fragments both within a cluster and within the 
whole dataset.  The colour coding for each fragment outlined in the Dendogram applies 
to the 3D sphere as it did in the cell display.  The colour coding connection between the 
two features allows easy comparison of the two methods.  If the cut-level in the 
Dendogram is adjusted, subsequently the colour in the 3D plot is also updated. 
The goodness of fit of the results is indicated in the top-left corner of the display.  This 
is computed as a correlation coefficient between the observed distance matrix and the 
derived calculated one.  The closer the number is to 1.0, suggests a good fit.  Low 
numbers suggest the program may have had trouble adequately partitioning the data, 
(Barr, 2006).   
4.2.2.4 Numerical Results 
This tab displays the correlation matrix generated from the raw numeric data that is used 
as the basis for the cluster analysis.   
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The screen will display the refcodes of the fragments and values which tell users how 
well fragments are correlated.  A value of 1.0 signifies a perfect 100% correlation, 
whereas a value of 0.0 signifies a 0% correlation.  Thus, a value closer to 1.0 the better 
correlation between two fragments, the more similar they are.  It is also possible to have 
negative values.  This suggests anticorrelation, (Barr, 2006).   
 
4.2.2.5 Variable space results display 
The Variables tab on the left-hand tab bar allows users to view the results in variables 
space (Barr, 2006). 
Figure 4.4: Tabs available in the dSNAP screen 
 
4.2.2.6 Cell Display 
 
This display is different to the one discussed earlier.  The cell display presents a display 
with a different number of cells as it is now showing the number of independent 
variables (angles and distances) instead of the number of fragments, (Barr, 2006).   
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Figure 4.5: Cell display in the variables space, each node represented a structural variable in the 
fragment of the structure being probed.   
 
In data space, cells represent single fragments, where as in variables space each cell 
represents a single structural variable in the fragment that was defined in the original 
search query.  Clustering of the variables is according to how well they have correlated 
to each other.  It should be expected that the clusters in variables space will be more 
diffuse than in data space, (Barr, 2006).   
4.2.2.7 Dendrogram 
The Dendogram shows individual defined variables in the fragment.  The tie bars 
indicate the level of correlation between the variables it joins.  Variables that have been 
joined by a low tie bar are highly correlated, in turn, variables joined by high tie bars 
have low correlation.  Variables space can be a useful tool for accessing and interpreting 
the important factors that give rise to the clustering in data space, (Barr, 2006).   
4.2.2.8 3D MMDS Plot 
In data space, each sphere is a representation of individual fragments, whilst in variable 
space each sphere represents a structural variable in the fragment.   
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Spheres that are plotted close to each other are variables that are considered to be highly 
correlated, (Barr, 2006). 
4.2.2.9 Variable Space Scatter Plots 
A scatter plot is opened in a new window by clicking on a cell in the Numerical Results 
pane.  Each of the plotted points represents a fragment, the colours used in the scatter 
plot are taken from the data space Dendogram.  This allows users to analyse any 
possible relationship between trends in particular variable values and the resulting 
fragment clusters, (Barr, 2006).   
A scatter plot can only be created for two different variables.  There will be entries in 
the numerical display where the variable has been correlated to itself and has a 
correlation of 100%, a scatter plot for this is not possible to obtain.  However, for two 
variables with 100% correlation a scatter plot is possible, however this is rare, (Barr, 
2006).   
Figure 4.6: Typical scatter plot viewed from a set of data which give a) scatter plot with poor 
correlation and b) scatter plot of good correlation  
 
4.3 Worked example dSNAP 
Central to the work on the pair wise contacts present in a co-crystal based on amides is 
the intermolecular contacts found in amides and carboxylic acids.  For this reason a re-
run of the   example involving primary amides-carboxylic acid interactions and 
a) b) 
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carboxylic acid-carboxylic-acid motifs of Parkin et al 2006 was undertaken (section 
4.4).  This was also undertaken to ensure the current version of dSNAP available for 
this work was generating outputs consistent with previous studies.  The results 
presented are based on the fragments shown in Figure 4.7.  The fragments had defined 
contacts 1-8 for bond length, angle and torsions and were used to search the CSD, 
(Parkin, 2006).  The results below are taken from Parkin et al 2006, and give an idea of 
the expected output from such fragments.   
Figure 4.7: The two search fragments used.  Contact was defined between any of the atoms 2, 3 or 4 
and any of atoms 6, 7 or 8.  The atom numbering is shown in blue extracted from (Parkin, 2006)  
 
 
A cluster analysis using dSNAP of these fragments gives the following results, (Parkin, 
2006), see Figure 4.8.   
Figure 4.8: Dendrogram and MMDS plot of carboxylic acid-amide interaction, (Parkin, 2006) 
 
 dSNAP is able to represent data in several forms, Figure 4.8 shows the results in both a 
Dendogram format and a Metric multidimensional scaling (MMDS) plot, which is a 
three-dimensional Euclidean space in which one point or sphere represents one 
fragment in the data set.   
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The Dendogram is cut at the 68% similarity level, each cluster is shaded in a different 
colour.  The MMDS clearly shows that there are seven distinct clusters.  Another way 
dSNAP presents its results is through a scatter plot, the results are presented in Parkin et 
al Figure 4.9, (Parkin, 2006). 
Figure 4.9:  (a) Scatter plot of the N4…O7 distance (Dist5) against the O3…O8 distance (Dist10) 
 
 
As a result there are seven different clusters, however there are two distinct clusters that 
have been identified; other clusters are not clearly defined.  It is therefore wise to view 
these 2D scatter plots using two different contacts, Figure 4.10, (Parkin, 2006). 
Figure 4.10:  (b) the C1…C6 distance (Dist23) against the C2…C5 distance (Dist8), for the 
acid…amide fragment. 
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The scatter plot (Figure 4.10) shows a much more clear distinction of groups, and 
therefore suggests that a single parameter or a single pair of parameters is not enough to 
describe all the differences between the individual clusters, and illustrating the 
advantages of including the full geometric description of the search fragment.  The full 
cluster analysis consolidates all these geometric differences, and the structural scientist 
can use the convenient parameter plots to determine the important underlying drivers for 
the geometries obtained, (Parkin, 2006). 
With large datasets, dSNAP allows further classification by re-clustering larger groups 
to reveal sub clusters each of which are chemically and structurally distinct.   
This example was reworked initially to gain a benchmark for running the search in the 
Cambridge Structural Database (CSD).   
4.4 dSNAP results and discussion 
The work presented in this section is in collaboration with Dr Andy Parkin and 
Professor Chris Gilmore of The University of Glasgow.  dSNAP was used to analyse 
acid-amide interactions.  Initially the same acid-amide search done by Parkin et al 2006 
was undertaken using dSNAP version 0.9.5.  The raw files used by Parkin et al 2006 
were requested to see how they carried out the search. Initially the fragment shown in 
Figure 4.11 were drawn in CSD and used, this was the same fragment presented in 
Parkin et al. When searching the CSD, the same search restrictions were employed as 
reported in Parkin et al, this gave 101 hits, this was then put into dSNAP giving the 
following results shown below in Figure 4.13 
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 Figure 4.11: Search fragment employed by Parkin et al 
 
C
O
NH2
C
O
HO
 
Figure 4.12:  Search fragment as it would be drawn in ConQuest, 3D parameters have been selected 
and a contact has been outlined which is less than the sum of the van der Waals radii of the two 
closest atoms (highlighted in pink) 
 
 
Figure 4.13: Dendrogram showing the results from the search presented in Parkin et al (Parkin, 
2006). 
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The Dendogram shows that from the 101 hits, 179 fragments have been derived to have 
the carboxylic acid- primary amide interactions.  As expected the results are the same as 
those reported in Parkin et al 2006 paper, (Parkin, 2006).   
Figure 4.14: 3D MMDS plot of the results from the acid – amide fragment researched by Parkin et 
al (2006).  
 
 
The Dendogram in Figure 4.13 gives the seven clusters presented in the Dendogram and 
the MMDS plot in Parkin, (2006).  However, the research for this project consists of 
looking at carboxylic acid- primary amide interactions of Isonicotinamide and 
Benzamide and a series of carboxylic acid selected from a literature review. However 
the contacts specified were modified to make them relevant to the features in these co-
crystal systems.  Therefore, the search fragment used in the CSD search concentrates 
around the benzene ring where position 4 on the ring is labelled as ‗X‘ allowing for 
searches to include any substitute for the carbon being replaced as ‗N‘ nitrogen with an 
amide feature, this is shown in Figure 4.15: 
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Figure 4.15: Acid - Amide fragment used for the work in this project by searching the Cambridge 
structural database   
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The ConQuest (.cqs) file used by Parkin (2006) was adapted to show the fragment of 
interest to this research, Figure 4.16.  This was done so that dSNAP is able to calculate 
and cluster the similarities between two atoms using a larger peripheral.  An interaction 
was defined as a contact that is less than the sum of the Van der Waals radii of the two 
closet atoms.  Geometric parameters were identified and the CSD search was observed 
(Figure 4.16 below).  The CSD produced 57 hits from which dSNAP successfully ran 
the file producing 108 fragments which contain the carboxylic acid – primary amide 
fragment shown in Figure 4.16.   
Figure 4.16: CSD snap shot showing the fragment and all requested bond length and angles 
highlighted for the search.   
 
 
The dSNAP analysis shows a Dendogram very different to the ones shown earlier.   
117 
 
Figure 4.17: Dendrogram output of search results exported into dSNAP for this project.  Nine 
distinct groups have formed from the clustering analysis.   
 
 
The similarity bar of the Dendogram was set to 68%, showing that there are 9 distinct 
clusters.  The 3D MMDS plot shows an interesting image of clusters.  It can be seen that 
there are two clustering groups opposite to each other which are then sub clustered with 
respect to what is shown in the Dendogram.    
Figure 4.18: 3D MMDS plots showing the distribution of the fragments in 3D space,  showing the 9 
clusters and how they correlate 
  
By selecting the ‗Numerical results‘ tab, and then selecting the variables tab on the top 
left-hand side of the pane, angles and distances can be selected and compared by 
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plotting Variable scatter plots.  The dSNAP program automatically highlights 
significant correlation in bold.  However, in this instance the numerical result did not do 
this even when the cut-off value for the correlation was set higher/lower from the 
default of 0.8.  However, the data in the Numerical results tab show Figures of above 
0.8, but upon viewing the plot we see that the clusters identified in the Dendogram are 
scattered everywhere where as in the examples presented in Parkin (2006)  we would 
expect individual groups to be clustered in a linear or a group orientation.  Below we 
see a plot with a correlation of 0.922, Figure 4.19 
Figure 4.19: Scatter plot of d_2_4 against d_1_4, a linear clustering is expected but not seen here.   
 
 
This has been communicated to the Glasgow group, suggestions have been made that 
this is due to symmetry of atoms outlined in the CSD search, this is especially in the 
case of the acid groups. 
As mentioned previously, the Dendogram shows that there are 9 groups which can be 
viewed in the 3D feature of dSNAP.  This allows us to see how the contacts have been 
distributed between a primary amide and Carboxylic acid groups.  All observations are 
outlined in Table 4.1 
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Table 4.1: A summarised account of the observations of the clusters grouped in the Dendrogram 
Group  
A Acid-Pyridine Motif orientation, where O2 is orientated towards the N on 
Pyridine ring and O3 is away from it 
B Acid-Pyridine Motif slightly offset 
C Acid-Amide Motif slightly offset 
D Not clear-requires subclustering 
E Facing amide, showing the dimer interactions 
F Not clear-requires subclustering 
G Shows dimer and some deviations from it 
H Acid group facing pyridine ring 
I Acid group facing pyridine ring 
 
The most common motifs observed are of hydrogen bonded dimer which involves 35 
fragments and acid-pyridine motif involving 73 fragments.  However, as reported in 
Parkin et al, these groups do not represent the limits of the classification process.  Each 
of the larger groups can be re-clustered individually this should reveal further sub-
clusters each of which are chemically and structurally distinct, these can then be further 
clustered if necessary.  Appendix E presents the re-clustering of group, A, C, E, F, G 
and H.   
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Within the re-clustering, using its internal 3D viewer, dSNAP allows you to look at 
each node/group and the fragment(s) which is related to the node/group.  However, this 
only shows one interaction which is exhibited by the molecules in the fragment.  
4.4.1 Results of Re-clustering 
Systems which were used in the experimental have been highlighted and analysed.  A 
mono-carboxylic acid (Cinnamic acid, LUNMAI), di-carboxylic acid (Succinic acid, 
LUNNUD, LUNNUD01) and a benzoic acid derivative (3-Hydroxybenzoic acid, 
LUNMEM) have been selected and the analysis of which is reported here.   
 
Figure 4.20: Fragment viewer of re-clustered group Aa.  Fragment shows the pyridine ring pointing 
towards the acid group.   
 
 
In order to get a broad perspective of other interactions involved, dSNAP integrates 
with Mercury which allows users to look at the fragments in a particular clustering 
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presented in dSNAP.  This allows further analysis of packing patterns within a 
particular clustering. 
With reference to the re-clustered groups presented in Appendix E it is observed that the 
re-clustering of Group A re-clusters to a further 4 different cluster which have the same 
acid-pyridine interaction shown in the fragment viewer (Figure 4.20).   
4.4.2 Cinnamic Acid: Isonicotinamide Co-crystal 
Cinnamic Acid is a monocarboxylic acid and it has been found to have 4 substructures 
according to the CSD hit list.  These are read into dSNAP as LUNMAI_01, _02, _03, 
_04.  From the analysis carried out we see that Group Aa clusters LUNMAI_02 and _03 
to have some geometrical similarities, and Group Ce clusters LUNMAI_01 and _04 to 
have similarities.   
Selecting fragments from Group Aa Dendogram and opening into the internal fragment 
viewer we see that dSNAP has clustered this structure according to an acid-pyridine 
interaction.  
Figure 4.21: Typical Acid-Amide interaction observed in dSNAP 
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Viewing up the Y axis of the 3D plot we are able to see that the molecules are not 
entirely planar.  There is some deviation from the acid-pyridine interaction presented 
even though both fragments are within the same crystal structure.   
Figure 4.22: Fragment viewer of Cinnamic Acid : Isonicotinamide Co-crystal from dSNAP search. 
Highlighting the acid-pyridine interaction and a the conformation of the functional groups which 
make up the fragment of the Cinnamic acid : Isonicotinamide system    
  
 
Selecting the Cinnamic fragments from Group Ce Dendogram (see Appendix E) and 
opening into the internal fragment viewer we see that dSNAP has clustered this 
structure according to an acid-amide interaction with neighbouring supermolecules 
(Figure 4.23-24).   
Figure 4.23: Acid-Amide interaction of neighbouring molecules.   
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Figure 4.24:  Fragment viewer showing the configuration of the Cinnamic fragments clustered in 
Group Ce 
  
It is clear from the fragment viewer that these substructures are deviating from each 
other even though they present the same interactions with the same structure.   
The distortion and how the substructures are interacting beyond the acid-pyridine 
interaction outlined by dSNAP can be further investigated by using Mercury. 
4.4.2.1 Mercury analysis of LUNMAI  
It is observed that this crystal structure is formed from 4 components.  The primary 
interaction outlined is the acid-pyridine and the amide-amide homosynthons.  At first 
glance it looks like both substructures _02 and _03 are identical, however on close 
inspection this is not the case.   
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Figure 4.25: (i) Presents the LUNMAI fragments viewed in Mercury.  The conformation and 
distortion is shown in (ii) and (iii) 
 
  
 
Figure 4.25 (i) shows that the substructures are orientated opposite to each other.  In 
substructure _02, the carboxylic acid is orientated with the acid group facing the 
pyridine ring of the primary amide, Isonicotinamide, with a hydrogen bond forming 
from the nitrogen of the pyridine to the acid, NO-H.  Literature, (Aakeroy, 1997) 
suggests that there is flexibility in the geometry of the supermolecule due to rotation 
LUNMAI_03 
LUNMAI_02 
LUNMAI_03 
LUNMAI_02 
LUNMAI_03 
LUNMAI_02 
i) 
iii) 
ii) 
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around this NO-H hydrogen bond.  Such molecules can either be organised in a trans-
trans-trans conformation or cis-trans-cis conformation.  
Scheme 4.2.1: trans-trans-trans configuration 
R
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H
H O
N
H
N O
O
  
Scheme 4.2.2: cis-trans-cis configuration 
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In the case of Cinnamic acid Isonicotinamide and as reported in (Aakeroy, 2002) these 
substructures are in the trans-trans-trans conformation, with respect to its near planar 
geometry, the carbonyls from the acid and the amide are organised in this fashion.  
Figure 4.26-28. 
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Figure 4.26: Mercury view of Cinnamic Acid : Isonicotinamide co-crystal,  Amide-Amide 
interactions are highlighted, along with an Acid-pyridine interaction.   
 
Figure 4.27:  Trans-Trans-Trans conformation highlighted in Cinnamic Acid : Isonicotinamide co-
crystal 
 
Extension along the secondary interaction of such trans-trans-trans supermolecules 
results in an interconnection via anti-amide proton and carbonyl oxygen, this produces 
an infinite 1D tape (Aakeroy, 2002) Figure 4.28 shows the graph set of the infinite tape.   
  
Trans Trans 
Trans 
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Figure 4.28: The extended a infinite tape is formed, and a secondary ring, R
4
4(22), via N-H∙∙∙O and 
O-H∙∙∙N hydrogen bonds between the supermolecules 
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4.4.3 3-Hydroxybenzoic Acid: Isonicotinamide Co-crystal 
The crystal structure of 3-Hydroxybenzoic Acid with Isonicotinamide, has three 
substructures.  LUNMEM_01, _02, and_03.  The dSNAP program has clustered all 
three of these substructures into three different groups.   
LUNMEM_01 appears in group Aa, _02 in group Ca and _03 is found in group Ce.   
Group Aa, is a cluster that consists of fragments with acid-pyridine interactions.  Figure 
4.29 shows the 3-hydroxybenzoic acid: Isonicotinamide fragment view in the fragment 
viewer.   
Figure 4.29: 3-hydroybenzoic Acid: Isonicotinamide (LUNMEM) fragment from Group Aa 
 
 
Group Ca is a clustering of fragments which have the O2 positioned towards N1 of the 
Pyridine ring, slightly offset in orientation to group A sub cluster.  This is shown in 
Figure 4.30. 
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Figure 4.30: 3-hydroxybenzoic Acid fragment from Group Ca  
 
Group Ce is representing fragments with Orientation of acid group next to the amide 
group.  LUNMEM_03. 
Figure 4.31:  3-hydroxybenzoic acid : Isonicotinamide orientation view in the fragment viewer 
   
 
4.4.3.1 Mercury analysis of LUNMEM 
The first interaction is the acid-pyridine as outlined in group Aa as substructure 
LUNMEM_01.  Upon extension, we see a four component structure, where primary 
interactions are via acid-pyridine and a complementary homodimer is observed.  
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Isonicotinamide forms amide-amide homosynthon, R
2
2(8) with another Isonicotinamide, 
the primary aromatic nitrogen forms acid-amide interactions D
1
1(2),  
Figure 4.32:  Co-crystal for 3-hydroxybenzoic Acid: Isonicotinamide shown in Mercury, 
Interactions have been highlighted as amide-amide dimers and acid-pyridine interactions.   
 
Adjusting the viewing of the supermolecule we can see a near planar geometry, Figure 
4.33.  
Figure 4.33: Near planar geometry of the co-crystal for 3-hydroxybenzoic Acid: Isonicotinamide 
shown in Mercury 
   
Again a trans-trans-trans conformation has resulted, see Figure 4.34.   
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Figure 4.34:  Trans-Trans-Trans configuration of LUNMEM co-crystal.   
 
Group Ca observes the O2 positioned towards N1 of the Pyridine ring in the fragment 
but slightly offset.  However, upon viewing this in Mercury there is actually a short 
weak contact between C1 of Isonicotinamide and C13 of the acid.   
Trans 
Trans 
Trans 
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Figure 4.35: Mercury analysis of 3-hydroxybenzoic acid and Isonicotinamide, a discrete hydrogen 
bond has been picked up by dSNAP, this has been highlighted in Mercury to show there is some - 
stacking observed.   
 
Fragment LUNMEM_03 is clustered in the Ce group, this group shows the acid group 
next to the amide group in a perpendicular manner.  This is an N-H∙∙∙O interaction, 
which connects two chains to form 2D cross-linked laddered network.  Figure 4.36   
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Figure 4.36: i) Discrete interaction between N-H…O iii) Mercury analysis of the secondary ring formed 
via a N-H∙∙∙O and O-H∙∙∙O hydrogen bond interaction, giving R44(22) ring ii) Extension of the 
intermolecular interactions gives a laddered conformation  
  
 
 
 
 
 
 
Within this ladder conformation a secondary ring is formed via this N-H∙∙∙O and O-
H∙∙∙O hydrogen bond interaction, giving R44(22) ring.   
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4.4.4 Succinic Acid: Isonicotinamide Co-crystal 
Succinic acid is a di-carboxylic acid that has been reported to co-crystallise with 
Isonicotinamide, (Aakeroy, 2006).  The CSD shows that there are two structures 
reported, LUNNUD and LUNNUD01.  In our investigation using dSNAP both 
structures were included.  As a result, Group Fc clusters substructures LUNNUD_03 
and LUNNUD01_03, Group Fe clusters fragments LUNNUD_02 and LUNNUD01_01 
and Group Hd clusters LUNNUD_01 and LUNNUD01_02.   
Group Fc shows that the corresponding fragments have the acid group positioned near 
the pyridine, above/below plane   
Both LUNNUD_03 and LUNNUD01_03 have the same interaction with no deviation 
being picked up by dSNAP.  The fragment viewer shows that the acid group is 
positioned in the opposite direction to the amide, it is located above/below amide of the 
Isonicotinamide molecule.   
Figure 4.37:  Fragment viewer showing LUNNUD_03 and LUNNUD01_03 from Group Fc.   
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4.4.4.1 Mercury analysis for LUNNUD from Group Fc:  
The contact from the cluster analysis does not become obvious when opening the 
selected fragments in Mercury.  dSNAP has clustered the two fragments to have a O-
C∙∙∙C (3.392) and O-C∙∙∙O (3.219), this is only highlighted when the ‗short contacts‘ 
option is selected from Mercury.   
Figure 4.38: Interaction of LUNNUD_03 in Mercury 
 
 
Figure 4.39: Interactions highlighted in Mercury of fragment LUNNUD01_03 
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The fragments look exactly the same and so do the contacts with very little deviation.  
Extension of the primary contacts and the short contacts, we see that the fragment 
extends to layer as infinite sheets. 
Group Fe clusters the LUNNUD_02 and LUNNUD01_03 fragments to have acid 
group‘s located next to amide this suggests that there is some acid-amide interaction, 
Figure 4.40.  
Figure 4.40:  dSNAP Viewer showing the LUNNUD_02 and LUNNUD01_03 fragments 
 
 
4.4.4.2 Mercury analysis of LUNNUD_02 and LUNNUD01_03  
Mercury shows that the dSNAP observation is true; there is an interaction between the 
amide of Isonicotinamide and the carbonyl of the acid, N-H∙∙∙O.   
Figure 4.41:  Mercury analysis of Fragments LUNNUD_02 and LUNNUD01_03, interaction 
highlighted to show interaction between the amide of Isonicotinamide and the carbonyl of the acid, 
N-H∙∙∙O and acid-pyridine interactions 
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On extension of the N-H∙∙∙O interactions we see an infinite 1-D chain, which holds a 
R
4
4(28) and R
6
6(26) ring.  This is shown in Figure 4.42 and Figure 4.43.   
Figure 4.42: Extended sheet of co-crystal Succinic Acid : Isonicotinamide LUNNUD.  
 
 
Figure 4.43: Extended sheet of co-crystal Succinic Acid : Isonicotinamide LUNNUD01 
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Group Hd clusters LUNNUD_01 and LUNNUD01_02 to have O3 of the acid group 
facing towards N1 of pyridine.  This observation suggests that these fragments both 
exhibit the expected acid-pyridine interaction.   
Figure 4.44: Fragment viewer showing the LUNNUD_01 and LUNNUD01_01 fragments Clustered 
by dSNAP in group Hd 
  
 
4.4.4.3 Mercury analysis of LUNNUD_01 and LUNNUD01_02 
This example of Succinic Acid with Isonicotinamide, forms the expected acid-Pyridine 
hydrogen bonds, D
1
1(2), additionally upon expansion of the chain a homomeric self 
complementary amide-amide interaction R
2
2(8) is also observed (Figure 4.42-43).   
Another observation is the conformation of the molecules which make the supermolcule 
of di-carboxylic acid-amide.  This example differs from the monocarboxylic acid-amide 
and the benzoic acid derivative co-crystal structures presented in this section.  The 
conformation we observe is of a cis-trans cis conformation, Figure 4.45 
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Figure 4.45:  Cis-Trans-Cis conformation exhibited in the Succinic Acid-Benzamide co-crystal 
 
 
4.4 Summary 
 
The dSNAP analysis has been identified as a way forward, even with the code having 
issues with the symmetry of dimer pairs and the low number of Isonicotinamide co-
crystal in the database (N = 20).  The analysis by this means did highlight the subtleties, 
which were present in the packing motifs of the Isonicotinamide co-crystals.  In 
particular, the presence of chains with differing conformational orientation as these 
chain assemblies pack together to form the overall structure.  In particular the cis and 
trans orientation of the amide and acid carbonyl to each other and the planar and off 
planar layer assemblies.  All of which are required to maximise the hydrogen bond 
usage of the components comprising the co-crystals.  To further understand this 
behaviour of the model component comparison, attempts to maximise and grow single 
crystals have further been identified with the use of a high through-put screen coupled 
with further collaboration with the University of Glasgow to beta test the polySNAP 
software on screening co-crystals.   
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Chapter Five: Investigating and comparing 
co-crystallisation of 1° amides with 
carboxylic acids.  High through-put 
approach 
 
 
  
141 
 
5.1 Introduction 
A critical but potential rate-limiting step in co-crystal studies is the effort and 
turnaround of the initial screening for new entities.  To date low through-put and 
conventional approaches have been employed.  In order to potentially expand the data 
set required to address the focus of the project; which was to develop an understanding 
of the success rate profile noted for certain coformers with a Benzamide and 
Isonicotinamide.  The low through-put of conventional approaches was ported to a high 
throughput platform, with the assigned combinatorial set of condition set to search and 
fine tune crystallisation conditions pertaining to cooling rates, solution loading and 
solvent. 
 
This chapter describes the attempt to apply a high through-put to screening techniques 
to explore further the combinatorial crystallisation conditions associated with screening 
for co-crystals.  One allied outcome of this high through-put work was to enable the 
industrial partners to develop an in house protocol for co-crystal screening, and to 
assess how efforts of the partner companies and academic collaborators involved in 
diffraction setup (Pharmorphix), diffraction outputs (Syngenta, and Bradford) and 
diffraction analysis (polySNAP Glasgow) would integrate overall.   
The work presented was undertaken using the facilities at Syngenta Ltd Huddersfield 
site, where a High-through-put robot, Crissy® -Automation Platform by Zinsser 
Analytical, was made available to screen for co-crystals at various compositions.  For 
this work the laboratory screen initially used in previous chapters was further extended 
using the synthon approach, where compounds which hold desirable and most 
favourable donor/acceptor sites have been selected as the coformers for this screen.  All 
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the compounds to act as co-formers were selected from Sigma-Aldrich and ordered by 
Syngenta, these were further reduced from the hundreds available to 16 co-formers.  
The active ingredients were as before, Benzamide and Isonicotinamide with the addition 
of Nicotinamide.  The co-formers selection was based upon functional groups 
configuration by expanding co-former set to iso structural mono-carboxylic acid, di-
carboxylic acid and benzoic acid derivatives, and varying solvent polarity by including 
the following four solvents, o-xylene, isohexane, ethyl acetate and methanol all of 
which meet health and safety according to Syngenta laboratory policy.  All materials 
were approved and bought by Syngenta.   
 
Analysis of the data from the screen was sent to Pharmorphix for characterisation using 
a General Area Detector Diffraction System, better known as GADDS. The issue with 
using reflectance GADDS diffraction data is peak width, and resolution and background 
noise is prevalent in such diffraction patterns, and as such present a challenge with 
regards to data analysis.  Currently PolySNAP offers a platform to address this and the 
diffraction type would be a challenge to the algorithms, and for this reason, this was 
undertaken in collaboration with Prof Gilmore‘s group and Dr Parkin (Glasgow).   
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5.2 Experimental 
The screening grids were designed with the assistance of Dr James Forrest at Syngenta, 
the grids were set out to accommodate 1:2 , 2:1 and 1:1 ratios of the 3 active ingredients 
(AI), (Benzamide, Isonicotinamide, Nicotinamide), with the 16 conformers, and the four 
solvents. Evaporation plates with 96 wells were used; this allowed plates to be split into 
2 accommodating 16 coformers at a time and two solvents per active ingredient.  Please 
refer to Appendix F for full plate format used for high through-put screen.   
Co-crystallisation was attempted from supersaturated stock solutions of active 
ingredients and coformers, all weights and measurements of solvents used are given in 
the table below.  The stock solutions are placed in a rack along with the solvents which 
are to be used, all the data in table 5.1 and the plate format from Appendices c was input 
into a spreadsheet which programs the Zinsser of how much sample to inject into each 
well and at which ratios.   
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Table 5.1: Summary of the quantities used in the dispensing process for High through-put experiment with Zinsser Robot 
  RMM 
(g) 
Solubility 
(%) 
Solvent Mass 
(g) 
Solvent Volume 
(ml) 
Concentration 
(M/l) 
 Benzamide 121.14 10 Methanol 4.00 40 0.825 
 Isonicotinamide 122.12 10 Methanol 4.00 40 0.819 
Coformer no. Nicotinamide 122.12 10 Methanol 4.00 40 0.819 
1 1, 4 Benzene dimethanol 138.16 5 Propanol 1.75 35 0.362 
2 2 Nitrobenzoic acid 167.12 10 Methanol 1.75 17.5 0.598 
3 3 Aminobenzoic acid 137.14 3 Methanol 0.88 35 0.183 
4 3 Nitrobenzoic acid 167.12 10 Acetone 1.75 17.5 0.598 
5 4 Aminobenzoic acid 137.14 10 Methanol 1.75 17.5 0.729 
6 4 Nitrobenzoic acid 167.12 3 Acetone 0.88 35 0.150 
7 Adipic acid 146.14 10 Methanol 1.75 17.5 0.684 
8 Butanoic acid 88.1 10 Methanol 1.75 17.5 1.135 
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9 Fumaric acid 116.07 5 Methanol 1.75 35 0.431 
10 Maleic acid 116.1 10 Methanol 1.75 17.5 0.861 
11 Malic acid 134.09 10 Methanol 1.75 17.5 0.746 
12 Phthalic acid 166.14 5 Ethanol 1.75 35 0.301 
13 Pimelic acid 160.17 10 Methanol 1.75 17.5 0.624 
14 Succinic acid 118.09 10 Methanol 1.75 17.5 0.847 
15 Tartaric acid 150.09 10 Methanol 1.75 17.5 0.666 
16 Trans  hydromuconic 
acid 
144.13 3 Methanol 0.88 35 0.174 
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A total of 6 plates containing 96 wells were ran on the Zinsser, after the evaporation 
process the plates were dispatched to Pharmorphix Ltd who obtained the PXRD for 
each well, using a reflectance D8 Bruker GADDS diffractometer. The PXRD patterns 
obtained were then analysed using PolySNAP.  
 
5.3 Results and Discussion 
The GADSS diffraction data generated was analysed using the program PolySNAP 
courtesy of Prof Chris Gilmore and Dr Gordon Barr of the University of Glasgow. This 
collaboration was motivated by the need for users to further test the types of diffraction 
data the PolySNAP approach would be capable of processing,  in this case, GADSS 
data with high noise and of low resolution with non uniform base line.   
5.3.1 PolySNAP 
In previous chapters we have discussed dSNAP and how this program clusters discrete 
interaction in a large dataset.  Another program also developed by the Gilmore research 
group at University of Glasgow is PolySNAP.   
Previous papers by Barr ( 2005, 2006) have shown how pattern matching coupled with 
cluster analysis and multivariate statistical methods can be used to classify large 
numbers of powder patterns (PolySNAP) (Krzanowski, 2000).   
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5.3.1.1 What is PolySNAP? 
PolySNAP is a software package that is designed to match and analyse full profile 
spectral, powder patterns and other numerical data.  The use of full profile allows for 
more flexible and accurate identification of samples, even when data quality is low or 
when preferred orientation effects are significant.   
The software provides a user-friendly interface and several powerful and novel 
statistical methods to rank samples in order of their similarity to any other selected 
sample, allowing unknowns to be quickly identified.  In quantitative mode, patterns of 
mixtures and potential pure phases can be identified.   
The matching procedure can be automated for computer-controlled high-throughput 
analysis.  An unlimited number of patterns can be prescreened, and PolySNAP allows 
for datasets of up to 1, 500 patterns with four different data types to then be analysed in 
a single run, and provides highly flexible graphical output to summarise and visualise 
the results.  This highlights any unusual data, and means that time is not wasted looking 
at the many patterns that behave exactly as expected.  It can work with or without the 
provision of reference patterns, and includes additional features such as an automated 
report writer and a logfile to assist with audit trail procedures. 
The key component of the program is the visualisation tools based on Dendrogram and 
pie charts, as well as principal-component analysis (PCA) and metric multidimensional 
scaling as a basis of three-dimensional score plots.  Below, Figure 5.1, displays a flow 
chart representation of the main processes, further details of the methods are explained 
in previous papers by Barr et al (Barr, 2005, 2006, Parkin, 2006). 
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Figure 5.1: Flow chart representing the main processes and methods involved in the polySNAP 
program  
 
 
In this research, PolySNAP has been used to cluster powder pattern profiles generated 
from the high through-put screen approved and initiated in site at Syngenta 
Huddersfield.   
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The screening set consists of 6 plates, full analysis and examination of the results of 
plate BD001 is detailed in the next section and a brief discussion of the remaining 
plates, BD002-6. Tabulated results of plates 2-6 can be found in Appendix (F) 
5.3.2 Analysis of Plate BD001 
Plate one of the screen was of Benzamide with the 16 coformers in ratios 2:1, 1:1, 1:2 
and two solvents o-xylene, and isohexane.  The raw files from Pharmorphix were input 
into polySNAP and the cluster analysis was run.  The output seen in the cell display and 
Dendrogram is presented in Figure 5.2 and 5.3.   
Figure 5.2: Plate BD001 output of the PolySNAP analysis viewed in the Cell Display.  The different 
colours highlight clusters of groups with similarity.   
 
Figure 5.3: Output from Dendrogram Display, this shows the clustering in a tree diagram form. 
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Here, we see that polySNAP has successfully read the data files and clustered into 27 
groups, each sample has been denoted with a number, 1-96, which is in accordance to 
the PXRD raw files generated by Phamorphix.   
PolySNAP also produces a logfile, from which the amorphous samples have been 
highlighted as shown below   
 
\par Sample OS_BD001_01_18.raw has only 1 marked peaks, and an amorphous indicator of 95.2 - 
Probably amorphous. 
\par Sample OS_BD001_01_27.raw has only 1 marked peaks, and an amorphous indicator of 95.6 - 
Probably amorphous. 
\par Sample OS_BD001_01_49.raw has only 1 marked peaks, and an amorphous indicator of 95.7 - 
Probably amorphous. 
\par Sample OS_BD001_01_51.raw has only 1 marked peaks, and an amorphous indicator of 95.8 - 
Probably amorphous. 
\par Sample OS_BD001_01_87.raw has only 0 marked peaks, and an amorphous indicator of 96.1 - 
Probably amorphous. 
\par Sample OS_BD001_01_89.raw has only 0 marked peaks, and an amorphous indicator of 96.0 - 
Probably amorphous. 
\par Sample OS_BD001_01_91.raw has only 1 marked peaks, and an amorphous indicator of 96.1 - 
Probably amorphous. 
\par Sample OS_BD001_01_92.raw has only 0 marked peaks, and an amorphous indicator of 95.5 - 
Probably amorphous. 
\par Sample OS_BD001_01_94.raw has only 1 marked peaks, and an amorphous indicator of 95.1 - 
Probably amorphous. 
\par 9 samples were flagged as possibly non-crystalline. 
 
These files were extracted out of the data set as were other files that gave poor spectra.   
The remaining samples from the high through-put were re-run into polySNAP along 
with the raw files of pure components using the quantitative mode; this element of the 
program allows patterns of mixtures and potential pure phases to be identified.   
Once matching analysis finished the users can view the ‗cell display‘ tab.  Here, users 
are able identify samples which are new phases, amorphous and mixtures, however in 
this case and for each plate this was not possible to achieve as the expected cell display 
was not visible, just a black background.  This error/bug in the program has been 
communicated to Professor Gilmore‘s research group at The University of Glasgow.   
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The Dendrogram display was visible and clustering is shown below.  Upon looking at 
the logfile and further communication with Dr Gordon Barr of the University of 
Glasgow, the quantitative results from the logfile are meaningless due to the huge 
background noise in the data and the poor correlation in the clusters.   
The dataset was run again with the following advanced options tick boxed in order to 
subtract the background noise: 
 
 
The cell display was visible and is shown below Figure 5.4.  The remaining samples 
after eliminating amorphous and poorly diffracted sample and eliminating background 
noise have all been highlighted as 'Other' as suggest from the key on the left hand side 
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this suggests that these may possibly be co-crystals as neither of the pure components 
powder patterns have been identified by this clustering analysis.   
Figure 5.4: Output from Cell Display, highlighting samples from the plate which have been 
coloured in a stripy brown manner, from the key on the left this suggest that these samples are 
‘Other’ and not any of the pure components   
 
The Dendrogram below had a cut point of 0.4, however this was adjusted to 0.61 which 
is below the upper confidence level, this results in a cluster analysis giving 31 groups in 
their individual colors, Figure 5.5  
Figure 5.5: Output from Dendrogram Display with a cut level adjusted to 0.61, this shows the 
clustering in a tree diagram form.  The clusters are different colours according to samples which 
hold similar pattern profiles.   
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It is possible to examine these clusters and compare powder patterns using the PXRD 
pane, which is located below the dendrogram window in the polySNAP program.  
Hopefully by cross-referencing with the plate format in Appendix F the groups should 
consist of samples with same components.  Below are the results of plate 1 tabulated, 
which have clustered as explained. 
Table 5.2:  Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 02, 08 3 (1:2, 1:2) 
Yellow 03 6 (1:1) 
Green 17 12 (2:1) 
Light Blue 35 12 (1:1) 
Blue 48 15 (1:1) 
Pink 09, 21 
10 
6 (1:1, 1:2) 
9 (2:1) 
Stripy Brown 58  
Stripy Green 14, 20, 26 4, (2:1), (2:1), (1:1) 
Stripy Greeny Blue 15,  
32, 38 
6 (1:2) 
4 (1:1), (1:2) 
Stripy Light Blue 12 14 (1:1) 
Stripy Purple 77 13 (1:2) 
Stripy Pink 62,  
79 
5 (1:1) 
3 (2:1) 
Salmon Pink 64 10 (1:2) 
Pastel Yellow 41 12 (1:2) 
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Pastel Green 22 9 (1:1) 
Pastel Light Blue 11 11 (1:2) 
Pastel Sky Blue 59, 71 13 (2:1) (1:1) 
Pastel Pink 65 13 (1:1) 
Stripy Brown 24 14 (1:2) 
Stripy Green 54 15 (1:2) 
Stripy Greeny Blue 42 15 (1:1) 
Stripy Blue 76 11 (2:1) 
Stripy Purple 66 16 (2:1) 
Stripy Pink 72, 84 16 (2:1) (1:1) 
Pale Orange 78 16 (1:1) 
Pale Yellow 30, 60 15 (2:1) (1:2) 
Pale Green 70 10 (1:2) 
Pale Blue 40 10 (2:1) 
Pale Sky Blue 53 13 (2:1) 
Pale Pink 82 11 (2:1) 
Stripy Light Brown 80 5 (1:2) 
 
From table 5.2 it shows there are some clusters which included samples with differing 
components, but many clusters include two or more samples clustered with same 
samples in their respective ratios and solvents.   
The results of plate one show that there are many samples that have clustered with 
sample with similar components and composition which are available in different 
solvents, however, there are still many samples within the dataset with poor powder 
patterns.   
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The 3D MMDS presents these results in 3D space, samples that are similar will be 
clustered close to each other whereas unlike samples are far apart.  For plate BD001 the 
resulting MMDS plot is given below in various view points to appreciate the spread of 
the data.   
Figure 5.6: Various views of the 3D MMDS plots for plate 1 
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It is clear to see that the MMDS plot data set highlights a spread of the data with only 
samples 20 and 26 clustered close together and have the highest similarity in their 
respective powder pattern.   
 
Figure 5.7: A zoomed in view of the MMDS plot of plate 1 showing samples 20 and 26, which 
cluster close together as compared to the other samples 
                                                                                                  
Below we see patterns 20 and 26 overlaid in pattern viewer.  PolySNAP gives these 
patterns a similarity rank of 0.949.  We can see that there is similarity in the patterns 
and these two samples would be the exact same crystalline material produced from the 
co-crystal screen.                                                                                                                                                                                                       
 
Form the table and the dendrogram analysis above we know that these sample consist of 
Benzamide with coformer 4 which is 3-nitrobenzoic acid at ratios 2:1 for sample 20 and 
1:1 for sample 26.   
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A comparison with the AI, Benzamide and the carboxylic acid co-former, 3-
nitrobenzoic Acid, it is possible to identify characteristic peaks from the starting 
components in the final product and highlight new peaks which suggest a new phase has 
been formed.  Figure 5.8 depicts the sample 20 and 26, and overlays them with the pure 
components which enables us to view whether a new phase peak is present.  
 Figure 5.8: Powder patterns display of the sample 20 and 26 overlaid with the pure components to 
identify peaks that suggest new phases 
 
The characteristic peaks according to the pure components can be identified between 2θ 
angles of 22-24˚, which could be from both Benzamide, and 3-nitrobenzoic acid.  A 
Benzamide peak at 16˚ 2θ is also present in both sample 20 and 26.  Peaks between 14-
16˚ 2θ and at 26.2˚ 2θ suggest a new phase is present as neither of these peaks are 
present in the starting components.   
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5.3.3 Summary of the  Analysis of Plate BD002 
Plate two of the screen was of Benzamide with the 16 coformers in ratios 2:1 1:1 1:2 
and two solvents ethyl acetate, and methanol.  The raw files from Pharmorphix were 
input into polySNAP and the cluster analysis was run as highlighted above. Appendix F 
shows the cell display and Dendrogram of plates 2-6 
Again polySNAP has clustered samples with similar ratios and same components 
together as well as samples with different coformers such as the light blue, stripy greeny 
blue and stripy light blue groups. (Appendix F a shows the clustering in the 
Dendrogram BD002)   
Observing the MMDS plot, Figure Fa1 (appendix F ) the data is spread with only a 
close cluster present in the light blue group and a clustering with the salmon pink and 
pastel yellow group.  Further examination as presented in appendix c shows that 
although the software has clustered a well defined groups, to maximize and fully 
understand the findings, data correlation with the design of the plates and the 
components highlights a shift in peaks of some of the powder patterns, example 
highlighted in samples belonging to the salmon pink group and yellow group 
demonstrate this, (please refer to powder patterns in appendix F Figure Fa4).  We see 
that there are new peaks are present in these samples, suggesting potential new phases, 
however to fully validate this, DSC and possibly Raman spectroscopy may need to be 
established and exercised through polySNAP.      
  
159 
 
5.3.4 Summary of the Analysis of Plate BD003 
Plate three of the screen was of Isonicotinamide with the 16 coformers in ratios 2:1 1:1 
1:2 and two solvents o-xylene, and isohexane.  The raw files from Pharmorphix were 
input into polySNAP and the cluster analysis was run.  This gave the output found in 
appendix F b.   
The cell display and Dendrogram of plate 3 clusters the samples nicely into 25 groups, 
closer examination via 3D MMDS plot, Figure Fb1.-3, shows only a few groups closely 
clustered.  By cross referencing with the plate format, some groups have been found to 
consist mixed components which can only possibly be explained by cross contamination 
when transporting and preparing plates for diffraction experiments.   
 
5.3.5 Summary of the Analysis of Plate BD004  
Plate four of the screen was of Isonicotinamide with the 16 coformers in ratios 2:1, 1:1, 
1:2 and two solvents ethyl acetate, and methanol.  The raw files from Pharmorphix were 
input into polySNAP and the cluster analysis was ran as highlighted above this gave the 
output tables in appendix F c.   
The polySNAP clustering shows that there are many clustering groups which consist of 
multiple co-formers,  closer examination via 3D MMDS plots shows the samples in the 
groups have a high similarity rank, however cross referencing with the plate format 
shows that the co-former components do not match up.  A closer view of the diffraction 
patterns from this plate can be found in appendix F Figure Fc2.  
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5.3.6 Summary of the Analysis of Plate BD005 
Plate five of the screen was of Nicotinamide with the 16 coformers in ratios 2:1 1:1 1:2 
and two solvents o-xylene, and isohexane.  The raw files from Pharmorphix were input 
into polySNAP and the cluster analysis was run.  This gave the output in the cell display 
and Dendrogram shown in appendix F d.   
The Dendrogram displayed in appendix F, Figure Fd1-2 shows the clustering of 10 
groups, the 3D MMDS plot show the data is much more spread in space with nothing 
being clustered close together,  Again, the output shows the same miss match of sample 
as discussed in the above plates. 
 
5.3.7 Summary of the Analysis of Plate BD006  
Plate six of the screen was of Nicotinamide with the 16 coformers in ratios 2:1 1:1 1:2 
and two solvents ethyl acetate, and methanol.  The raw files from Pharmorphix were 
input into polySNAP and the cluster analysis was run as highlighted above this gave the 
output shown in Appendix F e.   
The cell display shown for plate BD006 presents data of 30 samples labelled as ‗other‘ 
(light pinky purple colour), suggesting new phases, and two samples which could be 
possible mixtures of several components.  Ideally a mixture of the two components is 
desirable but here we see that polySNAP has highlighted sample 51 to consist of a 
mixture of 7 possible components, and sample 89 of 5 components.  It could be 
speculated that this is due to cross contamination when handling/ preparing the plate for 
PXRD analysis.   
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Closer examination of the data using the 3D MMDS , Figure Fe2, feature highlights the 
clustering of the red and blue group to be quiet close, cross referencing with the plate 
format highlights that the groups consist of mixed co-formers as previously seen in 
plates 1-5.  The two groups where re-clustered individually to take a closer look, the 
findings are given in appendix F Figures Fe3-Fe11. 
 
5.4 Summary 
This chapter discusses the high through-put method used to maximise co-crystal output 
using a coformer set which is an extension of the one used in chapter 3, for the 
component model active ingredients, Isonicotinamide and Benzamide.  Extending the 
components and coformers used for the low through-put screen has also been the 
subject of the work presented. This included the addition of Nicotinamide and a 
contribution of a further 16 acid co-formers selected using the acid – amide synthon 
approach.  Implementing, the high through-put method has been a challenge with 
regards set up and organisation layout of the well plates, along with format and method 
development.  However, experiments have been established with the use of an 
automated robotic high through-put device.  Analysis of this sample generated from the 
screen has been addressed with the use of reflectance GADDS, a diffraction device 
which is able to cater for such high through-put data.  The resulting diffraction patterns 
have further been analysed by collaborating with University of Glasgow, and using the 
polySNAP program.  The screen has tested the software as a protocol to identify new 
phases from the co-crystal screen, as a result, the data shows that there are issues with 
background noise which results in poor correlation in the clustering.  This has 
repeatedly been viewed for each of the plates, after further analysis, the plates show that 
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data has been classed as other, which is expected since the aim was to grow co-crystals, 
however, after cross referencing with the plate format to pin point and highlight which 
components should be present there seems to be a disagreement, which could be due to 
cross contamination when handling the plates and shipping to Pharmorphix for GADDS 
analysis.  Additionally, since the plates have been split into two sections, 
accommodating for experiments in two solvents per plate, it is expected that a sample 
with ratio or 1:1 in solvent 1 should be same in solvent 2.  This is not the case, results 
show that sample with same stoichiometric ratio in each solvent are clustered 
individually, or with sample which consist of a different coformer.  For these reasons, 
solvent selection and solubility may need to be further refined, and a screening protocol 
fine tuned to identify the clustering problems faced.  Due to the discrepancies from this 
method, Hotstage microscopy has been developed for the AI and the 16 acid coformers 
studied.   
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Chapter Six: Screening with Hotstage 
Microscope and validating with 
complementary thermal methods 
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6.1 Introduction 
Previously in chapter 3 the implementation and outcomes of a solvent evaporation route 
to co-crystal screening was presented. Within this low throughput screen thermal 
microscopy was used to verify the components which gave rise to new co-crystal 
presented by eutectic profiles consistent with co-crystal formation.  In this chapter the 
thermal microscopy was used as a pre-screening tool for an extended set of co-formers.  
The opportunity and implementation of the Hotstage microscopy technique in 
highlighting co-crystal phase in multi component systems was previously outlined in 
chapter 2.  As the thermal microscopy techniques provide visual confirmation and 
eutectic information on new crystal phase formation between two components, when a 
new phase formation or a phase separation is likely to occur during the heating process 
and in this chapter we extended the application of this technique to a larger set of co-
formers.  To date the successful co-crystal phases formed during the low through-put 
solution screen in chapter 3 and the results in appendix B show this trend for the 
components of this screen, the emergence of these eutectic points are also reflected and 
confirmed by DSC traces as discussed in chapter 3.   
 
In this chapter we discuss the outcomes of thermal microscopy on a pre-screen for the 
systems screened in the high through-put method. The high through-put screening 
included the three active ingredients, Benzamide, Isonicotinamide and Nicotinamide, 
and a host of acid coformers consisting of families of di-carboxylic acids and benzoic 
acid derivatives (chapter 2 Figures 2.4 - 2.5).  As mentioned earlier these acid coformers 
have been carefully selected and used to fit the health and safety guidelines at Syngenta 
Ltd.  All the samples used for this work and the high through-put work were initiated on 
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site at Syngenta Huddersfield.  Sample slides for the Hotstage work were prepared at 
Syngenta as chemicals were not permitted to be taken off site, with permission, slides 
were transported to University of Bradford, Institute of Pharmaceutical Innovation 
building, so that samples could be ran on the Zeiss microscope, equipped with Linkam 
controlled heated stage and axioplan imaging software.  The screen is an expansion of 
the initial screen discussed on chapter 3,  
6.2 Experiment 
The preparation of the slides uses the Kofler contact method, (Kofler, 1941), which is a 
means to identifying the eutectic profile consistent with that required of co-
recrystallisation of two compounds from their hot molten state.  The details of the 
method have been previously presented, in chapter 1 and 2 sections 1.10.1.3 and 2.6.  
However, to summarise the approach, on a glass microscope slide, under a cover slip at 
one end contains pure acid and the other pure amide.  The region in between the pure 
phases, also referred to as the mixing zone, holds the presence of a new phase upon 
heating, this can be observed under a polarised light microscope.  A detailed account of 
the preparation of the slides has been described in chapter 1 and 2.   
 
Again to summarise, and as mentioned in chapter 3, the heating stage (Hotstage) was 
purchased from Linkam, a Zeiss microscope was used which has the axioplan imaging 
software.  A heating profile from room temperature to 280° C at a rate of 1° C per 
minute was used.  Images were captured at 5x‘s magnification at 60 seconds intervals.  
Maximum temperature may vary with respect the melting points of the component 
being discussed in this chapter.  We have used the Kofler contact method to detect the 
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possibility of physical interactions of the two phases and evaluated using the method by 
differential scanning calorimeter (DSC) as a primary thermal analysis method.   
For the DSC experiments, physical mixtures were made of the Isonicotinamide and 
carboxylic acids, and Benzamide with carboxylic acids, these were accurately weighed 
using the quantities summarised in Table 3.1 chapter 3.  Samples were heated in 
crimped and sealed hermetic aluminium pans.  Similarly, an empty pan was used as a 
reference.  Sample were heated over the relevant temperature range for each material 
(up to a maximum range of 25-260° C) under a stream of nitrogen gas at a heating rate 
of 10° C/min.     
 
6.3 Results and discussion 
6.3.1 Hotstage Microscopy 
The first screen consists of the components previously studied in the solution screen in 
chapter 3.  The outcomes are given in Table 6.1, which represents the samples which 
hold new phases and the respective temperatures at which starting material melts and at 
which the new phases emerge and melt away.  Table 6.2, is a summary of the 
components involved in the low through-put screen.  From these tables (6.1 and 6.2) we 
note that this method of screening proves that there are more potential phases visible 
with the Benzamide matrix.  However, with the exception of Fumaric and Tartaric acid 
which sublime upon heating during the preparation of the microscope slide and the 
exception of 3-hydroxybenzoic acid which did not show any new phases, all the other 
phases found in the solution screen have been identified as well as new phases for the 
unsuccessful Glutaric, Adipic, 2-hydroxybenzoic, 4-hydroxybenzoic acid and Benzoic 
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acid.  These have all been discussed in chapter 3 and results are displayed in appendix 
B.  Additionally to this, it has been possible to suggest the composition ratios as 
component phases melt away.  For example, the Benzamide with 2-hydroxybenzoic 
acid has two potential phases.  The first phase has been suggested to be a 1:1 phase 
which appears at 110.5° C and melts at 112.3° C (Figure 6.1 images 1 and 2).  At the 
same time there seems to be another phase present that begins to melt once the first 
phase melts away, with the emergence of a phase growing at 115.6 ° C melting at 121.5 
° C (Figure 6.1 images 3-9), it can be suggested that this is the 2:1 co-crystal phase of 
this system.   
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Table 6.1: A summary of Hotstage microscopy results from low through-put screen and high through-put screen of Isonicotinamide, Benzamide and 
Nicotinamide.  The results show the number of new phases and the respective temperatures. 
  Isonicotinamide 
Mp 155-157° 
C 
Benzamide 
Mp 127-
130° C 
Nicotinamide 
Mp 128-
131° C 
 Mp °c New Phases 
New Phase 
Melt (°C) 
New Phases 
New Phase 
Melt (°C) 
New Phases 
New Phase 
Melt (°C) 
1, 4 Benzene 
dimethanol 
116-119 no n/a 1 92.2 1 105.1 
2-Hydroxybenzoic 
Acid 
158 2 135.8, 137.8 2 
112.3, 
120.3 
1 140.7 
3-Hydroxybenzoic 
Acid 
201 1 196.3 no n/a 1 123.3 
4-Hydroxybenzoic 
Acid 
214 1 182.6 1 88.1 2 95, 183.1 
2-Nitrobenzoic Acid 146-148 1 129 1 117 1 81.5 
3-Nitrobenzoic Acid 139-141 no n/a 2 
140.2, 
164.2 
3 
134.1, 143, 
154 
4-Nitrobenzoic Acid 237 1 221 1 180 - 185.6 1 183.7 
3-Aminobenzoic 
acid 
178-180 2 137.3, 149.3 no n/a no n/a 
4-Aminobenzoic 187-189 1 149 no n/a 1 113 
169 
 
acid 
Adipic Acid 152 1 169.3 1 101.1 1 132.4 
Benzoic Acid 121 1 153.5 1 82.5 2 89.2, 95.2 
Cinnamic Acid 133 2 136.3, 159.3 no n/a 2 99.3, 121.3 
Fumaric Acid 287 
decompose/subli
me 
n/a 
decompose/subli
me 
n/a 
decompose/subli
me 
n/a 
Glutaric Acid 95 1 151.2 1 88.9 1 138.6 
Maleic acid 130-131 
decompose/subli
me 
n/a 
decompose/subli
me 
n/a 
decompose/subli
me 
 
Malic acid 131-133 1 230 no n/a 1 125.5 
Mandelic Acid 119 1 113.9 1 76 no n/a 
Phthalic acid 200 1 134.1 no n/a no n/a 
Pimelic acid 103-105 1 135 1 94.4 1 110.2 
Succinic Acid 185 1 203 1 117 1 148.5 
Tartaric acid 170 
decompose/subli
me 
n/a 
decompose/subli
me 
n/a 
decompose/subli
me 
n/a 
Trans β 
hydromuconic acid 
195-196 1 181.7 no n/a 2 131.2, 134.2 
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Table 6.2: A summary of the Hotstage microscopy results of Isonicotinamide and Benzamide with 
components used for the low through-put screen.  The results show the number of new phases and 
the respective temperatures and ratios 
  Isonicotinamide 
Mp 155-157° 
C 
Benzamide 
Mp 127-
130° C 
 
Acid 
Mp 
°C 
New Phases 
New Phase 
Melt ° C 
New Phases 
New Phase 
Melt ° C 
Fumaric Acid 287 Sublimes n/a Sublimes n/a 
Succinic Acid 185 1 (1:1) 203 1 (1:1) 117 
Tartaric acid 170 Sublimes n/a Sublimes n/a 
Glutaric Acid 95 1 (1:1) 151.2 1 (1:1) 88.9 
Adipic Acid 152 1 (1:1) 169.3 1 (1:1) 101.1 
Benzoic Acid 121 1 (1:1) 153.5 1 (1:1) 82.5 
2-
Hydroxybenzoic 
Acid 
159 2 (1:1, 2:1) 135.8, 137.8 2 (1:1, 2:1) 
112.3,  
121.5 
3-
Hydroxybenzoic 
Acid 
201 1 (1:1) 196.3 no n/a 
4-
Hydroxybenzoic 
Acid 
214 1 (1:1) 182.6 1 (1:1) 88.1 
Mandelic Acid 119 1 (1:1) 113.9 1 (1:1) 76 
Cinnamic Acid 133 2 (1:1, 2:1) 136.3, 159.3 no n/a 
4-Nitrobenzoic 
Acid 
237 1 (1:1) 221 1 (1:1) 180 - 185.6 
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Figure 6.1: Images highlighting the emergence of new phases of the Benzamide 2-hydroxybenzoic 
acid system, using Hotstage microscopy method with Linkam controlled heating stage mounted on 
a Zeiss Microscope using cross polarised light and axiocam camera at times 5 magnification lens.   
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A similar picture is portrayed for the Isonicotinamide with 2-hydroxybenzoic acid 
Kofler melt.  Similarly to Benzamide, there are two phases present upon melting, 1:1 at 
135.8° C and 2:1 at 137.8° C.  The co-crystal structure has been solved and presented in 
McMahon et al 2004 who have reported that the melting temperature of the co-crystal is 
between 119-121° C.  However for the Hotstage this does not coincide with the reported 
work, Figure 6.2 shows the Hotstage images for Isonicotinamide with 2-
hydroxybenzoic acid.   
8 
7 
9 10 
7 
9 10 
8 
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Figure 6.2: Hotstage images highlighting the phases viewed for Isonicotinamide with 2-
hydroxybenzoic acid 
 
 
The procedure was repeated on Hotstage, and the same results were achieved, to ensure 
that this was not the only thermal method employed; DSC has been exploited as a 
means to validate the Hotstage results.  This is discussed in the section below.  
Additionally, it was decided by all parties involved in the project to introduce 
Nicotinamide as an active ingredient for the high through-put screen since it is a well 
studied Pharmaceutical which holds to be a robust acceptor/donor.  Therefore, Hotstage 
analysis was executed for all of the coformer acids used in this study with 
Nicotinamide.  These have all been summarised in Table 6.1.  The table shows that 
there are 17 out of the 22 coformers with Isonicotinamide which successfully melt and 
show a new phase.  Only 2 of these failed to show new phases upon melting where the 
remaining 3 decomposed/sublimed upon preparation of the slide.  Nicotinamide has 
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successfully shown phases with 16 of the coformers examples, with only the 3-
Aminobenzoic acid, Phthalic and Mandelic failing to show new phases in the mixing 
zone upon melting.  The test example, which literature has shown to be least studied and 
least successful to co-crystallise has from the Kofler contact method screen, shown new 
phases with 12 of the 22 coformer acid examples used in the project discussed here.  
One of these has been reported, Succinic acid with Benzamide, in the Cambridge 
structural database.  There are 7 coformers which have failed to show that a co-crystal 
phase is present, along with 3 which decompose/sublime upon heating.   
The images of the Hotstage analysis for the components can be found on the compact 
disc provided in Appendix I.   
The components used for the high through-put screen have only been analysed using 
Hotstage microscopy; it was unfortunate not to have been able to carry out DSC to 
verify the result due to Syngenta migrating to their new site in Berkshire.  The Hotstage 
analysis however does show that there are many new phases present and the technique 
is invaluable as a screening tool.   
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6.3.2 Results and Discussion of DSC  
The DSC analysis of the samples from the low through-put screen are summarised in 
Table 6.3.  The melting temperatures found during the Hotstage compared with the 
endothermic peaks identified during the DSC analysis are displayed. 
We see that in some cases for both the Isonicotinamide systems and Benzamide 
systems, there is correlation where during Hotstage analysis a phase that melts at a 
temperature higher or lower than the starting components, is also identified by an 
endothermic peak during the DSC analysis.  These peaks can be seen in the examples 
displayed in Figure 6.3. This Figure shows the Isonicotinamide DSC trace and the 
Benzamide trace with 2-hydroxybenzoic acid.  All remaining DSC traces can be viewed 
in Appendix G.   
These results do suggest that there should be a number of Benzamide co-crystals in 
existence, and the co-former profile would be comparable in usage with those seen for 
the other principal components Nicotinamide and Isonicotinamide.  The current 
outcomes from melt need to be contrasted with those from solution growth and ternary 
phase behaviour in order to rationalise the historical lack of reported co-crystal using 
Benzamide over the other amides.   
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Table 6.3: Summary of the endothermic peak detected from DSC analysis of the primary screen viewed in low through-put analysis compared with the 
results achieved form Hotstage analysis 
  Isonicotinamide   Mp 155-157° C Benzamide  Mp 127-130° C 
 Mp 
°c 
DSC endothermic (°C) 
Average peak 
New Phase Melt 
(°C) 
DSC endothermic (°C) 
Average peak 
New Phase Melt 
(°C) 
Fumaric Acid 287 156.13, 207.71 sublime/decompose
d 
119.77, 134.49 sublime/decompose
d 
Succinic Acid 185 155.92, 165.95 203 118.46, 128.34 117 
Tartaric acid 170 128.53, 153.76, 174.94 sublime/decompose
d 
119.47, 139.93 sublime/decompose
d 
Glutaric Acid 95 91.48, 133.12, 145.60 151.2 79.75, 86.40, 90.27 88.9 
Adipic Acid 152 141.99, 151.82, 156.53 169.3 93.48, 96.84 101.1 
Benzoic Acid 121 120.15, 141.27, 161.26 153.5 84.83 82.5 
2-Hydroxybenzoic Acid 158 121.84, 124.24, 131.50 135.8, 137.8 111.17, 118.00 112.3, 120.3 
3-Hydroxybenzoic Acid 201 148.15, 192.12 196.3 93.29 none 
4-Hydroxybenzoic Acid 214 145.23, 184.34 182.6 93.00, 130.06, 169.15 88.1 
Mandelic Acid 119 81.57, 107.50 113.9 74.93 76 
Cinnamic Acid 133 127.38, 139.01, 144.79, 
156.18 
136.3, 159.3 85.93 none 
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4-Nitrobenzoic Acid 237 155.05, 223.28 221 124.81, 180.60 180 - 185.6 
* All Figures in italic and highlighted blue have been identified as starting components 
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Figure 6.3: Summary of the endothermic peaks for A) Isonicotinamide with 2-hydroxybenzoic acid 
and B) Benzamide with 2-hydroxybenzoic acid 
 
 
  
A 
B 
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6.4 Summary 
The work presented in this chapter demonstrates the simplicity of the Hotstage 
microscopy technique as a tool of screening for co-crystal formation.  As described 
previously, upon melting of two phases, upon separation a new phase should emerge if 
the two starting components are capable of forming a co-crystal.  This can be observed 
under polarised microscope when heating. 
The results presented here are in two parts: 
a) Low through-put screen viewed in chapter 3 coupled with DSC analysis to 
confirm the melting phases and possible new phases 
 
b) Components which have previously been subjected to the high through-put 
analysis in the previous chapter. 
 
The aim of this study is a comparison of the success rate of Benzamide with the model 
amide, Isonicotinamide.  The previous low through-put screen resulted in the co-
crystallisation characterisation via PXRD of 5 of the model coformers, chapter 3, here 
we find that a thermal technique, using the Kofler contact method produces 
identification of 8 potential new phases, the remaining two coformers, sublime when 
preparing the slide.  To verify the results of hot melt, DSC has been used, it has been 
found that this technique complements the results from the thermal microscopy screen.   
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To increase the success rate, the components involved in the high through-put screen 
have undergone this method of Hotstage microscopy technique, in total resulting in 17 
hits of co-crystals with the model amide, Isonicotinamide, and 12 for the Benzamide 
which has not been thought to co-crystallise as well according to literature review.  
Additionally, Nicotinamide has been introduced, which has a hit of 16 new phases.  
Unfortunately, DSC has only been implemented for the low through-put screen, this is 
due to restrictions of taking chemicals off site from Syngenta and because of the 
relocation of the Syngenta site to southern England.   
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Chapter Seven: Phase Diagram 
determination 
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7.1 Introduction 
In previous chapters, we have explored and identified screening methods ranging from 
simple bench evaporation method to a high through-put screen and complementary 
screening with thermal microscopy.  Additionally, a feature of the project was to 
undertake a comparison of the primary amide Benzamide, and Nicotinamide success 
rate with a library of co-formers with an amide which has been reported to co-crystallise 
with a healthy success rate (Isonicotinamide) with the same library of co-formers.  An 
important factor was the understanding the deviation between a successful co-crystal 
through host stage studies and poor performance and lack of propensity towards 
crystallisation or failure in large number of solvents when attempted from solution.  
Within this work the low through-put method was employed as the route to achieve the 
growth of single crystals, as identified from the Hotstage microscopy of the minor 
matrix screen (chapter 3) as well as a high through-put method of an extended screen 
carried out at Syngenta Ltd.  The resulting crystallisation outcomes employed in the 
project have established a further understanding of the impact of the solvent choice 
made upon crystallisation outcomes.  To further this understanding from the screening 
results, a series of complementary pairs of co-crystal using the amides and co-former 
Succinic acid ternary phase diagrams were measured.  
As previously mentioned in chapter 1, the preferred manufacture route to co-crystal 
growth is solvent crystallisation.  In order to achieve this and also gain a further 
appreciation of why melt co-crystal formation transferred to solution fails the following 
ternary phase diagram studies were undertaken.  The choice of approach through the 
construction of a phase diagram of a two-component system was undertaken as these 
phase diagrams can give a practical insight for preparing co-crystals.  Previously it has 
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been discussed how similar solubility determines the straight forward phase diagram of 
a 1:1 mixture where all the regions are well defined, however, components with a less 
comparable solubility tend to map a phase diagram skewed like the one shown in the 
study by Chiarella et al, 2007, thus narrowing the region where co-crystal growth is 
possible. 
Within this chapter, we view phase diagrams of Isonicotinamide with Succinic Acid, 
Benzamide with Succinic Acid and Nicotinamide with Succinic Acid in water and 
methanol.  The crystal structures of the former two systems have been published and 
deposited in the CSD, in this study, we have successfully grown single crystal of the 
Nicotinamide and Succinic acid co-crystal and this will also be presented here.   
 
7.2 Experiment 
The methods for determining ternary phase diagrams have been reported widely, 
consequently a brief over view of the approach routinely adopted will be given.  In the 
first instance for mapping a phase diagram a measurement of the solubility of the 
starting components and co-crystals is undertaken.  The literature was reviewed for 
solubility, and where this was not reported the simplest gravimetric method was 
established to evaluate solubility.  Typically, 0.1g of each starting material has been 
weighed out and solvents, methanol and water were added gradually until samples 
complete dissolved at room temperature.  All results have been tabulated below.   
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Table 7.1: Solubility of all the starting components and co-crystal in water and methanol 
Solubility Water (0.1g) Methanol (0.1g) 
Isonicotinamide 2 ml 1 ml 
Benzamide 
Slightly Soluble * 
10 ml 
1 ml 
Nicotinamide 
Easily Soluble * 
1.1 ml 
1.2 ml 
Succinic Acid 1.3 ml 1.3 ml 
Co-crystal Solubility Water (0.1g) Methanol (0.1g) 
Isonicotinamide: Succinic 
Acid 
17 ml 23 ml 
Benzamide: Succinic Acid 16 ml 2.5 ml 
Nicotinamide: Succinic Acid 2.5 ml 2 ml 
 
From these solubilities, we are able to note an expected level skew in the phase 
diagrams.  For the following: Benzamide and Succinic acid system in water with a 
significant skew and a slight skew in the Isonicotinamide: Succinic acid in methanol 
system.   
 
After determining the solubility of the starting components, the next step is to locate the 
co-crystal regions.  For this, mixtures of the amide and acid at various molar ratios but 
fixed molar content were weighed out.  A fixed amount of solvent was added to each 
vial containing the sample mixture weighed and allowed to slurry for an hour at 50°C 
for each water and methanol system, after slurrying, samples were allowed to cool.  
These samples were then capped and incubated at 20 °C for at least 7 days.  The solid 
from each was collected by Buchner filtration and examined by powder diffraction for 
new crystal phases.  This weighing procedure was repeated, as the amount of solvent 
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varied, this allowed crystal samples to be prepared in a cross section manner across the 
phase diagram, eventually identifying the regions where co-crystal phases begin to 
grow.  The quantities used for this study are given in the table below.  Experiments 
were delayed 3
+
 months due to breakdown of the RUMED incubator unit with-in the 
laboratory, once fixed, experiments were set up simultaneously for all systems in the 
two solvents mentioned, Methanol and Water.   
Table 7.2: Summary of the quantities used to map phase diagram.  * Isonicotinamide and 
Nicotinamide have same molecular weight, therefore the same weights have been used 
% Mole Acid Succinic Acid Benzamide 
Isonicotinamide/Nicotinamide
* 
% Mole 
Amide 
100 2.362 0 0 0 
90 2.213 0.248 0.244 10 
80 1.889 0.498 0.489 20 
70 1.653 0.746 0.733 30 
60 1.417 0.995 0.977 40 
50 1.181 1.244 1.221 50 
40 0.945 1.493 1.466 60 
30 0.709 1.742 1.710 70 
20 0.472 1.990 1.954 80 
10 0.024 2.239 2.198 90 
0 0 2.488 2.443 100 
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7.3 Results and Discussion 
The phase diagrams obtained from the solution slurries after incubation are displayed 
below, characterisation of the sample after filtration was with PXRD.  A freely available 
and user-friendly software, ProSim, (www.prosim.net) has been used to map the co-
ordinates for the sample onto a ternary phase diagram plot.  Figure 7.1shows that the 
data when plotted are concentrated into the top 90% of the ternary phase diagram, this 
makes it difficult to view the phase behaviour of the samples collected.  ProSim has a 
zoom in and zoom out function, allowing users to view the top 90% region and further 
view the outlined regions from experimental data Figure 7.2.  
 
Figure 7.1: Ternary Phase diagram of Isonicotinamide, Succinic Acid in water 
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Figure 7.2: Ternary Phase diagram of Isonicotinamide, Succinic Acid in water Zoomed into the top 
90% 
 
 
Figure 7.2 and Table 7.1 show that there is a significant difference in the solubility 
between Succinic acid and Isonicotinamide in the water system (0.1g in 1.2ml vs. 0.1g 
in 2ml) leading to a strongly skewed phase diagram.  The 1:1 co-crystal region from the 
slurry samples have been identified, as have the pure phases and a region which seems 
to be a mixture of co-crystal and the amide pure phase.  The methanol system (Figure 
7.3, 7.4) paints a picture similar to the expected model shown in chapter 1, Figure 1.11a, 
this is due to the solubilities of the components involved differing only very slightly 
from each other.  We see that the 1:1 complex in this methanol system is much lower in 
solubility compared to the water system.  The data also has highlighted a mixture of co-
crystal complex with the Isonicotinamide in 10 ml of methanol.  This could be an 
Succinic Acid Pure 
1:1 Co-crystal 
Co-crystal + Amide 
Benzamide Pure 
 
 
 
 
Succinic Acid Isonicotinamide 
1:1 Co-crystal 1:1 Co-crystal + 
Isonicotinamide 
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anomaly therefore further sampling is required to map the regions with solvent less than 
10 ml.   
 A similar example given in the work contributed by Seaton, 2008, uses Isonicotinamide 
and benzoic acid in water and methanol.  The work, displays a heavily skewed phase 
diagram in the water system, and a better behaved plot in the methanol system.   
 
Figure 7.3: Ternary Phase diagram of Isonicotinamide, Succinic Acid in methanol 
 
The Benzamide with Succinic acid in water system also maps a skewed organisation of 
the phases, Figure 7.5, 7.6, this is expected, as Benzamide is slightly soluble in water.  
The emergence of the 1:1 phase has been established, as has the mixture of the co-
crystal with Benzamide.   
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Figure 7.4: Ternary Phase diagram of Isonicotinamide, Succinic Acid in methanol Zoomed into the 
top 90% 
 
 
Figure 7.5: Ternary Phase diagram of Benzamide, Succinic Acid in Water 
 
 
 
Succinic Acid Pure 
1:1 Co-crystal 
Co-crystal + Amide 
Benzamide Pure 
 
 
 
 
Succinic Acid 
1:1 Co-crystal 
Isonicotinamide 
1:1 Co-crystal + 
Isonicotinamide 
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Figure 7.6: Ternary Phase diagram of Benzamide, Succinic Acid in methanol Zoomed into the top 
90% 
 
 
However, the Benzamide system in methanol produces a phase diagram, Figure 7.7, 7.8, 
with a well defined eutectic which seems more normalised and expected given the 
solubilities of the starting components are similar.  In methanol, it is possible to see that 
the co-crystal undergoes congruent dissolution, therefore suggesting that it is possible to 
crystallise the co-crystal by evaporating an under-saturated solution containing the 1:1 
stoichiometric amounts of Benzamide and Succinic acid in solution.  However, this 
requires further experimental work to generate a better defined eutectic curve.  
  
 
 
 
 
 
1:1 Co-crystal + 
Benzamide 
Benzamide 
1:1 Co-crystal 
Succinic 
Acid 
Succinic Acid Pure 
1:1 Co-crystal 
Co-crystal + Amide 
Benzamide Pure 
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 Figure 7.7: Ternary Phase diagram of Benzamide, Succinic Acid in Methanol 
 
 
Figure 7.8: Ternary Phase diagram of Benzamide, Succinic Acid in Zoomed  
 
1:1 Co-crystal + Benzamide 
Benzamide 
1:1 Co-crystal 
Succinic Acid 
Succinic Acid Pure 
1:1 Co-crystal 
Co-crystal + Amide 
Benzamide Pure 
--- Solution Phase 
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The Nicotinamide system in water produces an experimental representation of the ideal 
phase diagram theorised in chapter 1, Figure 7.9, 7.10.  Again we see that Nicotinamide 
and Succinic acid have similar solubility, leading to a diagram from which we can see 
that the co-crystal undergoes congruent dissolution as the solubility curve of the co-
crystal crosses the co-crystal component stoichiometric ratio line (dotted line a) of 1:1 
co-crystal component.  This means that the co-crystal can grow in an unsaturated 
solution as well as a saturated solution of 1:1 stoichiometric amounts of acid and amide.   
In methanol, the phase diagram of Nicotinamide and Succinic acid, Figure 7.11, 7.12, 
also shows three phases, co-crystal, pure Nicotinamide and pure Succinic acid phase 
regions.  Although the solubility curve is not as well defined as the water system, it is 
still possible to say that the same observation of co-crystal growth can be envisaged as 
seen for the water system.   
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Figure 7.9: Ternary Phase diagram of Nicotinamide, Succinic Acid in Water 
 
 
Figure 7.10: Ternary Phase diagram of Nicotinamide, Succinic Acid in Zoomed  
  
1:1 Co-crystal  
 Succinic Acid Pure 
 1:1 Co-crystal 
 Co-crystal + Amide 
 Nicotinamide Pure 
…. Stoichiometric ratio 
line 
 
 
 
 
Nicotinamide  
Succinic Acid  
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Figure 7.11: Ternary Phase diagram of Nicotinamide, Succinic Acid in Methanol 
 
 
Figure 7.12: Ternary Phase diagram of Nicotinamide, Succinic Acid in Zoomed  
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195 
 
7.3.1 Single crystal analysis 
During this study, sample containing the single crystal of the Nicotinamide and Succinic 
acid system has been grown and analysed using single crystal, courtesy of University of 
Bradford‘s in-house crystallographer, Dr Ian Scowen.  The analysis is given below.   
From the X-ray powder diffraction new phases have been identified, Figure 7.13.  
Suitable material for single crystal structure determination has been grown for water and 
methanol system, the experimental details for structures are given below in Table 7.3. 
Figure 7.13:  Powder diffraction data comparison of the Nicotinamide with Succinic Acid grown 
from water and methanol compared to pure starting components to identify potential new peaks. 
 
From the powder pattern a new peak is identified between 6-7˚ 2 for both the water 
and methanol derived co-crystals.  The single crystal data is presented in the table 7.3.  
A full detail of refinement, atomic coordinates, isotropic displacement parameters (Å
2
), 
atomic displacement parameters (Å
2
), geometric parameters (Å), and hydrogen-bond 
geometry (Å) is given in appendix D. 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
2 Theta
Co-crystal phases for Nicotinamide with Succinic Acid in water and Methanol
Co-crystal in Methanol
Nicotinamide
Succinic Acid
Co-crystal in Water
New Phases 
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Table 7.3: Crystallographic Data for Nicotinamide with Succinic Acid in water and Methanol 
 
 
Both crystals derived from water and methanol belong to the triclinic crystal system as 
the angles between axes       90, similarly, the length of the axes a  b  c, 
suggest the P-1space group.   
The expected packing of a Nicotinamide with a carboxylic acid should contain a 
hetero/homo dimer consisting of the amideacid or an amideamide interaction as well 
as an acid pyridine interaction.  These have proven to be robust intermolecular 
interactions leading to multicomponent complex formation, Aakeroy, 2006.  This next 
Compound Nicotinamide: 
Succinic Acid  (H2O) 
Compound Nicotinamide: 
Succinic Acid  
(MeOH) 
Formula C10H12N2O5 Formula C10H12N2O5 
Mass, Mr 240.11 Mass, Mr 240.11 
Temp (K) 173 (2) K Temp (K) 173 (2) K 
Cryst Syst Triclinic Cryst Syst Triclinic 
Space Group P-1 Space Group P-1 
Z 4 Z 4 
a (Å) 5.0946 (10) Å a (Å) 5.0864 (5) Å 
b (Å) 11.601 (3) Å b (Å) 11.5807 (15) Å 
c (Å) 14.324 (3) Å c (Å) 14.2811 (15) Å 
α (deg) 77.633 (12)° α (deg) 77.655 (4)° 
β (deg) 86.608 (11)° β (deg) 86.734 (6)° 
γ (deg) 89.369 (11)° γ (deg) 89.337 (6)° 
V (Å) 825.5 (3) Å
3
 V (Å) 637.72 (8) Å
3 
R-Factor % 4.85 R-Factor % 7.07 
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section will investigate the packing of the Nicotinamide co-crystal grown from water 
and methanol.   
 
7.3.2 Packing Analysis of Nicotinamide: Succinic Acid co-crystal 
 
7.3.2.1 Packing arrangement for Co-crystal in water: 
A Mercury analysis of this system shows that the structure has a Z value of 4.  The 
Figure below depicts the hydrogen bonding between the components as a homo 
amideamide dimer synthon (bong length 2.944 Å) and an acidpyridine (bond length 
2.688 Å) interaction with the neighbouring Succinic acid, Figure 7.14.  Expanding the 
contacts further, we can see the stacking is of a zigzag conformation which upon further 
expansion stacks to form layers of sheets, Figure 7.15.  (All the relevant CIF files are 
contained in a CD within Appendix H)   
 
Figure 7.14:  Mercury analysis of Nicotinamide: Succinic Acid crystal structure showing the hetero 
dimer and acid-amide interaction.  
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Figure 7.15:  Stacking conformation with the unit cell of Nicotinamide: Succinic Acid i) Axis a, 
zigzag conformation, ii) offset of a direction of the unit cell showing formation of sheets 
 
 
 
The hydrogen bonding angles and distances for the dimer interaction and acid pyridine 
interaction are shown in the table 7.4. 
 
i) 
ii) 
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Table 7.4: Hydrogen-bond geometry (Å, °) of the amide – amide and acid – pyridine interactions 
D—H···A D—H H···A D···A D—H···A 
N2—H3···O1 1.65 (3) 1.96 (3) 2.944 (3) 174 (4) 
O2—H1···N1 1.04 (3) 1.65 (3) 2.688 (2) 175 (3) 
 
7.3.2.2 Packing arrangement for co-crystal in Methanol 
Similarly, as observed with the water system, the Z value for this structure is 4.  The 
complex grown from methanol has a unit cell dimension very close to the one observed 
for the system grown from water (see table 7.3).  From Figure 7.16, we see that after 
Mercury analysis the hydrogen bonding is the expected hetero dimer and acidpyridine 
interaction.  Further expansion along these interactions shows packing similar to the 
previous crystal structure, a zigzag conformation which stacks in an offset manner and 
further extends to develop into a rippled sheet layers Figure 7.17 i-ii.  Table 7.5, 
represents the hydrogen bonding angles and distance involved in this crystal structure.   
Figure 7.16:  Mercury analysis highlighting the hydrogen bonding of the hetero dimer and acid-
pyridine interaction in the Nicotinamide: Succinic Acid crystal structure grown from methanol.  
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Figure 7.17:  Stacking conformation with the unit cell of Nicotinamide : Succinic Acid i) Axis a, 
showing the zigzag conformation, ii) offset of  axis a direction of the unit cell showing formation of 
sheets comprising of molecules stacking via the hetero dimer and acid-pyridine hydrogen bonding 
   
 
Table 7.5: Hydrogen-bond geometry (Å, °) of the amide – amide and acid – pyridine interactions 
D—H···A D—H H···A D···A D—H···A 
N2—H3···O1 0.99 (5) 2.01 (5) 2.953 (6) 177 (4) 
O2—H1···N1 1.61 (5) 1.08 (5) 2.689 (5) 179 (5) 
 
ii) 
i) 
i) 
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7.4 Summary 
Chapter 7 presented the phase diagrams as a tool to further understand phase behaviour 
of three model co-crystal systems: Isonicotinamide with Succinic acid, Benzamide with 
Succinic acid and Nicotinamide with Succinic acid.  The former two have crystal 
structures reported in the literature, so it was thought to be a nice comparison to map the 
behaviour in water and methanol.  Nicotinamide has been introduced, since this system 
has not been published, and from the thermal analysis, a new phase has been 
highlighted in the Kofler contact melt described in previous chapters.   
The Isonicotinamide system and Benzamide system show a co-crystal zone which is 
skewed towards the Succinic acid side of the ternary plot.  This skewness is a result of 
solubility differences of the starting components.  For the Nicotinamide system, well 
behaved phase diagrams have been derived for the water and methanol systems.  
Additionally, single crystals have been grown during this investigation of the 
Nicotinamide with Succinc acid. 
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Chapter Eight: Conclusion 
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8.1 Conclusion 
The overall aim of this study was to develop an appreciation and generate a protocol 
which would enable a comparison to be made between model components which result 
in a co-crystal compared to a structurally similar compound, which emerged as 
problematic or unsuccessful at forming co-crystals, even though a viable pairing from a 
crystal engineering perspective exists.  Progressing this understanding required gaining 
an appreciation of the hydrogen bonding interaction exhibited by this class of co-
formers, and the overall behaviour of the surrounding peripheral functional groups of a 
co-former within a co-crystal to build an understanding of system design that have been 
established from the literature.   
Overall a critical feature of the project was to understand the inter relationships and 
defining parameters which could lead to designing co-crystal complexes of benefit to 
the pharmaceutical or fine chemicals industry.  
An initial screening matrix was established using Isonicotinamide and its reported co-
crystals from the CSD, and as a comparative model, Benzamide was used to screen with 
the same set of co-formers.  We find that from a simple bench evaporation method, only 
five out of the systems studied showed new phases from PXRD patterns.  However, 
yielding a suitable crystal for single crystal determination has been a further challenge 
when adopting a low through-put approach, in particular when using a ReactArray 
Microvate device.  Consequently, only two single crystals have successfully been grown 
and characterised in the study.  This situation highlights the issue that crystallisation 
propensity may hinder the overall successful single crystal structures obtained.  This 
then subsequently hinders the attempts of understanding the behaviour and nature of 
why one compound is more robust over another from the perspective of potential sites 
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for intermolecular interaction through envisaged design and the observed packing 
obtained from crystal structure determination. We note that powder diffraction data may 
be used to determine the crystal structure, however, this was not pursued due to quality 
of powder diffraction obtained from the sample generated.  This would be a future 
direction to take with regards the project in light of the number of potential new systems 
this current work has generated.   
Even though, from this initial hurdle, it has not been possible to maximise and grow 
enough material to further study the crystal structure for a comparative study within the 
systems studied. Collaboration with University of Glasgow has led to a project using 
dSNAP to enable the small number of structures we have to be classified with regards 
the molecular packing against the amide co-crystals in the CSD data base.   
The outputs from the dSNAP study, consist of the structures extracted from CSD which 
contain our specimen amides, profiled for packing features and trends, these outcomes 
were subsequently employed in decoding in the crystal structures of the systems for 
which we obtained single crystal structures.  This was a productive collaboration with 
the dSNAP developers.  Despite the problems encountered with the code of the 
algorithm, the subtleties which are present in the packing motifs of the model amide, 
Isonicotinamide, were identified, this structural aspect of the work highlighted an 
interesting conformational situation within the co-former packing of the co-crystal.  
Where a key feature was found to be the cis and trans orientation of the amide and acid 
carbonyl to each other and the planar and off planar assemblies; all of which contribute 
to hydrogen bonding of the components that are the building blocks of a co-crystal.   
This identification of these subtle orientations of the acid components  formed the basis 
for the design and development of a sophisticated high through-put screen with 
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Syngenta.  The screen design concept was to beta test, the notion of using this approach 
to deconvolute packing and use the outcomes to inform design strategy through 
maximising the co-crystal information contained in the output of the CSD.   
This high throughput screening contribution was to show that results obtained indicate 
that the technique shows great potential and is viable route for screening for co-crystal 
as demonstrated from the polySNAP output.  However, as a beta test of the technique 
utilising the polySNAP program, has brought a number of faults to light in the code to 
the developers of polySNAP.  For this project a specific contribution, was the inclusion 
in the studies of a screening protocol developed specifically to this project to explore 
the impact of crystallisation condition and co-former functionality with polySNAP 
being used to verify similar crystalline forms within the screen.  This was in self a 
significant contribution from the point of being an end user of the code and 
implementing the application of the code in such a high throughput screen.   
Specifically, the challenge was implementing a successful analysis of the samples 
generated from the screen and this has been addressed with the use of reflectance 
GADDS diffraction data as the input to polySNAP.  The screen has tested the software 
as a protocol to identify new phases from the co-crystal screen, as a result, the data 
shows that there are issues with background noise which results in poor correlation in 
the clustering.  This has repeatedly been viewed for each of the plates, after further 
analysis, the plates show that data has been classed as ―Other‖, which is expected since 
the aim was to grow co-crystals, however, after cross referencing with the plate format 
to pin point and highlight which components should be present there seems to be a 
disagreement, which could be due to cross contamination when handling the plates and 
shipping to Pharmorphix for GADDS analysis.  Additionally, since the plates have been 
split into two sections, accommodating for experiments in two solvents per plate, it is 
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expected that a sample with ratio or 1:1 in solvent 1 should be same in solvent 2.  This 
is not the case, results show that sample with same stoichiometric ratio in each solvent 
are clustered individually, or with sample which consist of a different coformer.  For 
these reasons, solvent selection and solubility may need to be further refined, and a 
screening protocol fine tuned to identify the clustering problems faced.   
Due to the discrepancies from solution co-crystal screening method, the Hotstage 
microscopy (a melt crystallization approach) has been developed for the active 
ingredients and the all acid coformers studied here, and the outcomes on this aspect of 
the project are  summarised here are in two parts: 
 Low through-put screen viewed in chapter 3 coupled with DSC analysis to 
confirm the melting phases and possible new phases 
 Components which have previously been subject to the high through-put 
analysis in the previous chapter. 
 
The aim of these DSC and thermal microscopy studies was a comparison of the success 
rate of Benzamide with the model amide, Isonicotinamide without any solvent present, 
as this is a melt crystallisation approach.  The previous low through-put screen with 
solvent present resulted in the co-crystallisation characterisation via PXRD of 5 of the 
model coformers, with a thermal technique, without solvent present using the Kofler 
contact method produces identification of 8 potential new phases, the remaining two 
coformers, sublime when preparing the slide.  To verify the results of hot melt, DSC has 
also been used, and it was found that this technique complements the results from the 
thermal microscopy screen.   
To increase the success rate of possible co-crystals, all the components involved in the 
high through-put screen have also undergone this Hotstage microscopy screening 
technique.  In total this resulted in 17 hits of co-crystals with the model amide, 
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Isonicotinamide, and 12 hits for the Benzamide which has not been thought to co-
crystallise as well according to literature review.  Additionally, Nicotinamide has been 
introduced, which has a hit of 16 new phases.  Unfortunately, DSC has only been 
implemented for the low through-put screen, this is due to restrictions of taking 
chemicals off site from Syngenta and because of the relocation of the Syngenta site to 
southern England. 
In the examples presented for Hotstage microscopy, where samples have sublimed upon 
heating, it might be possible to use a ‗cold contact‘ method over the Kofler contact 
method.  This method would involve the components dissolved in a supersaturated 
solution where a drop of which is left to crystallise under the cover slip and create a 
mixing zone with the second component, upon heating under the microscope a new 
phase can be identified.  This method would further maximise the output of thermal 
microscopy screening technique   
To further understand phase behaviour of the three models discussed in this work, the 
mapping of a ternary phase diagram has also been a focus of this work.  
The trends obtained were as follows:  Isonicotinamide system and Benzamide system 
show a co-crystal zone that is skewed towards the Succinic acid side of the ternary plot.  
This skewness is a result of solubility differences of the starting components.  In 
contrast the Nicotinamide system, exhibited as well behaved phase diagrams in both 
water and methanol.  Additionally, single crystals have been grown during this 
investigation of the Nicotinamide with Succinic acid.  
Significantly for the ternary phase work, there are a limited number of experimentally 
derived phase diagrams which have been report, and these show similar trends linked to 
solvent component solubility.   Here we find that solubility of the components is 
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important, as the difference alters the location and size of the phase space regions of 
where the co-crystal is thermodynamically stable. This was then found to significantly 
influence the accessible solution composition available to maximise the formation of 
co-crystal over the crystallisation of mixtures or components.  All of which was found 
to be solvent choice sensitive, in particular the critical impact of component solubility 
on the skewness of the overall phase diagram and the impact this has on the viable co-
crystal region.  A future approach to developing this further would be to map solution 
speciation over composition as defined by the ternary phase diagrams in a systematic 
way.  This would enhance the perspective on solution chemistry and pre nucleation on 
co-crystal formation.  This latter area is of immense debate in the overall understanding 
of crystal engineering in the context of nucleation control. 
8.2 Future work 
 
A number of crystallisation routes have been explored here to maximise the number of 
co-crystals available in order to fully understand co-crystal formation.   The key model 
has been of small acid – amide.  Many flaws have come to light with the protocols 
employed in this study.   The lead for this work is the link between the pair wise design 
strategies to further study the objectives set out, the homo systems also need to be 
explored, such as acid – acid and amide – amide combinations allowing full 
appreciation of the hierarchical approach and design of and component suitability of co-
crystallising compound.  Coupling this work with the mathematical model discussed in 
chapter two section 2.8 could be the beginning of developing a predictive computational 
led mode/tool for co-crystal design using MOPAC,     
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Appendices 
Appendix A: Packing of previously reported Co-crystals 
 
AJAKEB 
Isonicotinamide with 4-Nitrobenzoic Acid supermolecule is formed with 4 components 
that form amide-amide homosynthons, this leads to a ring, R
2
2(8), and acid-pyridine 
interactions which leads to D
1
1(2).  These interactions extend to give 2-D cross linked 
laddered networks.   
 
 
BUDWEC 
Four component supermolecule are formed by amide-amide homosynthon, forming a 
R
2
2(8) ring and an acid-pyridine interactions leading to a D
1
1(2), these are extended to 
give cross linked ladder networks. 
 
 
D
1
1(2) 
R
2
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R
2
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BZASUC 
Here the Benzamide: Succinic acid components are assembled via acid-amide 
heterosynthons, forming a dimer with a R
2
2(8) ring.  Once extended via the N-H∙∙∙O 
interactions a tape configuration is formed and we observe a secondary ring formation 
of R
4
6(22).   
 
 
R
4
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D
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JAWWAG 
 
 
The structure of the Acetic Acid : Isonicotinamide co-crystal is formed with four 
components, where two of the Acetic Acid and two Isonicotinamide molecules are 
assembled via acid-pyridine synthon D
1
1(2) and complementary amide-amide hydrogen 
interactions, forming a R
2
2(8) ring.  This co-crystal is extended to a 2D sheet formed via 
N-H∙∙∙O and O-H∙∙∙O hydrogen bonds between the supermolecules, this secondary ring 
can be denoted to have a graph set of R
4
4(22). 
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LUNMAI 
Isonicotinamide with Cinnamic Acid supermolecule is formed with 4 components that 
form amide-amide homosynthons, R
2
2(8), and acid-pyridine interactions, when 
extended an infinite tape is formed, and a secondary ring, R
4
4(22), via N-H∙∙∙O and O-
H∙∙∙N hydrogen bonds between the supermolecules.  
 
 
 
 
D
1
1(2
) 
R
2
2(8) 
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D
1
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LUNMEM 
Isonicotinamide forms amide-amide homosynthon, R
2
2(8) with another Isonicotinamide, 
the primary aromatic nitrogen forms acid-amide interactions D
1
1(2), once this is 
extended we see a 2-D cross linked laddered network.  
 
 
 
  
R
2
2(8) 
D
1
1(2) 
R
4
4(22) 
Within the ladder conformation, a 
secondary ring is formed via N-
H∙∙∙O and O-H∙∙∙O hydrogen 
bonds, giving R
4
4(22) 
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LUNNOX 
A 4 component supermolcule via acid-pyridine hydrogen bond interactions and self 
complementary amide-amide, R
2
2(8) dimer, is observed.  This extends to form a 1-D 
chain.  Extension on N-H∙∙∙O interaction between these chains give rise a 2-D sheet, 
within which a R
6
6(26) ring is  formed. 
.   
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LUNNUD 
This example of Succinic Acid with Isonicotinamide, forms the expected acid-Pyridine 
hydrogen bonds, D
1
1(2), and homomeric self complementary amide-amide interaction 
R
2
2(8).  Further expansion of these structures via N-H∙∙∙O  interactions we see an 
infinite 1-D chain, which holds a R
4
4(28) and R
6
6(26) ring.   
LUNNUD and LUNNUD01 are both the same crystal structures. 
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LUNNUD01 
 
 
 
LUNPAL 
The supermolcule is formed with 4 components, (2 Isonicotinamide and 2 Mandelic 
acid), these are assembled via acid-pyridine, D
1
1(2), and complementary amide-amide 
hydrogen interactions, R
2
2(8).  When extended, this gives 2-D cross linked laddered 
network which consists of two secondary rings, R
2
3(9) and R
4
4(22).   
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ULAWOT 
A tape is formed with interaction between Glutaric acid group and the Pyridine of the 
Isonicotinamide.  A sheet is formed via N-H∙∙∙O and C-H∙∙∙O interactions between the 
tapes resulting in the formation of R
6
6(26).   
 
 
ULAWUZ  
A tape is formed with interaction between Adipic acid group and the Pyridine of the 
Isonicotinamide.  A sheet is formed via N-H∙∙∙O interactions between the tapes as a 
result we see two secondary rings R
4
4(22) and R
6
6(36).   
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ULAXAG 
Here we see that the COOH group of the Glutaric Acid is identical, however they 
hydrogen bond via different synthons, acid-pyridine giving a discrete interaction D
1
1(2) 
and acid-amide interaction forming a dimer, R
2
2(8). The molecule interacts to form 
tapes which are then connected via N-H∙∙∙O hydrogen bonds between the tapes.  From 
here a secondary ring of R
4
4(22) is formed.   
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ULAXEK 
A tape is formed via dimer interactions of the acid-amide interactions, R
2
2(8), and acid-
pyridine D
1
1(2).  A sheet is formed via N-H∙∙∙O interactions between the tapes, this 
gives and extended ring of R
6
6(38).  
 
 
 
VAKTOR 
Supermolecules are formed with 4 components, in the case of 4-Hydroxybenzoic Acid 
and Isonicotinamide a zigzag tape is formed, hydrogen interactions consist of phenol-
pyridine, D
1
1(2), and acid-amide heterodimer R
2
2(8).   
D
1
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D
1
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R
2
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R
6
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XAQQEM 
The 2-Hydroxybenzoic Acid : Isonicotinamide co-crystal is an aggregate of four 
components these are assembled via acid-pyridine heterosynthons, D
1
1(2), and 
homosynthon formed by amide-amide interactions, R
2
2(8), from two Isonicotinamide 
molecules.  There is also an intramolecular 6-membered hydrogen bond ring, R
1
1(6), 
with the carbonyl group of the carboxylic acid.  The four component units are extended 
into 2-D sheets via N-H∙∙∙O that generate an infinite tape.  This tape consists of a R24(8) 
ring.   
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Appendix B: Critical peaks of New Benzamide co-crystal phases 
Critical Peaks present in powder patterns of Benzamide co-crystal phases  
Table Ba: Benzamide: Fumaric Acid Powder Pattern 
Benzamide Fumaric Acid Co-crystal 
8.027 18.520 6.02 
15.796 22.859 10.052 
18.016 24.574 11.906 
 28.812 15.311 
 29.417  
 
Table Bb: Benzamide: Tartaric Acid Powder Pattern 
Benzamide Tartaric Acid Co-crystal 
8.027 11.65 5.424 
15.796 16.906 10.557 
18.016 18.823  
 20.740  
 
Table Bc: Benzamide:3-Hydroxybenzoic Acid Powder Pattern 
Benzamide 3-
Hydroxybenzoic 
Acid 
Co-crystal 
8.027 7.724 9.297 
15.796 16.401 14.015 
18.016 16.704  
 19.428  
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Table Bd: Benzamide: Mandelic Acid Powder Pattern 
Benzamide Mandelic Acid Co-crystal 
8.027 11.054 7.284 
15.796 13.980 9.10 
18.016 16.906  
 18.419  
 
 
Table Be: Benzamide:4-Nitrobenzoic Acid Powder Pattern 
Benzamide 4-Nitrobenzoic 
Acid 
Co-crystal 
8.027 8.330 5.799 
15.796 17.007 11.544 
18.016 24.776  
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Appendix C: Materials 
Compound, suppliers, purity and batch identification number are given for all the 
materials used during experimental work at University of Bradford.   
Active Ingredients 
 Benzamide (batch number 521355-484) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 Isonicotinamide (batch number 14725DE) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 Nicotinamide (Lot & filling code number 1347071/22507P08) Purity 99%, 
Fluka, Riedel –de Haën®, Sigma-Aldrich Labrochemikalien GmbH 
 
Coformer Acids 
 Adipic Acid (Lot number A016837701) Purity 99%, Acros Organics, New 
Jersey, USA 
 Benzoic Acid(batch number 10505AE) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 2-hydroxybenzoic Acid(batch number 066K3666) Purity 99%, Sigma-Aldrich 
Co. Ltd, Gillingham, Dorset 
 3-hydroxybenzoic Acid(batch number S15664-434) Purity 99%, Sigma-Aldrich 
Co. Ltd, Gillingham, Dorset 
 4-hydroxybenzoic Acid(batch number S17122-465) Purity 99%, Sigma-Aldrich 
Co. Ltd, Gillingham, Dorset 
 Succinic acid(batch number 058K0706) Purity ≥99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 Fumaric Acid(Lot number A016609001) Purity 99%, Acros Organics, New 
Jersey, USA 
 Tartaric Acid(batch number 504823-227) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 Glutaric Acid(Lot number A009716901) Purity 99%, Acros Organics, New 
Jersey, USA 
 Mandelic Acid(batch number U11516) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 4-nitrobenzoic Acid(batch number 521355-484) Purity 99%, Sigma-Aldrich Co. 
Ltd, Gillingham, Dorset 
 Cinnamic Acid(batch number S23228-065) Purity 99%, Sigma-Aldrich Co. Ltd, 
Gillingham, Dorset 
 
 
Solvents 
 Methanol (batch number 0768457, 0919133, 0950855, 0958514) Purity 99.99% 
(HPLC grade), Fisher-Scientific UK Ltd, Bishop Meadow Road, Loughborough, 
Leics. Sigma-Aldrich Co. Ltd, Gillingham, Dorset 
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 Ethanol (batch number 0892401, 0892401) Purity 99.99% (HPLC grade), 
Fisher-Scientific UK Ltd, Bishop Meadow Road, Loughborough, Leics. Sigma-
Aldrich Co. Ltd, Gillingham, Dorset 
 Tetrahydrofuran(Lot number K29133125) 99.99% , BDH, Laboratory supplies, 
Poole, UK 
 Ethyl Acetate (batch number 80015) Purity 99.99% (HPLC grade), Sigma-
Aldrich Co. Ltd, Gillingham, Dorset 
 
Water used was double distilled, Milli-RO®15 Water Purification System and Milli-Q® 
Reagent Grade Water System 
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Appendix D: Single crystal Data 
 
Detailed crystal structure data from CIF files of Benzamide Fumaric and 4-nitrobenzoic 
acid Co-crystals. 
 
Title Benzamide:Fumaric Acid 
 
Hafsa Shamim Javed 
Department of Pharmacy, University of Bradford, IPI Building, Richmond Road, 
Bradford, West Yorkshire, BD7 1DP, UK 
 
Correspondence e-mail: h.s.javed@bradford.ac.uk 
 
(BZAMD_FA) 
 
Crystal data 
 
C9H9N1O3 Dx = 1.419 Mg m
−3
 
Mr = 179.18 Melting point:? K 
Monoclinic, P21/n 
Mo Kα radiation  
λ = 0.71073 Å 
Hall symbol: ? Cell parameters from 2331 reflections 
a = 5.318 (6) Å θ = 4–28° 
b = 5.351 (6) Å µ = 0.11 mm
−1
 
c = 29.64 (4) Å T = 150 K 
β = 96.03 (5)° Cell measurement pressure: ? kPa 
V = 838.8 (18) Å
3
 Block, colourless 
Z = 4 0.40 × 0.30 × 0.25 mm 
F000 = 376 
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Data collection 
 
Rigaku R-AXIS RAPID Image Plate  
diffractometer 
3322 measured reflections 
Radiation source: ? 1296 independent reflections 
Monochromator: graphite 969 reflections with I > 2.0σ(I) 
Detector resolution: ? pixels mm
-1
 Rint = 0.048 
T = 150 K θmax = 27.5° 
P = ? kPa θmin = 3.8° 
ω scans h = −6→6 
Absorption correction: multi-scan 
FSPROCESS 
k = −6→6 
Tmin = 0.90, Tmax = 0.97 l = −38→38 
 
Refinement 
 
Refinement on F
2
 Secondary atom site location: ? 
Least-squares matrix: full 
Hydrogen site location: inferred from 
neighbouring sites 
R[F
2
 > 2σ(F2)] = 0.057 
H atoms treated by a mixture of 
independent and constrained refinement 
wR(F
2
) = 0.192 
  Method = Modified Sheldrick w = 
1/[σ2(F2) + ( 0.13P)2 + 0.02P] ,  
where P = (max(Fo
2
, 0) + 2Fc
2
)/3 
S = 1.04 (Δ/σ)max = 0.0002 
1291 reflections Δρmax = 0.31 e Å
−3
 
128 parameters Δρmin = −0.26 e Å
−3
 
? constraints 
Extinction correction: Larson (1970), 
Equation 22 
Primary atom site location: structure-
invariant direct methods 
Extinction coefficient: 150 (60) 
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Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å
2
) 
 
 x y z Uiso*/Ueq 
 
C1 0.8791 (5) −0.9717 (5) 0.49571 (8) 0.0224  
C2 0.7848 (6) −0.7569 (5) 0.46707 (8) 0.0217  
O3 0.9586 (4) −0.6423 (4) 0.44584 (6) 0.0320  
O4 0.5658 (4) −0.6942 (4) 0.46395 (7) 0.0362  
C5 0.5092 (5) 0.0164 (5) 0.35356 (8) 0.0210  
C6 0.5736 (5) −0.1817 (5) 0.38860 (8) 0.0198  
O7 0.7915 (4) −0.2663 (4) 0.39453 (6) 0.0287  
N8 0.3883 (5) −0.2589 (5) 0.41218 (7) 0.0265  
C9 0.3064 (5) 0.1788 (6) 0.35469 (9) 0.0265  
C10 0.2602 (6) 0.3617 (6) 0.32154 (9) 0.0302  
C11 0.4133 (6) 0.3790 (5) 0.28698 (9) 0.0289  
C12 0.6141 (6) 0.2187 (5) 0.28545 (8) 0.0290  
C13 0.6656 (6) 0.0392 (5) 0.31881 (8) 0.0243  
H11 0.7527 −1.0792 0.5092 0.0273*  
H91 0.1932 0.1646 0.3795 0.0324*  
H101 0.1160 0.4805 0.3228 0.0364*  
H111 0.3780 0.5087 0.2629 0.0344*  
H121 0.7235 0.2318 0.2601 0.0350*  
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H131 0.8152 −0.0734 0.3180 0.0299*  
H81 0.427 (6) −0.400 (7) 0.4311 (10) 0.0324*  
H82 0.217 (7) −0.215 (6) 0.4032 (10) 0.0324*  
H31 0.884 (6) −0.504 (7) 0.4288 (11) 0.0389*  
 
Atomic displacement parameters (Å
2
) 
 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
C1 
0.0193 
(16) 
0.0231 
(17) 
0.0257 
(13) 
−0.0052 
(12) 
0.0067 (9) 
0.0040 
(10) 
C2 
0.0215 
(18) 
0.0205 
(17) 
0.0239 
(13) 
−0.0029 
(13) 
0.0065 (9) 0.0020 (9) 
O3 
0.0209 
(13) 
0.0351 
(15) 
0.0417 
(12) 
0.0024 (9) 0.0120 (8) 0.0225 (9) 
O4 
0.0216 
(14) 
0.0358 
(15) 
0.0524 
(13) 
0.0020 (10) 0.0096 (8) 0.0221 (9) 
C5 
0.0229 
(18) 
0.0171 
(16) 
0.0228 
(12) 
−0.0057 
(13) 
0.0011 (9) 
−0.0011 
(9) 
C6 
0.0172 
(17) 
0.0186 
(15) 
0.0240 
(12) 
−0.0017 
(13) 
0.0044 (9) 
−0.0026 
(9) 
O7 
0.0239 
(14) 
0.0306 
(14) 
0.0323 
(11) 
0.0027 (10) 0.0056 (7) 0.0110 (8) 
N8 
0.0220 
(15) 
0.0274 
(16) 
0.0315 
(13) 
0.0061 (12) 0.0094 (9) 
0.0080 
(10) 
C9 
0.0252 
(17) 
0.0240 
(18) 
0.0311 
(14) 
0.0055 (13) 0.0061 (10) 
0.0011 
(10) 
C10 
0.0272 
(19) 
0.0212 
(18) 
0.0412 
(16) 
−0.0001 
(14) 
−0.0008 
(11) 
0.0029 
(11) 
C11 0.034 (2) 
0.0187 
(17) 
0.0322 
(14) 
−0.0044 
(14) 
−0.0052 
(11) 
0.0061 
(10) 
C12 0.034 (2) 
0.0267 
(18) 
0.0272 
(14) 
−0.0001 
(15) 
0.0064 (10) 
0.0061 
(10) 
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C13 
0.0226 
(18) 
0.0221 
(17) 
0.0290 
(14) 
0.0005 (13) 0.0058 (9) 
0.0009 
(10) 
 
Geometric parameters (Å, °) 
 
C1—C1i 1.319 (6) N8—H81 0.95 (3) 
C1—C2 1.484 (4) N8—H82 0.95 (4) 
C1—H11 1.000 C9—C10 1.390 (4) 
C2—O3 1.322 (3) C9—H91 1.000 
C2—O4 1.206 (4) C10—C11 1.377 (5) 
O3—H31 0.96 (4) C10—H101 1.000 
C5—C6 1.498 (4) C11—C12 1.374 (4) 
C5—C9 1.388 (4) C11—H111 1.000 
C5—C13 1.396 (4) C12—C13 1.385 (4) 
C6—O7 1.240 (3) C12—H121 1.000 
C6—N8 1.332 (4) C13—H131 1.000 
 
C1
i—C1—C2 123.5 (3) C5—C9—C10 120.3 (3) 
C1
i—C1—H11 118.2 C5—C9—H91 120.0 
C2—C1—H11 118.2 C10—C9—H91 119.8 
C1—C2—O3 114.8 (3) C9—C10—C11 119.9 (3) 
C1—C2—O4 121.7 (2) C9—C10—H101 120.1 
O3—C2—O4 123.5 (3) C11—C10—H101 120.0 
C2—O3—H31 110 (2) C10—C11—C12 120.3 (3) 
C6—C5—C9 123.2 (2) C10—C11—H111 119.8 
C6—C5—C13 117.6 (2) C12—C11—H111 119.8 
C9—C5—C13 119.2 (2) C11—C12—C13 120.4 (3) 
C5—C6—O7 119.9 (2) C11—C12—H121 119.8 
C5—C6—N8 117.1 (3) C13—C12—H121 119.8 
O7—C6—N8 123.0 (3) C5—C13—C12 119.9 (3) 
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C6—N8—H81 115.4 (18) C5—C13—H131 120.1 
C6—N8—H82 121.0 (18) C12—C13—H131 120.0 
H81—N8—H82 120 (3)   
 
Symmetry codes: (i) −x+2, −y−2, −z+1. 
 
Hydrogen-bond geometry (Å, °) 
 
D—H···A D—H H···A D···A D—H···A 
N8—H81···O4 0.95 1.95 2.893 (2) 169 
O3—H31···O7 0.96 1.67 2.620 (2) 171 
 
 
 
Refinement 
 
Hydrogen atoms were located in geometrically defined positions and refined as riding 
groups, except for those involved in hydrogen bonds. The three hydrogen bonded 
protons were studied using 2 dimensional difference Fourier maps to check for potential 
site disorder; none was observed. The protons were placed geometrically and their 
positions refined. 
 
Computing details 
 
Data collection: d*trek/CrystalClear; cell refinement: FSProcess/CrystalClear; data 
reduction: FSProcess/CrystalClear; program(s) used to solve structure: SIR92 
(Altomare et al., 1994); program(s) used to refine structure: CRYSTALS (Betteridge et 
al., 2003); molecular graphics: Mercury; software used to prepare material for 
publication: CRYSTALS (Betteridge et al., 2003). 
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Benzamide: 4-Nitrobenzoic Acid 
 
Crystal data 
 
C14H12N2O4 F000 = 284 
Mr = 272.26 Dx = 1.418 Mg m
−3
 
?, ? Melting point: ? K 
Hall symbol: ? 
Mo Kα radiation  
λ = 0.71073 Å 
a = 6.3184 (4) Å Cell parameters from ? reflections 
b = 6.8802 (5) Å θ = ?–?° 
c = 15.6401 (11) Å µ = 0.11 mm
−1
 
α = 95.749 (5)° T = 296 (2) K 
β = 98.806 (4)° Cell measurement pressure: ? kPa 
γ = 106.239 (4)° ?, ? 
V = 637.72 (8) Å
3
 0.31 × 0.14 × 0.06 mm 
Z = 2  
 
Data collection 
 
? diffractometer 1849 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed tube Rint = 0.077 
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Monochromator: graphite θmax = 27.3° 
T = 296(2) K θmin = 1.3° 
P = ? kPa h = −8→8 
Absorption correction: ? k = −8→8 
27857 measured reflections l = −19→20 
2815 independent reflections Standard reflections: ? 
 
Refinement 
 
Refinement on F
2
 
Hydrogen site location: inferred from 
neighbouring sites 
Least-squares matrix: full 
H atoms treated by a mixture of 
independent and constrained refinement 
R[F
2
 > 2σ(F2)] = 0.120 
  w = 1/[σ2(Fo
2
) + (0.1P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
wR(F
2
) = 0.317 (Δ/σ)max = 0.032 
S = 1.93 Δρmax = 1.20 e Å
−3
 
2815 reflections Δρmin = −0.38 e Å
−3
 
190 parameters Extinction correction: none 
? constraints Absolute structure: ? 
Primary atom site location: structure-
invariant direct methods 
Flack parameter: ? 
Secondary atom site location: difference 
Fourier map 
Rogers parameter: ? 
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Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for 
negative F
2
. The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating 
R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-
factors based on F
2
 are statistically about twice as large as those based on F, and R– 
factors based on ALL data will be even larger. 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å
2
) 
 
 x y z Uiso*/Ueq  
C5A 0.0776 (7) 0.1798 (7) 0.1871 (3) 0.0192 (10)  
H5A −0.0158 0.1409 0.1323 0.023*  
C1A 0.1319 () 0.2382 (6) 0.3446 (3) 0.0175 (10)  
C3A 0.4519 (7) 0.3079 (7) 0.2747 (3) 0.0229 (10)  
H3A 0.6066 0.3508 0.2781 0.027*  
C4A 0.3082 (7) 0.2453 (7) 0.1954 (3) 0.0205 (10)  
C6A −0.0091 (7) 0.1740 (7) 0.2622 (3) 0.0235 (11)  
H6A −0.1637 0.1268 0.2584 0.08*  
C7A 0.0238 (7) 0.2271 (7) 0.4232 (3) 0.0224 (10)  
C2A 0.3591 (7) 0.3055 (7) 0.3504 (3) 0.0228 (11)  
H2A 0.4527 0.3502 0.4050 0.027*  
O2A −0.1759 (5) 0.1519 (6) 0.4192 (2) 0.0361 (10)  
O1A 0.1657 (5) 0.3133 (6) 0.49628 (19) 0.0338 (10)  
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O3A 0.610 (6) 0.2948 (6) 0.1246 (2) 0.0400 (10)  
O4A 0.2803 (6) 0.2012 (6) 0.0456 (2) 0.0362 (9)  
N1A 0.4050 (7) 0.2472 (6) 0.1158 (3) 0.0280 (10)  
C1B 0.7689 (7) 0.2642 (6) 0.7393 (3) 0.0213 (10)  
C6B 0.5527 (7) 0.2172 (7) 0.7576 (3) 0.0260 (11)  
H6B 0.4276 0.1831 0.7128 0.031*  
C5B 0.5291 (8) 0.2227 (7) 0.8452 (3) 0.0267 (11)  
H5B 0.3857 0.1871 0.8583 0.032*  
C3B 0.9251 (8) 0.3298 (8) 0.8925 (3) 0.0291 (12)  
H3B 1.0498 0.3709 0.9377 0.035*  
C7B 0.8142 (7) 0.2548 (7) 0.6470 (3) 0.0211 (10)  
C4B 0.7078 (8) 0.2779 (7) 0.9111 (3) 0.0285 (11)  
H4B 0.6874 0.2817 0.9688 0.034*  
C2B 0.9521 (7) 0.3192 (7) 0.8062 (3) 0.0198 (10)  
H2B 1.0957 0.3497 0.7935 0.024*  
O1B 1.0070 (5) 0.3173 (6) 0.6354 (2) 0.0361 (10)  
N1B 0.6385 (7) 0.1820 (6) 0.5814 (2) 0.0300 (10)  
 
Atomic displacement parameters (Å
2
) 
 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
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C5A 0.018 (2) 
0.023 
(2) 
0.014 (2) 
0.0025 
(18) 
0.0002 (17) 0.0015 (18) 
C1A 0.025 (2) 
0.017 
(2) 
0.016 (2) 
0.0117 
(18) 
0.0056 (17) 0.0059 (17) 
C3A 0.017 (2) 
0.023 
(2) 
0.033 (3) 
0.0085 
(18) 
0.0085 (19) 0.007 (2) 
C4A 0.028 (3) 
0.017 
(2) 
0.020 (2) 
0.0073 
(19) 
0.0118 (19) 0.0017 (18) 
C6A 0.016 (2) 
0.028 
(3) 
0.026 (2) 
0.0054 
(19) 
0.0062 (19) 0.002 (2) 
C7A 0.020 (2) 
0.020 
(2) 
0.029 (3) 
0.0079 
(19) 
0.0065 (19) 0.005 (2) 
C2A 0.023 (2) 
0.029 
(3) 
0.015 (2) 0.006 (2) 0.0039 (18) 0.0014 (19) 
O2A 0.029 (2) 
0.053 
(2) 
0.0205 
(18) 
0.0013 
(17) 
0.0103 (14) 
−0.0003 
(16) 
O1A 
0.0238 
(18) 
0.057 
(2) 
0.0154 
(17) 
0.0056 
(16) 
0.0060 (14) 
−0.0008 
(16) 
O3A 0.029 (2) 
0.063 
(3) 
0.0274 
(19) 
0.0107 
(17) 
0.0119 
15) 
0.0033 (17) 
O4A 0.033 (2) 
0.059 
(3) 
0.0179 
(18) 
0.0163 
(17) 
0.0033 (15) 0.0063 (16) 
N1A 0.035 (3) 
0.025 
(2) 
0.032 (2) 
0.0112 
(18) 
0.023 (2) 0.0115 (18) 
C1B 0.031 (3) 
0.016 
(2) 
0.018 (2) 
0.0060 
(19) 
0.0085 (19) 0.0019 (18) 
C6B 0.021 (2) 
0.028 
(3) 
0.030 (3) 
0.0077 
(19) 
0.0065 (19) 0.007 (2) 
C5B 0.028 (3) 0.025 0.029 (3) 0.009 (2) 0.013 (2) 0.000 (2) 
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(3) 
C3B 0.034 (3) 
0.036 
(3) 
0.014 (2) 0.009 (2) 0.0004 (19) 0.000 (2) 
C7B 0.031 (3) 
0.018 
(2) 
0.014 (2) 
0.0059 
(19) 
0.0055 (19) 0.0040 (18) 
C4B 0.044 (3) 
0.021 
(3) 
0.027 (3) 0.013 (2) 0.018 (2) 0.005 (2) 
C2B 0.020 (2) 
0.025 
(3) 
0.016 (2) 
0.0086 
(18) 
0.0030 (17) 0.0014 (18) 
O1B 
0.0230 
(19) 
0.058 
(3) 
0.0224 
(18) 
0.0013 
(16) 
0.0099 (14) 0.0060 (16) 
N1B 0.031 (2) 
0.037 
(2) 
0.020 (2) 
0.0082 
(18) 
0.0046 (17) 0.0020 (17) 
 
Geometric parameters (Å, °) 
 
C5A—C6A 1.369 (6) O4A—N1A 1.206 (5) 
C5A—C4A 1.380 (6) C1B—C2B 1.373 (6) 
C1A—C2A 1.365 (6) C1B—C6B 1.394 (6) 
C1A—C6A 1.402 (6) C1B—C7B 1.511 (6) 
C1A—C7A 1.493 (6) C6B—C5B 1.400 (7) 
C3A—C4A 1.370 (6) C5B—C4B 1.344 (7) 
C3A—C2A 1.399 (6) C3B—C2B 1.383 (6) 
C4A—N1A 1.469 (6) C3B—C4B 1.402 (7) 
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C7A—O2A 1.212 (5) C7B—O1B 1.222 (5) 
C7A—O1A 1.310 (5) C7B—N1B 1.332 (6) 
O3A—N1A 1.231 (5)   
 
C6A—C5A—C4A 117.8 (4) O4A—N1A—C4A 118.8 (4) 
C2A—C1A—C6A 119.7 (4) O3A—N1A—C4A 117.8 (4) 
C2A—C1A—C7A 122.8 (4) C2B—C1B—C6B 120.2 (4) 
C6A—C1A—C7A 117.6 (4) C2B—C1B—C7B 117.0 (4) 
C4A—C3A—C2A 118.0 (4) C6B—C1B—C7B 122.8 (4) 
C3A—C4A—C5A 123.1 (4) C1B—C6B—C5B 118.2 (4) 
C3A—C4A—N1A 118.2 (4) C4B—C5B—C6B 121.8 (4) 
C5A—C4A—N1A 118.7 (4) C2B—C3B—C4B 119.2 (4) 
C5A—C6A—C1A 121.0 (4) O1B—C7B—N1B 122.7 (4) 
O2A—C7A—O1A 123.6 (4) O1B—C7B—C1B 119.5 (4) 
O2A—C7A—C1A 123.3 (4) N1B—C7B—C1B 117.7 (4) 
O1A—C7A—C1A 113.1 (4) C5B—C4B—C3B 119.8 (4) 
C1A—C2A—C3A 120.4 (4) C1B—C2B—C3B 120.7 (4) 
O4A—N1A—O3A 123.4 (4)   
 
 
All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell e.s.d.'s are taken into account individually in 
the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between 
e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An 
approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving 
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l.s. planes. 
 
 
Computing details 
 
Data collection: ?; cell refinement: ?; data reduction: ?; program(s) used to solve 
structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine structure: 
SHELXL97 (Sheldrick, 1997); molecular graphics: ?; software used to prepare 
material for publication: ?. 
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Appendix E: Re-clustering of dSNAP results 
Re-clustering has taken place where groups varied in similarity.  These re-clustering 
have been presented by a dendrogram and all observations of sub-clustering have been 
listed in the corresponding tables.  Please note that for each reclustered group the table 
is listed according to each coloured sub group which can be seen in the dendrogram, for 
example Group Aa refers to re-clustering of group A from the initial search, and the 
small case ‗a‘ refers to the red cluster observed in the re-cluster.   
Cluster A 
 
  
Group   
Aa O2 is orientated towards N1 
Ab Similar to Aa slight offset 
Ac Similar to Aa slight offset 
Ad Similar to Aa slight offset 
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Cluster C 
 
 
Group  
Ca O2 positioned towards N1 of the Pyridine ring, slight offset in 
orientation to group A sub cluster 
Cb Acid group orientated above/below the ring group of primary amide 
Cc 
(2 
Fragments) 
Frag 1, O2 orientated towards N1 of the pyridine ring on a slight offset 
Frag 2, O3 orientated towards the N1 of Pyridine ring, offset is in 
opposite direction of frag 1 
Cd 
(1 
fragment) 
Orientated above/below the amide group, however not parallel to the 
amide group. 
Ce Orientation of acid group is next to the amide group, showing a lot of 
deviation, fur sub clustering required.   
Cf O3 is orientated towards the N1 of Pyridine, O3 is away from it  
Cg O2 orientated towards the N1 of Frag 1, Frag 2 is opposite, i.e. O3 both 
have offset positions in orientation 
Ch Acid groups orientated towards the amide group, both acids are facing in 
opposite directions   
Ci O3 orientated towards N1 of Pyridine  
Cj Acid positioned above/below amide, O2 orientated towards N2 or amide  
Ck Orientation is above/below the amide but facing the opposite way to the 
amide 
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Cluster E 
 
 
Group  
Ea O3 and O2 facing the amide group forming a dimer 
Eb O3 and O2 facing the amide group forming a dimer 
Ec O3 and O2 facing the amide group forming a dimer 
Ed O3 and O2 facing the amide group forming a dimer 
Ee O3 and O2 facing the amide group forming a dimer 
Ef O3 and O2 facing the amide group forming a dimer 
Eg O3 and O2 facing the amide group forming a dimer 
Eh O3 and O2 facing the amide group forming a dimer 
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Cluster F 
 
 
Group  
Fa Acid group positioned near pyridine, above/below plane 
Fb Acid group positioned near pyridine, above/below plane 
Fc Acid group positioned opposite direction to amide above/below plane 
Fd Acid above/below plane, C7 of acid over N1, O3 away from amide, O2 
facing O1 of amide but slightly offset. 
Fe Acid group next to amide, too much deviation needs to be reclustered 
Ff Further clustering required  
Fg Acid above/below plane, positioning is slightly offset of the amide 
Fh Position of acid is away from amide more near to pyridine where O3 is 
facing towards N2 of Pyridine 
Fi O3 positioned towards N1 of amide, O2 facing away from it 
Fj O3 positioned towards N1 of amide 
Fk O2 positioned towards N2 of amide, whereas O3 is away 
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Cluster G 
 
 
Group  
Ga Ideal dimer is shown 
Gb Ideal dimer is shown 
Gc Ideal dimer is shown 
Gd Ideal dimer is shown 
Ge O2 facing N1 of amide, O3 is facing away 
Gf Acid group is above/below plane of amide, O2 directly above/below N1 
as O3 is above/Below O1 of amide.   
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Cluster H 
 
 
Group  
Ha O2 facing N1 of pyridine, O3 pointing away 
Hb Both Oxygen‘s facing towards the Pyridine ring 
Hc Both Oxygen‘s facing towards the Pyridine ring but with a lot of 
deviation 
Hd O3 towards N1 of pyridine, O2 facing opposite direction 
He Acid is position to left/right of N1 of pyridine where O3 is towards N1 
Hf Acid is position to left/right of N1 of pyridine where O3 is towards N1 
Hg Acid group positioned left/right of pyridine, O3 is positioned near N1, 
O2 of acid is facing away. 
 
 
255 
 
Appendix F: High through put screen and polySNAP output 
i) Plate format used for HTP 
 
Active 1 Benzamide  Solvent 1 o-xylene 
Active 2 Nicotinamide  Solvent 2 Isohexane 
Active 3 Isonicotinamide  Solvent 3 Ethyl acetate 
    Solvent 4 Methanol 
Stoichiometric 
ratios per well      
 1 2 3 4 5 6 7 8 9 10 11 12 
A 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 
B 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 
C 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 
D 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 
E 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 
F 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 
G 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 
H 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 1:1 2:1 1:2 
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Evaporation plate 
1&3            
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 3 6 9 11 14 1 3 6 9 11 14 
B 1 4 6 9 12 14 1 4 6 9 12 14 
C 1 4 7 9 12 15 1 4 7 9 12 15 
D 2 4 7 10 12 15 2 4 7 10 12 15 
E 2 5 7 10 13 15 2 5 7 10 13 15 
F 2 5 8 10 13 16 2 5 8 10 13 16 
G 3 5 8 11 13 16 3 5 8 11 13 16 
H 3 6 8 11 14 16 3 6 8 11 14 16 
 Solvent 1 Solvent 2 
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Evaporation plate 
2&4 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 3 6 9 11 14 1 3 6 9 11 14 
B 1 4 6 9 12 14 1 4 6 9 12 14 
C 1 4 7 9 12 15 1 4 7 9 12 15 
D 2 4 7 10 12 15 2 4 7 10 12 15 
E 2 5 7 10 13 15 2 5 7 10 13 15 
F 2 5 8 10 13 16 2 5 8 10 13 16 
G 3 5 8 11 13 16 3 5 8 11 13 16 
H 3 6 8 11 14 16 3 6 8 11 14 16 
 Solvent 3 Solvent 4 
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ii) polySNAP  analysis of plates BD002-6 
 
a) Plate BD002 
 
Cell Display 
 
Dendrogram  
 
We exhibit a clustering from the dendrogram with 18 defined groups, these groups have 
been examined and highlighted in the table below.   
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Table Fa1: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 01,  
28 
1 (2:1) 
9 (1:2) 
Yellow 12,  
70 
12 (1:1) 
10 (1:2) 
Green 11 11, (1:2) 
Light Blue 09,  
10,  
14, 26, 38 
6 (1:1) 
9 (2:1) 
4 (2:1) (1:1) (1:2) 
Blue 39, 45, 61,  7 (1:1) (1:1) 2 (1:2) 
Pink 68, 71 5 (1:1) 13 (1:1) 
Stripy Brown 54 15 (1:2) 
Stripy Green 58, 64 10 (1:1) (1:2) 
Stripy Greeny Blue 02,  
03,  
74 
3 (1:2) 
6 (1:1) 
5 (1:2) 
Stripy Light Blue 40,  
52 
10 (2:1) 
15 (1:2) 
Stripy Purple 56 5 (2:1) 
Stripy Pink 46 10 (2:1) 
Salmon Pink 66, 78 16 (2:1) (1:1) 
Pastel Yellow 84 16 (1:1) 
Pastel Green 83 13 (1:2) 
Pastel Light Blue 36 15 (2:1) 
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Pastel Sky Blue 48 15 (1:1) 
Pastel Pink 63 8 (2:1) 
 
 
Figure Fa1: Various views of the 3D MMDS plots for plate 2 
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Figure Fa2: A zoomed in view of the MMDS plot of plate 2 showing samples 9 and 10, which cluster 
close together as compared to the other samples 
 
The MMDS plot has highlights that in the light blue cluster we samples 9 and 10 cluster 
together, Figure Fa2, cross reference of these samples with the dendrogram and the 
tabulated analysis above shows that these samples consist of component 6, (4-
nitrobenzoic acid) with ratio of 1:1 and component 9 (Fumaric acid) with a ratio of 2:1.  
The samples have been overlaid in the pattern viewer and have been assigned a 
similarity rank of 0.821. 
 
It is evident from this example that the quality of the pattern is poor with only one 
defined peak for these samples.  It can only be suggested that there has been some 
contamination when handling the plate before the analysis.   
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Figure Fa3: MMDS plot of plate 2 showing samples 78 and 84, which cluster close together as 
compared to the other samples 
 
Rotating the 3D MMDS plot, Figure 5.11 we see that salmon pink (78) and pastel 
yellow (84) spheres are clustered close together.  The PXRD pane shows the overlaid 
patterns of these samples.   
 
We see there is some similarity in the patterns with a slight shift, the quality of the 
pattern matching is poor for these samples.  Using the dendrogram analysis, both the 
pastel yellow and salmon pink cluster sample consisting of Benzamide with conformer 
16 which is Trans  hydromuconic acid.  Although the salmon pink group has two 
samples clustered in the dendrogram, in the MMDS plot these are plotted with a 
significant distance between them.  Below is the PXRD comparison of samples 78 and 
84 with starting components Benzamide and Trans β hydromuconic acid, Figure Fa4.   
Salmon pink and 
yellow sphere 
touching 
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Figure Fa4: Powder patterns display of the sample 78 and 86 overlaid with the pure components to 
identify peaks that suggest new phases 
 
It seems to be evident that the samples from the screen are the same with a slight shift.  
A new peak has been highlighted between 20-22˚ 2θ and a peak between 24-26˚ 2θ 
which also seem to be new peaks not present in the starting components.  However, 
further data from DSC and Raman maybe required and input into polySNAP to back up 
this sampling similarity.   
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Sample 78 Sample 84 Benzamide Trans β hydromuconic acid
New Phase 
New Phase 
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b) Plate BD003 
Cell display 
 
Dendrogram
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Table Fb1: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 04 9 (2:1) 
Yellow 47 12 (1:2) 
Green 11 11 (1:2) 
Light Blue 17 12 (2:1) 
Blue 64 10 (1:2) 
Pink 09, 21, 15,  
10,  
31 
6 (1:1), (1:2), 1:2) 
9 (2:1) 
1 (1:2) 
Stripy Brown 14, 38, 26,  
68 
4 (2:1), (1:2), (1:1) 
5 (1:1) 
Stripy Green 50 5 (2:1) 
Stripy Greeny Blue 28 9 (1:2) 
Stripy Light Blue 71 13 (1:1) 
Stripy Purple 39 7 (1:1) 
Stripy Pink 69 8 (2:1) 
Salmon Pink 51 7 (2:1) 
Pastel Yellow 30 15 (2:1) 
Pastel Green 34 9 (1:2) 
Pastel Light Blue 59 13 (2:1) 
Pastel Sky Blue 07, 19 1 (2:1) (1:1) 
Pastel Pink 43 2 (2:1) 
Stripy Brown 58 10 (1:1) 
Stripy Green 46 10 (2:1) 
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Stripy Greeny Blue 16 9 (1:1) 
Stripy Blue 54 15 (1:2) 
Stripy Purple 66 16 (2:1) 
Stripy Pink 63 8 (2:1) 
Pale Orange 62 5 (1:1) 
 
Figure Fb1: MMDS plot of plate 3  
 
The purple stripy sphere and green sphere cluster very close together, Figure Fb1, 
however from overlaying the powder patterns, shown below Figure Fb2 we see the 
patterns are very different with a similarity rank of 0.190 
Cross referencing these samples with the dendrogram analysis tabulated above, the 
stripy purple sample is sample 39, consisting of Isonicotinamide with co-former 7, 
Adipic acid, with a composition ratio of (1:1) and the sample clustered in the green 
group is Isonicotinamide with co-former 11 which is Malic acid with a composition 
ratio of (1:2).   
 
 
Stripy purple and 
green spheres 
clustered closely 
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Figure Fb2 Overlaid powder diffraction patterns as would be observed from the pattern viewing 
pane in polySNAP.  Powder pattern red is the stripy purple sphere represented in the dendrogram, 
highlighted as sample 66 and blue is sample 11, which is the green sphere.  
 
Further examination of the 3D MMDS plot shows a small cluster of the pink group.  
The close clustered spheres are samples 09 and 10, Figure Fb3.   
Figure Fb3: MMDS plot of plate 3 showing samples 9 and 10, which cluster close together as 
compared to the other samples 
 
In the PXRD overlay pane below we see a strong similarity of the samples which 
polySNAP has ranked to have a similarity of 0.961.  However, cross referencing this 
information with the dendrogram analysis shows that these two samples consist of 
Isonicotinamide with co-former 6 and 9, which are Adipic acid and Fumaric acid, 
respectively.  This does not explain what the new phase is and how it is similar unless 
there has been some cross contamination during the screening process or when 
transporting to Pharmorphix for PXRD analysis.   
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c) Plate BD004 
Cell display 
 
Dendrogram 
The cut of level is 0.49 giving a clustering of 14 groups.  These groups were further 
examined and cross referenced with the plated format.  The details are given in the table 
below.   
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Table Fc1: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 05,  
23 
11(1:2) 
12 (2:1) 
Yellow 11 11 (1:2) 
Green 21,  
41,  
55 
6 (1:2) 
12 (1:2) 
2 (1:1) 
Light Blue 38,  
50 
4 (1:2) 
5 (2:1) 
Blue 45,  
53 
7 (1:1) 
13 (2:1) 
Pink 65, 71, 77 13 (1:1) (1:1) (1:2) 
Stripy Brown 33 7 (2:1) 
Stripy Green 54,  
78 
15 (1:2) 
16 (1:1) 
Stripy Greeny Blue 59 13 (2:1) 
Stripy Light Blue 62 5 (1:1) 
Stripy Purple 35,  
58, 64 
12 (1:1) 
10 (1:1), (1:2) 
 
Stripy Pink 66 16 (2:1) 
Salmon Pink 22, 28,  
46, 40 
9 (1:1), (1:2) 
10 (2:1), (2:1) 
Pastel Yellow 36 15 (2:1) 
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Again, the polySNAP clustering has shown that there are many groups clustering which 
consist of Isonicotinamide with different acid co-formers such as the red, green, light 
blue, blue group, stripy green, stripy purple and salmon pink groups.  This shows the 
program lacks consistency in its clustering techniques as well as the data consisting of 
poor diffracted samples.   
3D MMDS plot in Figure Fc1 shows clustering of pink group, samples 65 and 71.   
Figure Fc1: Top image is MMDS plot of plate 4, Bottom, close up of the MMDS plot identifying 
close clustering of sample 65 and 71  
 
Overlaying the powder patterns of these samples given a similarity rank 0.730, below 
we can see that there are few distinct similarities in the peaks.   
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Cross referencing these samples with the dendrogram analysis highlights that sample 65 
and 71 both have a composition ratio of 1:1, as experiments were carried out using two 
different solvents per plate.  The conformer identified is conformer 13, which is Pimelic 
acid.  These samples have been displayed below along with the starting components to 
identify new peaks and similarities in the powder patterns, Figure Fc2.   
Figure Fc2: Powder patterns display of the sample 65 and 71 overlaid with the pure components to 
identify peaks that suggest new phases 
 
Upon analysis and comparison a small peak at 14.3˚ 2θ suggests a new phase peak. 
However it is difficult to highlight new phases and characteristic peaks from the starting 
components as the data collection is not a full profile collection.  As we can see Pimelic 
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New Phase 
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acid has the emergence of a peak at 12˚ 2θ, powder patterns of the starting components 
are from 2˚ 2θ to 50˚ 2θ, where as for high through-put screen sample, analysis is only 
from 11.25˚ 2θ, it also involves large amounts of background noise.   
 
d) Plate BD005 
Cell Display 
 
Dendrogram 
The dendrogram has clustered to give a similarity level cut of 0.41, resulting in presents 
the dendrogram below, resulting in 10 groups.  The table below presents the analysis of 
the groups by cross referencing with plate format in Appendix F(i). 
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Table Fd1: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 01, 13,  
02,  
26,  
77 
1 (2:1), (1:1) 
3 (1:2) 
4 (1:1),  
13 (1:2) 
Yellow 04, 16, 22 9 (2:1) (1:1) (1:1) 
Green 39 7 (1:1) 
Light Blue 23 12 (2:1) 
Blue 21 6 (1:2) 
Pink 60 15 (1:2) 
Stripy Brown 11,  
56 
11 (1:2) 
5 (2:1) 
Stripy Green 58,  
59 
10 (1:1) 
13 (2:1) 
Stripy Greeny Blue 69 8 (2:1) 
Stripy Light Blue 71 13 (1:1) 
 
From this analysis it is observed that polySNAP has clustered samples into groups with 
different co-formers.  Looking at the 3D MMDS plot, the clustering is much more 
spread in space, Figure Fd1.   
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Figure Fd1: MMDS plot of plate 5 
 
PolySNAP is showing that for this data set nothing is clustered close together in the 
MMDS plot. 
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Figure Fd2: Dendrogram of plate 5 
 
If we look back at the dendrogram we can see that sample 01 and 02, as highlighted 
above, Figure Fd2, cluster to have a similarity of 0.78.  Over laying the PXRD spectra 
of these is shown below. 
 
This looks like that these samples are the same, however from the table above sample 
01 and 02 are co-formers 1, 1, 4 Benzene dimethanol, and coformer 3, 3 aminobenzoic 
acid respectively.   
Therefore these powder patterns should be different to each other.  It can be assumed 
that these powder patterns are the same because of cross contamination during 
experiment and/or during preparation for sample plates to be transported to 
Pharmorphix.   
However, for this plate, polySNAP has clustered sample 4, 16 and 22 together in the 
dendrogram. These samples are of Nicotinamide with carboxylic acid co-former 9, 
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Fumaric acid, with the respective composition ratios of 2:1, 1:1, in solvent o-xylene, 
and 1:1 in isohexane.  The powder patterns have been plotted in Excel and compared 
with the starting components to identify potential new phase peaks, Figure Fd3.   
Figure Fd3: Powder patterns display of the sample 16 and 22 overlaid with the pure components to 
identify peaks that suggest new phases 
 
The powder patterns show various characteristic peaks from the two starting 
components, and new peaks which suggest a new phase between 16-17˚ 2θ.  However, 
further analysis of the sample as mentioned earlier such as DSC and Raman analysis of 
this data could be employed to back up these findings.   
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e) Plate BD006 
Cell display 
 
This display of plate 6 presents data of 30 samples labelled as ‗other‘, suggesting new 
phases, and two samples which could be possible mixtures of several components.  
Ideally a mixture of the two components is desirable but here we see that polySNAP has 
highlighted sample 51 to consist of a mixture of 7 possible components, and sample 89 
of 5 components.  It could be speculated that this is due to cross contamination when 
handling/ preparing the plate for PXRD analysis.   
It would be expected that these two samples, 51 and 89, would be clustered into 
individual groups.  However, the dendrogram does that show this to be the case for 
sample 89, which has been clustered with the light blue group and sample 51 is 
clustered on its own as stripy purple group.   
The cut level of the dendrogram is 0.65 that defines 15 groups.  
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Figure Fe1: Dendrogram of plate 6  
  
The table below shows the samples in the clustering groups and highlights the 
component compositions.   
Table Fe1: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 02,  
61, 37,  
13, 25,  
28, 04, 16 
41,  
3 (1:2) 
2 (1:2) (2:1) 
1 (1:1), (1:2) 
9 (1:2), (2:1), (1:1) 
12 (1:2) 
Yellow 03 6 (1:1) 
Green 07 1 (2:1) 
Light Blue 43 2 (2:1) 
Blue 14, 26 
53, 38, 65,  
63,  
15,  
4 (2:1), (1:1) 
13 (2:1), (1:2), (1:1) 
8 (2:1) 
6 (1:2) 
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89,  
62, 50 
14 (2:1) 
5 (1:1), (2:1) 
Pink 64 10 (1:2) 
Stripy Brown 22 9 (1:1) 
Stripy Green 46 10 (2:1) 
Stripy Greeny Blue 11 11 (1:2) 
Stripy Light Blue 27 7 (2:1) 
Stripy Purple 51 7 (1:2) 
Stripy Pink 57 7 (1:2) 
Salmon Pink 44 4 (1:2) 
Pastel Yellow 59 13 (2:1) 
Pastel Green 21 6 (1:2) 
 
For this plate, polySNAP has clustered many samples into individual groups, and two 
larger clustering groups which have samples with different starting components.   
The 3D MMDS plot below, Figure Fe2, also shows the two groups, red and blue, to 
form close packed clustering, however, since these groups consist of sample with 
different starting components they have been re-clustered and analysed below, Figure 
Fe3.   
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Figure Fe2: MMDS plot of plate 6 
 
Figure Fe3: Dendrogram as shown in Figure Fe1, dendrogram is a representing the re-clustering of 
red group from plate 6 
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After re-clustering the cell display, Figure Fe4, and dendrogram highlight that there are 
3 clustering groups, the table below details the samples per group and the component 
and composition ratios.   
Figure Fe4: Cell display and dendrogram of re-clustering of red group from plate 6 
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Table Fe2: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 02,  
61, 37 
13, 25 
28 
3 (1:2) 
2 (1:2) (2:1) 
1 (1:1), (1:2) 
9 (1:2),  
Yellow 41 12 (1:2) 
Green 04, 16 9 (2:1), (1:1) 
 
Again the samples here have been clustered as seen previously where one group 
consists of many carboxylic acids.  The 3D MMDS plots, Figure Fe5, are slightly better 
looking with the red group clustering close together but having a heavily tight clustering 
of three spheres as highlighted below, Figure Fe6, Fe7   
Figure Fe5: MMDS plot of re-cluster of red group from plate 6 
 
 
283 
 
Figure Fe6: A zoomed in view of the MMDS plot of re-clustered red group from plate 6 showing 
samples 2, 3 and 61, which cluster close together as compared to the other samples 
 
These have been highlighted to be sample 02, 13 and 61.  Overlaying these samples 02, 
13 shows that these patterns are very alike and have been assigned with a similarity rank 
of 0.977. 
 
Figure Fe7: A zoomed in view of the MMDS plot of re-clustered red group from plate 6 showing 
samples 2, and 16 
 
Overlaying samples 02 and 61 also presents patterns that are alike and have a similarity 
rank 0.984.   
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However, from the table above these samples consist of different co-formers.  A similar 
story is observed after the re-clustering analysis of the blue group, Figure Fe8. 
Figure Fe8: Re-clustering of blue group from plate 6 
 
Figure Fe9: Cell display of re-clustering of blue group from plate 6 
 
This data from the dendrogram was cross referenced with the plate format and is 
presented in the table below.   
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Table Fe3: Summary of the clustering viewed from Dendrogram, these have been cross referenced 
with the plate format as shown in Appendix F  * respectively to sample number column 
Group Sample Number Coformer,  
(Composition ratios *) 
Red 14 
53 
4 (2:1) 
13 (2:1) 
Yellow 38,  65 
63 
13 (1:2), (1:1) 
8 (2:1) 
Green 15 6 (1:2) 
Light Blue 89 14 (2:1) 
Blue 26 4 (1:1) 
Pink 62 5 (1:1) 
Stripy Brown 50 5 (2:1) 
 
The 3D MMDS plot shows that there is a strong cluster of two samples from the yellow 
group and a sample from the red group, Figure Fe10.   
Figure Fe10: MMDS plot of re-cluster of blue group from plate 6, highlighted are two spheres 
which cluster close, samples 63 and 65 
 
 Sample 63 and 65 highlighted above in the MMDS has a rank 0.864 and the powder 
patterns of these samples are given below.   
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From this pattern we see that the notable peak could be the reason why these samples 
are clustered with such a high similarity level.  Additionally, these samples consist of 
different staring co-formers.  Sample 63 should have Nicotinamide with co-former 8, 
butanoic acid, with a composition ratio of 2:1 and sample 65 should consist of 
Nicotinamide with co-former 13, pimelic acid, in 1:1 composition ratio.   
Figure Fe11: MMDS plot of re-cluster of blue group from plate 6, highlighted are two spheres 
which cluster close, samples 63 and 14 
 
The red and yellow sample clustered together here, Figure Fe11, are samples 63 and 14 
for which the powder pattern below has been displayed showing the same dominant 
peak, which could possibly be giving the similarity rank of 0.900.   
 
However these samples are of differing carboxylic acid co-formers.  Sample 14 should 
consist of Nicotinamide with co-former 4, 3-nitrobenzoic acid, in a 2:1 composition 
ratio. 
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Appendix G: DSC traces from thermal study as discussed in chapter 6 
Figure 6.4: Summary of the endothermic peaks for A) Isonicotinamide with 3-hydroxybenzoic acid 
and B) Benzamide with 3-hydroxybenzoic acid 
 
 
 
A 
B 
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Figure 6.5: Summary of the endothermic peaks for A) Isonicotinamide with 4-hydroxybenzoic acid 
and B) Benzamide with 4-hydroxybenzoic acid 
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Figure 6.6: Summary of the endothermic peaks for A) Isonicotinamide with 4-nitrobenzoic acid and 
B) Benzamide with 4-nitrobenzoic acid 
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Figure 6.7: Summary of the endothermic peaks for A) Isonicotinamide with Adipic acid and B) 
Benzamide with Adipic acid 
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Figure 6.8: Summary of the endothermic peaks for A) Isonicotinamide with Benzoic acid and B) 
Benzamide with Benzoic 
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Figure 6.9: Summary of the endothermic peaks for A) Isonicotinamide with Cinnamic acid and B) 
Benzamide with Cinnamic acid 
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Figure 6.10: Summary of the endothermic peaks for A) Isonicotinamide with Mandelic acid and B) 
Benzamide with Mandelic Acid 
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Figure 6.11: Summary of the endothermic peaks for A) Isonicotinamide with Fumaric acid and B) 
Benzamide with Fumaric Acid 
 
 
A 
B 
295 
 
Figure 6.12: Summary of the endothermic peaks for A) Isonicotinamide with Glutaric acid and B) 
Benzamide with Glutaric acid 
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Figure 6.13: Summary of the endothermic peaks for A) Isonicotinamide with Succinic acid and B) 
Benzamide with Succinic Acid 
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Figure 6.14: Summary of the endothermic peaks for A) Isonicotinamide with Tartaric acid and B) 
Benzamide with Tartaric acid 
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